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ABSTRACT 
 
Apoptosis plays a crucial role in sculpting the developing central nervous system (CNS) 
but can, under certain conditions, contribute to neurodegeneration in the mature CNS. Metabolic 
disturbances have long been associated with apoptosis-inducing agents, however, the mechanism 
underlying such changes remains controversial. In this study, our hypotheses was that decreased 
ATP turnover may bring about other metabolic changes in apoptotic neurons. Accordingly, 
change in metabolic reactions other than ATP turnover may not be important in the study of 
apoptotic mechanism. In a living cell, metabolic reactions are highly connected and thus are 
highly sensitive to kinetic change in one or more reaction, making analysis of direct kinetic 
change in ATP turnover is experimentally infeasible. For these purposes, a comprehensive 
detailed map of the control distribution in healthy neurons using the metabolic control analysis 
was obtained for the first time. This information was important to distinguish the direct kinetic 
changes caused by the apoptotic stimulus from those occurring indirectly because of changes in 
the levels of key metabolites to which the reactions respond 
Our results showed kinetic inhibition in ATP consumers (ATC) in response to Apoptosis. 
However, and despite the observed kinetic inhibition in ATC, this kinetic change could not fully 
explain the decreased rates of glucose uptake, glycolysis, mitochondrial substrate oxidation and 
mitochondrial phosphorylation. Kinetic stimulation of the oxidative pentose phosphate pathway 
by apoptosis was a major contributor to the decrease in glycolysis, while kinetic inhibition of 
mitochondrial phosphorylation was a major contributor to the decrease in mitochondrial 
iii 
 
substrate oxidation. Direct inhibition of mitochondrial ATP synthesis coupled with direct 
activation of mitochondrial proton leak resulted in the neurons becoming more reliant on 
glycolytic ATP. Direct stimulation of the pentose phosphate pathway as well as proton leak 
could be consequences of increased oxidative stress that is commonly associated with apoptosis. 
These findings didn't prove our initial hypotheses, but implying a directly targeted 
metabolic reactions by apoptotic stimulus. On the other hand, early reactive oxygen species was 
suggested to stimulate oxidative phase of pentose phosphate pathway oxidative phase of pentose 
phosphate pathway  and proton leak rate which were suggested to play an antioxidant role to 
maintain neuronal redox status. Despite kinetic activation of oxidative phase of pentose 
phosphate pathway, glycolysis was stimulated in response to low K stimulus implying a shift of 
the reliance of ATP sources from mitochondrial to glycolytic.  
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CHAPTER 1: APOPTOSIS: PHYSIOLOGICAL 
SIGNIFICANCE, AND MECHANISMS OF 
CONTROL 
1 
 
 
 
A. Significance 
A.0. Introduction 
Apoptosis, the Greek word meaning leaves falling from a tree, was first coined and 
described by Kerr et al, 
1
in 1972 as a controlled mechanism of cell death involved in regulation 
of animal‟s cell population. Apoptosis is one mode of programmed cell death (PCD) 
characterized by morphological and molecular changes including shrinkage of the cell, nuclear 
membrane breakdown, DNA fragmentation and the formation of apoptotic bodies that are small 
membrane-bound vesicles phagocytosed by resident macrophages
2,3
 . In contrast to necrosis, a 
form of cell death due to cellular insult, PCD is not accompanied by an inflammatory response, 
as the cells do not release their contents in the interstitial fluid, and are phagocytosed rabidly by 
the surrounding macrophages
4
 .In contrast, necrosis is typically associated with cell swelling the 
results in loss of membrane integrity and an inflammatory response in the extracellular 
surroundings due to release of the cell‟s contents. Apoptosis is tightly controlled process that 
depends on the activities of a number of pro-and anti- apoptotic proteins that can be affected by a 
diverse array of environmental and physiological factors.  
Apoptosis is beneficial to organisms as it takes place during the embryonic 
developmental stages to eliminate excess cells due to over-proliferation of progenitor cells, and 
throughout the life of mature tissues to eliminate damaged or dysfunctional cells. Aberrant 
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regulation of apoptosis can contribute to pathologies such as neurodegenerative diseases 
(inappropriate apoptosis) and cancer (insufficient apoptosis)
5
.  
Although the interactions of key pro- and anti- apoptotic proteins have been determined, 
the regulatory mechanisms that  affect these interactions remain unclear. Of particular interest is 
the role that glucose metabolism may play in affecting the activities of pro-apoptotitc Bcl-2 
family proteins. Depressed glucose metabolism has long been associated with apoptosis, but it 
remains a matter of speculation if this is a cause or consequence of apoptosis.  
Glucose metabolism could have a causal role in apoptosis because it critically affects the 
cell‟s redox state (by both producing reactive oxygen species (ROS), and producing reducing 
equivalents which protect against ROS), which is known to activate a number of pro-apoptotic 
Bcl-2 proteins.  
To clearly resolve what role, if any, glucose metabolism has, it is first necessary to 
identify the reactions within the pathway that are responsible for the perturbed metabolism, and 
to understand the how the reactions are affected. This information is critical to developing 
rational, focused hypotheses on the molecular mechanism that couple metabolism to apoptosis. 
The goal of this dissertation is to study the cerebellar granule neurons metabolic behavior during 
healthy and apoptotic conditions and to distinguish the metabolic defects that are facilitating 
apoptotic mechanism from those that occur in response to apoptotic stimuli. The information 
from this work is useful for identifying apoptotic targets within the neuronal glucose metabolic 
pathway. This, ultimately, opens the door for therapeutic strategies to many incurable diseases 
caused by unregulated apoptosis and associated with altered cellular metabolism such as cancer 
and neurodegenerative disease. 
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A.1. Physiological relevance of apoptosis to non-neuronal tissues 
In mutli-cellular organisms, the cell community is highly organized and controlled. The 
cell number is not only controlled by the rate of cell division but also by the rate of cell loss. 
Apoptosis is the form of programmed cell death through which billions of cells commit to 
suicide in developing and adult vertebrates. Although it seems wasteful, particularly for healthy 
cells to die, cell death is found to be beneficial for those organisms. Apoptosis occurs as a 
physiological mechanism in embryonic tissues (i.e. establish organs morphology), and in adult 
tissue (i.e. tissue homeostasis, and immune response). It has been identified in the remodeling of 
the arterial wall in animals after birth
6
, and in cultured vascular smooth muscle cells of normal 
humans and rats
7
 . Also, it is involved in establishing the architecture of many body organs such 
as kidney
8
,and hollowing certain ducts in the reproductive system, and mammalian 
gastrointestinal tract
9
. Furthermore, apoptosis is involved in metamorphosis in amphibian and 
insects to remove the unwanted cells in the transition from the amphibian tadpole or in larval 
locomotion (Figure 1-A, A.).Also, it plays a key role in carving out paw digits in many 
vertebrates. (Figure 1-A, B.)
10
. Apoptosis occurs as a repair or a quality control mechanism 
during development that corrects genetic and developmental errors. For instance, the 
mispatterning and outgrowth of drosophila embryos due to impairment inthe anterior 
bicoidmorphogen, is eliminated during the development into normal larvae
11
.In adult animals, 
apoptosis occurs to balance cell division where it maintains organs size (i.e. in adult human 
approximately 10 billion cells are formed per day to compensate cell loss by apoptosis). For 
example, the removal of a part of a rat liver leads to an increase in liver cells proliferation to 
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compensate for the lost cells.  Similarly, treatment of the liver with a cell division stimulator 
(phenobarbital) is usually followed by severe cell loss. This cell loss continues until the liver has 
returned to its normal size. Such balance between the regulation of both cell division and cell 
loss is important in maintaining adult organ size. Moreover, apoptosis can be considered as a 
defense mechanism for certain cell types against viruses and microbes
12
 .It provides a powerful 
tool to reduce viral replication and spread throughout the host cells, by facilitating the cell‟s 
death either through an intracellular or extracellular mechanism (i.e.by activation of cytotoxic T 
lymphocytes). 
 
 
 
 
 
 
 
 
 
A) B) 
Figure 1-A. Physiological apoptosis during development. A) During development of a tadpole into a frog, 
tadpole tail cells undergo apoptosis which results in sequential loss of the tail. B) A human embryo paw stained 
with a dye (in red) specific for apoptotic cells. Death of interdigital cells leads to eventual loss of interdigital 
tissue between developing digits. [Adapted from   
10
] 
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A.2. Physiological relevance of apoptosis to development of neuronal tissue 
           In the developing nervous system, at least half of the original nervous system population 
including neurons, glial cells, and neuronal progenitor cells ,are eliminated
13
.  Several lines of 
evidence indicate that developing neurons die through apoptosis
14,15
.The elimination of 
overproduced immature neurons occurs by two major rounds of apoptosis. The first apoptotic 
period occurs in the ventricular and subventricular zones (where stem cells differentiate into 
neurons and glial cells) before the migration and population of the immature neurons to selected 
regions of the brain and spinal cord 
15
. This apoptotic period has recently been identified but its 
mechanism is poorly understood. The second apoptotic period, the most characterized one, 
includes loss of approximately half of the newly born neurons due to failure to form synapses 
after migration to their final destinations. During this period apoptosis plays a key role in 
sculpting certain brain regions (before and within a few weeks after birth). 
Apoptosis occurs during development of both the central and peripheral nervous systems 
in a time that coincides with the formation of synapses with target cells. The central nervous 
system (CNS) in particular shows great rates of apoptosis in vertebrates during and after birth. 
Apoptosis in the human CNS was first described in 2000 at early embryonic stages 
16
 where the 
apoptotic index was found to be the highest at the first trimester of gestation in the proliferative 
zones (ventricular, subventricular, and ganglionic zones). Occurrence of apoptosis is correlated 
with the distribution and density of some key anti-and pro-apoptotic proteins in different parts of 
nervous system. The anti-apoptotic protein Bcl-2 is highly expressed in the CNS during 
neurogenesis, while it remaines unchanged within the PNS. Regions of CNS undergoing 
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postnatal neurogenesis and differentiation such as the cerebellum, hippocampus, and olfactory 
bulb express high levels of Bcl-2, which may explain the initial survival of excess cells that will 
undergo apoptosis at later stages. Apoptosis in the cerebellum and substantia nigra of mice 
occurs during the second postnatal week while in the cortex it lasts between 15th ED (embryonic 
day) and 14
th
 PD (postnatal day) 
17
. In the thalamus, apoptosis is severe during the first postnatal 
week. High levels of Bcl-2 expression are found in postmitotic granule neurons precursors that 
reside at the outer layer of the developing cerebellum. After differentiation and migration of 
those cells through the internal layer, Bcl-2 expression dropped which parallels formation of 
axons and synapses. The same pattern of Bcl-2 expression is observed in developing cortical 
layers of the forebrain and neurons of olfactory epithelium. Furthermore, the ratio of anti-
apoptotic: pro-apoptotic and estrogen level are found to play key role in regulating  sexually 
dimorphic cell numbers in certain brain areas 
18
. The sexually dimorphic nucleus of preoptic area 
(SDN-POA) is found to be larger in volume with more neurons in early postnatal and developing 
males compared to same age female rats. Whereas, the anteroventral periventricular (AVPV) 
nucleus, another sexually dimorphic nucleus, is larger in females than in males. These findings 
are reversed in adulthood so that the number of cells and size of SDN-POA and AVPV are 
increased in female and male rat respectively
18
.  This pattern of cell loss is accompanied by 
fluctuation in Bcl-2 proteins implying a potential role of BcL-2 in mediating apoptosis during 
development 
16
. On the other hand, in developing and adult PNS,Bcl-2 expression is maintained 
at a invariant level, which may contribute to PNS axon survival and ability for axonal re-growth 
of neurons within the PNS. Studies on transgenic mice, cell cultures and cell lines provide 
supportive evidences for the occurrence of apoptosis in different regions of both developing and 
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adult nervous system. Severe cell loss has been observed in sympathetic neurons, dorsal root 
ganglion neurons, superior cervical ganglion and facial motor neurons in Bcl-2 knockout mice 
19
. 
Deletion of the pro-apoptotic Bax protein from developing neonatal cortex, facial motor neurons, 
and superior cervical ganglion (SCG) neurons is found to support their survival and induce cell 
growth (2.5 fold more SCG neurons and 51% increase in facial motor neurons) 
20
. Knockout of 
the pro-apoptotic caspases-9 in mice results inectopic cellular overgrowth in the forebrain but not 
brainstem and spinal cord due to restricted apoptosis 
21
. Similarly, knockout of the pro-apoptotic 
protein Apaf-1 resulted in cranioschesis and exencephaly
22
. Withdrawal of neurotrophic growth 
factor (NGF) and serum deprivationresulted in apoptosis in cell linesof developing neurons 
including sympathetic neurons,
23
 hippocampal neurons
24
, cortical neurons 
25
and cerebellar 
granule neurons (CGNs)
26
.Furthermore, apoptosis in cell lines of cerebral cortical neurons is 
induced by activation of death receptors (Fas/Apo) 
27
 and/or inactivation of certain survival 
pathways (AKT/PI3K) 
28
. Studies of in vitro neuronal apoptosis not only provide supportive 
evidence about the occurrence of apoptosis during neuronal developmental stages but also clarify 
many causes and mechanisms that facilitate this process. 
A.3. Factors dictating neuronal apoptosis 
A.3.1. Neutrophins 
Neurotrophins, including nerve growth factors (NGF), brain-derived neurotrophic factor 
(BDNF), neurotrophin-3 (NT-3), and neurotrophin-4(NT-4) are paracrine factors produced by 
glial cells as well as peripheral tissues innervating the nervous system and function to prevent 
neuronal PCD. According to the neurotrophic theory
29
, limited availability of neurotrophic 
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factors due to relatively limited production along with an overabundance of immature neurons 
constitutes the major cause of apoptosis during nervous system development. It has been found 
that during the first post neonatal week, sympathetic neurons undergo PCD due to low nerve 
growth factor (NGF) supply
30
. The death rate of dorsal thalamus neurons of wild mice is reduced 
due to increased cortical brain derived neurotrophic factor (BDNF) while it is increased in 
mutant mice (lacking functional BDNF receptors)
31
. There are two major types of neurotrohpins 
receptors differentiated according to their binding affinity: the high affinity tyrosine kinases 
receptors (Trk) A, B, and C; and the low affinity P75 receptors
20
. Three isoforms of the high 
affinity TrK are known to specifically bind to each neurotrophin (i.e. TrK T & A binds to NGF; 
TrK B binds to BDNF and NT-4; TrK C binds to NT-3). The P75 receptors (a cell surface 
glycoprotein) which belong to tumor necrosis factor superfamily, bind with low affinity to each 
of these neurotrohpins. Both TrK and P75 are usually present on the surface of same cell where 
their interplay (which may oppose each other) controls the neuronal response to neurotrophins 
exposure. Interestingly, while TrK receptors induce survival signal transduction that promotes 
cell survival and growth, P75 receptors induce both survival and death signal transduction
20
. 
The death (apoptotic) signaling of P75 is found to be a TrK-independent pathway, 
however, its physiological role remains unclear mainly due to the direct interaction with TrK 
receptors which affects its signaling capacity
32
. On the other hand, the interaction of P75 and 
TrK, which signals neuronal survival and growth, have gained more attention in research during 
the past few years
33,34
. Neurotrophins in many neuronal populations including sensory, motor, 
and cerebellar play a key role in neuronal survival. The development of these populations either 
in vivo or in culture is greatly dependent on the presence of optimal concentration of 
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neurotrohpins
32
. Activation of neurotrophin receptors directly activates the small GTP-binding 
protein Ras which is known to be recruited in neuronal survival
35,36
.As a consequence, activation 
of Ras induces neuronal survival through the recruitment of two major signaling pathways, 
MEK/MAPK and PI-3K/Akt. Survival induced by the Ras-MEK/MAPK pathway is promoted 
via up regulation and/or increased expression of anti-apoptotic Bcl-2 proteins and the 
transcription factor cAMP response element binding protein (CREB). The second survival 
pathway is Ras-PI-3/Akt which accounts for approximately 80% of neutrophin- regulated cell 
survival 
37,38
. This pathway activates and recruits several signaling proteins, of these is the 
serine/threonine kinase Akt (or protein kinase B). In sympathetic neurons, Akt is responsible for 
as much as 80% of NGF-dependent survival 
38
whereas it accounts for approximately 20% of 
neurotrophin dependent survival in cerebellar neurons
39
. Akt regulates neuronal survival through 
phosphorylation and inactivation of direct targets including Bad (a pro-apoptotic protein known 
to inhibit the anti-apoptotic Bcl-2 proteins), pro-caspase-9 (a pro-apoptotic pro-enzyme that is 
activated during apoptosis), and forkhead protein, a pro-apoptotic protein that increases 
transcription of the apoptotic Fas ligand (FasL)
32
. Additionally, Akt induces survival by 
stimulating the influx of Ca 
2+
 through L-type calcium channels in cerebellar neurons
39
, whereas 
it promotes survival of sympathetic neurons by acting downstream both L-type calcium channels 
and Ras-PI3K activation
32
. Activity of calcium channels and level of intracellular calcium are 
directly affecting neuronal energy metabolism (see section C.). This Akt activity is considered as 
a convergence point between signaling pathways(see section B.2.5.) which promote neuronal 
survival on levels of both signaling pathways and neuronal energy metabolism. 
10 
 
A.3.2. Excitatory neurotransmitters 
In addition to neurotrophins, excitatory neurotransmitters are considered as survival 
factors because of their role in affecting the plasma membrane potential and cytoplasmic Ca
2+
 
concentration
40
.Neurons are excitable cells that are highly sensitive to electrochemical changes. 
In the CNS, glutamate, which is the main excitatory neurotransmitter, induces Ca 
2+
influx 
directly by activating glutamate receptors (i.e. α-amino-3-hydroxy-5-methylisoxazole-4-
propionate acid (AMPA) and N-methyl-D-aspartate (NMDA) ) and indirectly by activating 
voltage-dependent and ligand gatedCa
2+
 channels 
41
.The influx of Ca 
2+
is important for the 
process of neurotransmitter release from pre-synaptic terminals and for the postsynaptic neurons 
responses. One of these responses is the change in membrane potential and energy metabolism of 
neurons. Membrane depolarization at high potassium level and electrical stimulation has been 
found to support neuronal survival and development in vitro. Cultured cerebellar granule neurons 
(CGNs) showed PCD upon switching from a non- physiological 25mM (high K) to a 
physiological 5mM extracellular potassium
42,43
. In vitro high K mimics the physiological 
depolarization of CGNs by excitatory neurotransmission (L-glutamate release) from mossy fibers 
during development of the cerebellum(see section C.). Pre-synaptic neurotransmission in vivo as 
well as high K in vitro results in alteration in intracellular calcium level, [Ca
2+
]c, in the post-
synaptic neurons. The [Ca
2+
]c is a dynamic balance between influx rate determined by the 
number of opened Ca
2+
channels, and efflux rate determined by activity of plasma membrane and 
mitochondrial Ca
2+
pumps. Calcium acts as a second messenger that affects a number of survival 
kinases including PI3K-Akt and Ca
2+
- calmodulin dependent kinase (which mediate activity of 
downstream targets such as BcL-2 proteins see section A.3.2). Increased concentration of [Ca
2+
]c 
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stimulates survival kinases (i.e. PI3K-Akt and Ca
2+
- calmodulin dependent kinase) as well as 
promotes CGNs energy metabolism (see section C. ) 
A.3.3. Cellular oxidation-reduction (redox) state 
Oxidative stress due to imbalance between reactive oxygen species (ROS) production and 
anti-oxidant system scavenging constitutes one of the most potent threats to a neuron‟s viability 
that may ultimately leads to apoptosis in developing, adult, and aged cells. Treatment with low 
doses of oxidants such as hydrogen peroxide, redox-active quinones, or tert-butyl-hydroperoxide 
is sufficient to induce apoptosis
44
. In addition to exogenous ROS, intracellular ROS-mediated 
damage accumulated overtime as a byproduct of cellular metabolism especially in post-mitotic, 
non-dividing cells (i.e., neurons, muscle fibers, and cardiac myocytes) is considered an inducer 
of apoptosis. Of particular interest, brain tissue is highly vulnerable to ROS due to its natural 
biochemical composition, exposure to and metabolism of excitatory amino acids and 
neurotransmitters. High content of unsaturated lipids (highly targeted by free radicals), high 
oxygen consumption (brain uses 20% of total body oxygen intake), and high iron content 
increase the brain„s susceptibility to ROS45,46,47.  High levels of ROS particularly in non- 
dividing, post-mitotic excitable cells such as neurons leads to oxidative injury (i.e. damage of 
vital cellular proteins) which facilitates apoptosis and is responsible for many neurodegenerative 
diseases
48
.Oxidative stress may result from high ROS production or disturbance in the cellular 
antioxidant system or both.  
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The Electron transport chain (ETC) within mitochondria constitutes the main source of 
intrinsic ROS as it reduces about 1-2% of total cellular oxygen into superoxide
49
. The produced 
ROS can be released to the cytoplasm through voltage gate anion channels (VADC) located on 
the outer mitochondrial membrane. Strikingly, ETC and other mitochondrial components are the 
main targets of ROS which exacerbate ROS levels, leading to eventual loss of mitochondrial 
integrity and more damage cell-wide
50
. Among ROS susceptible mitochondrial components are 
key metabolic enzymes including complex I (NADH dehydrogenase), complex III (cytochrome c 
oxireductase), complex II (succinate dehydrogenase), aconitase, and α-ketoglutarate 
dehydrogenase (a-KGDH)
51
. Damage to such proteins disturbs their redox status which in turn 
alters matrix NADH/NAD pool leading to perturbed mitochondrial membrane potential (ΔΨm). 
Altered ΔΨm facilitates formation of mitochondrial permeability pore (MMP), a non-selective 
permeabilization of mitochondrial inner membrane that facilitate the release of pro-apoptotic 
proteins into the cytoplasm, which ultimately increase the leak rate of superoxide anions
52,53
. In 
addition to mitochondrial sources, peroxisomes provide another source of ROS especially H2O2. 
Additionally, the redox active metals Fe
2+
 and Cu
2+
 participate in ROS generation through the 
Fenton reaction. The highly active nitric oxide radical (NO
·
) generated by nitric oxide synthase 
isozymes can react with superoxide forming the highly reactive peroxynitrite radical ONOO
-
 
(Figure 3-A). Formation of such free radicals (molecules containing unpaired electron in the 
outer shell) leads to initiation of a chain of reactions which result in damaging the cell‟s 
macromolecules such as DNA, RNA, membrane lipids, and leading to mitochondrial 
dysfunction
54
.   
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Random or inherited mitochondrial mutations increase respiratory complexes defects 
causing increased superoxide leakage. As a result, increased ROS facilitate further mtDNA 
mutations thereby initiating positive feedback loop of ROS production and further mitochondrial 
damage
55. The cell‟s redox status may affect neuronal survival through regulation of apoptotic 
effector proteins including caspases, BcL-2, and cytochrome c(see section B.2.5.).Oxidative 
stress can be due to dysfunction of one or more of cellular antioxidant systems. Cellular 
antioxidant defenses are classified into enzymatic and non-enzymatic systems. The enzymatic 
systems include two distinct superoxide dismutases that catalyze superoxide anion dismutation 
into H2O2. The cytoplasmic dismutase form is a homodimer copper and zinc containing enzyme, 
SOD1 (CuZnSOD), while the mitochondrial form is tetramer manganese containing enzyme, 
SOD2 (MnSOD). Knockout of the mitochondrial form, SOD2, is found to be lethal in mice 
56
whereas, knockout of cytoplasmic form SOD1 induces familial amyotrophic lateral 
sclerosis
57
.The produced H2O2 is further reduced to H2O by the action of catalase enzyme, which 
is located primarily in the peroxisomes. Furthermore, the clearance of H2O2 is catalyzed by 
peroxiredoxin (PRX) enzyme and glutathione peroxidase (GPX).The resulted oxidized form of 
peroxiredoxin is reduced by thioredoxin enzyme (TRX) which is further reduced via thioredoxin 
reductase (TRXR). The reduction of H2O2throughGPX involves the conversion of reduced 
glutathione (GSH) into the oxidized form (GSSG) which can be further reduced to GSH by 
glutathione reductase (GR) catalysis. Both thiol-containing enzymes; TRXR and GR are 
dependent on continual supply of NADPH, a product of pentose phosphate pathway (PPP), to 
maintain the reduced forms of both peroxiredoxin and GSH respectively (Figure 2-A). 
Accordingly, the cellular redox status is tightly maintained by PPP flux which is dependent on 
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glucose-6-phosphate supply, a product of glucose phosphorylation catalyzed by hexokinase 
enzyme
58,59
. 
 
 
 
 
 
 
  
 
The non-enzymatic antioxidants include glutathione (GSH), vitamin E, uric acid, 
ascorbate, α-tocopherol, creatine, arginie, vitamin C, NADPH, and β-carotene. Also, they are 
called antioxidants ROS sequestrants as they inhibit the progression of free radical chain reaction 
and limiting their direct deleterious effect on cell proteins. They neutralize ROS and free radicals 
Figure 2-A. Reactive oxygen species (ROS) production and consumption pathways. Superoxide anion produced in 
peroxisomes by the catalysis of oxidase enzyme which then dismutated by cytoplasmic Cu-Zn-SOD to H2O2. 
Superoxide anion produced in mitochondria due to proton leakage from electron transport chain is released to 
cytoplasm (where it is dismutated by Cu-Zn-SOD) through voltage dependent anion channel (VDAC). Mitochondrial 
O2
-.
can be dismutated by Mn-SOD to H2O2 which further reduced by glutathion peroxidase (GPX). In cytoplasm, 
H2O2can produce another ROS (hydroxyl radical) through Fenton reaction. It can be reduced through enzymatic 
reactions including GPX (involving glutathione (GSH) oxidation) and peroxiredoxin (PRX). Reduced PRX is 
maintained by thioredoxin (TXR) enzyme. Reduced forms of GSH and TXR are maintained by NADPH level 
produced from pentose phosphate pathway (PPP) through which glucose-6-phosphate is oxidized by glucose-6-
phosphate dehydrogenase (G6PDH).     
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in general by either accepting or donating an electron to terminate their unpaired status. The 
resulting unpaired antioxidant is normally less reactive either due to its nature as large structure 
molecule or due to the continual termination of its unpaired status by other antioxidant 
molecules. Antioxidants supplementation to neurons seems to have a neuroprotective effect 
against oxidative damage. Increased endogenous antioxidant, uric acid, is found to prevent 
neuronal damage due to oxidative stress by suppressing the damage effect of oxyradicals and 
maintaining Ca
2+
 homeostasis 
60
. Furthermore, embryonic hippocampus supplemented by 
vitamine E and β-carotene showed protection against oxidative stress due to ethanol exposure 61. 
Other compounds participate in antioxidant system through chelation of transition metals thereby 
reducing the formation of free radicals. For example, transferrin and ferritin are iron-binding 
proteinsthat reduce ROS levels  by iron sequestration 
54
. Other chemical elements such as 
selenium and zinc are necessary for the activity of certain antioxidant enzymes (i.e. peroxides 
and reductase) 
62
.The tripeptide (glu-cys-gly) glutathione (GSH) is the most effective and 
abundant cellular antioxidant that mainly controls and regulates cellular redox state.  Drops in 
cellular GSH pool and parallel high ROS levels during apoptosis have been reported
63
. 
Glutathione is found to inhibit cytochrome c activity(oxidation after its release to cytosol) and 
inhibit apoptosis derived by high ROS in NGF-deprived neurons
64
.The high energy reducing 
equivalent molecule NADPH is one of the main antioxidant molecules that regenerate the 
reduced forms of many defense systems indicating the importance of NADPH in stabilizing the 
cellular level of ROS. In addition to its role in nucleotides biosynthesis, PPP provides an 
important route through which glucose is oxidized into ribose-5-phophate producing NADPH. In 
long–lived post-mitotic cells like neurons, most of the produced NADPH is consumed in the 
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maintenance of the cellular redox status
65
. Inhibition of pentose phosphate pathway (PPP) by 6-
anicotinamide (6-AN)or dehydroepiandrosterone (DHEA) is found to elevate cellular ROS and 
facilitate cytochrome c-mediated apoptosis in neurons 
58
.Furthermore, PPP activity is stimulated 
in response to exogenous ROS in neurons suggesting an anti-oxidant role of PPP 
66
. High 
endogenous ROS due to activation of monoamine oxidase in response to neurotransmitters such 
as dopamine or catecholamie can stimulate PPP activity in synaptosomes
67
.In addition to the 
direct link between cellular metabolism and ROS, the redox status of the cell has a signaling 
effect that mediates the cellular fate (see section B.2.5.)
68
. 
A.3. Physiological relevance to nervous system pathologies 
Neurons, in contrast to other cells of proliferative tissues, exhibit very little regeneration 
over an animal‟s life. This feature is thought to be vital to maintaining neuronal circuits and 
proper brain function. For instance, long-term memories and skeletal muscle function require 
stably maintained neuronal circuits. To date, there is no consensus about which form of cell 
death (apoptosis vs necrosis) predominates during nervous system pathologies as the aging 
nervous system degenerates. Additionally, because apoptosis rapidly occurs (i.e. several hours to 
a day) and apoptotic cells are neatly phagocytosed and removed from tissues this makes it hard 
to identify whether apoptosis or necrosis has occurred in postmortem samples. Also, living 
humans cannot be used in experiments to determine certain biochemical and molecular pathways 
characteristic to apoptosis. Accordingly, studies that provide supporting evidence about 
apoptosis as a mode of cell death during neuronal pathologies use experimental animals and cell 
cultures as models of human pathologies. Age-related degeneration including glutamate 
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excitotoxicity (stroke), traumatic brain injury, and neurodegenerative diseases(ND) are caused by 
both forms of death (apoptosis and necrosis).Nevertheless, studies used post-mortem tissues of 
ND patients, cell culture and animals imply apoptosis is one of the primary forms of cell loss 
during ND. In addition, apoptosis participates in severe cell loss in early-onset forms of 
Alzheimer‟s, Huntington‟s and amyotrophic lateral sclerosis implicating its role in 
neuropathologies
69
. Although apoptosis plays a crucial role in sharpening and patterning 
neuronal circuits during development, it results in loss of function of such circuits when 
deregulated during adulthood. What follows is a discussion on neuronal cell loss by apoptosis in 
different types of neurodegenerative disorders.  
Alzheimer‟s disease (AD) is one of the most pronounced neurodegenerative diseases and 
can occur either sporadically or genetically, with the sporadic form as the most common. 
Selective death of neurons in the hippocampus, neocortex, and forebrain cholinergic system that 
lead to dementia, cognitive, and emotional disturbances, are major characteristics of AD. 
Familial AD, the early onset form, is caused by autosomal dominant inheritance of one or more 
mutations in: amyloid precursor protein (APP), presenilin-1 (PS1) and presenilin-2 (PS2)
70
. 
Cellular inclusions, neurofibrillary tangles resulting from hyperphosphorylated tau protein, and 
extracellular senile plaques of β-amyloid peptide (Aβ) are detected in postmortem samples from 
AD patients. The sporadic form, the most common type, has late onset associated with a lot of 
hallmarks which make it hard to determine the precise mechanism of death in this form. High 
levels of Aβ were detected in mutant APP transgenic mice with higher levels of Aβ deposited in 
the hippocampus and cortex with age
71
. Furthermore, doubly mutated (APP and PS1) transgenic 
mice showed greater Aβ deposits in cerebral cortex and hippocampus. However, several lines of 
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evidence have shown that oxidative stress is critical in the induction of AD by affecting one or 
more signaling pathways in the cell. With aging, oxidative stress is facilitated by imbalance 
between the increased production of ROS and defects in the anti-oxidant machinery. Since 
mitochondria are the main source of ROS, mitochondrial dysfunction in AD patients has long 
been suspected. Key enzymes in citric acid cycle (α-ketoglutarate dehydrogenase and pyruvate 
dehydrogenase complex), complex I, and cytochrome oxidase (terminal enzyme in RC) are the 
most affected
72
.A low percentage of viable mitochondria compared to the number of completely 
damaged ones is observed in AD when compared to a control group at the same age
73
. 
Interestingly, mitochondria are found to be favorable targets for Aβ and APP accumulation in 
both brain slices of AD transgenic mice and cell lines expressing human mutant APP. Strikingly, 
high hydrogen peroxide levels as well as decreased cytochrome c activity has been found to be 
associated with high Aβ when compared to age matched wild type controls74. These findings 
suggest that both familial and sporadic AD may be facilitated by early mitochondrial dysfunction 
and oxidative damage. Accumulation of defective tDNA and decreased mitochondrial enzyme 
activities in muscle, liver, and brain of aged-primates provide supportive evidence for the former 
hypothesis. Mutated mtDNA is found to be selectively accumulated in various cortical regions 
and basal ganglia in aged human brain
75
. Oxidative damage and consequently reduction of 
cellular bioenergetic capacity was found to cause such mutation in mtDNA with age in both 
human and mouse
76
.  
Excessive neuronal death in dopaminergic neurons of nigrostraiatal circuit lead to 
Parkinson‟s disease development (PD) which involves lewy bodies, intracellular inclusions, 
formed due to the accumulation of α-synuclein. Most of PD cases are sporadic; however, some 
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early onset cases include many genetic mutations such as genes encoding α-synuclein, parkin, 
PTEN-induced kinase 1 (PINK1), and DJ-1
77
. Such mutation resulted in mitochondrial 
mutations, protein misfolding, impaired ubiquity-proteasome system and oxidative stress. Some 
of these proteins were found to be important to cell viability such as the mitochondrially 
localized PINK1. The ubiquitin E3 ligase, parkin, is one of the ubiquitin-proteasome systems 
while DJ-1 protein participates in the response of oxidative stress.  
Early mitochondrial dysfunctions due to translocation and accumulation of mutated α-
synuclein into mitochondria which in turn reduces activity of complex I and induces oxidative 
stress have been observed in PD vulnerable brain areas
78
.At different levels of its metabolism, 
dopamine is able to produce various endogenous toxins. At normal pH, dopamine can auto-
oxidized to hydrogen peroxide, superoxide radicals, and dopamine-quinone
79
. Also, it can be 
oxidized by monoamine oxidase (MAO) producing hydrogen peroxide which can be converted 
to highly reactive molecules if not dismutated by SOD enzymes 
80
.Reactive oxygen species are 
main byproducts of impaired complex I function and dopamine metabolism which may explain 
the cellular damage found in most postpartum PD samples. Elevated ROS due to inhibited 
complex I leads to ubiquitin-proteasome system dysfunction and facilitates Lewy body 
accumulation
81
. Furthermore, the interaction between oxidized metabolites of dopamine and α-
synuclein is found to potentiate cell death 
82
. Natural and synthetic environmental chemicals (i.e. 
1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridin, MPTP,  and the pesticide rotenone) are found to 
cause PD and parkinsonism in humans and rodents 
83
. Several lines of evidence suggest that 
oxidative stress is the main cause of the selective neuronal death of dopaminergic neurons due to 
those parkinsonism-inducing toxins. For instance, the plasma membrane dopamine transporter 
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(DAT) in dopaminergic terminals is transporting the active metabolites of MPTP, 1-methyl-4-
phenylpyridinium (MPP+) which inhibit complex II of electron transport chain leading to cell 
death similar to that in sporadic PD patients
84
. Also, MPP+ can selectively transport to 
dopaminergic vesicles due to its high affinity to vesicular monoamine transporter 2 (VMAT2) 
leading to redistribution of dopamine and facilitating dopamine-mediated oxidative stress
85
. The 
pesticide rotenone is known to block complex I activity leading to loss of cultured dopaminergic 
neurons
86
. Anti-oxidants treatment and dopamine depletion partially prevent dopaminergic 
neurons death due to MPP
+
. Interestingly, supplementation with energy preservative to the 
former condition is enough to prevent neuronal death completely indicating that MPP
+
 mediats 
neuronal cell death on two levels (i.e. ROS and mitochondrial bioenergetics)
87
. The selectivity of 
dopminergic neurons loss by ROS-mediated mechanism is rendered to the nature of such cells 
(i.e. large number of mitochondria, observed accumulation of iron in PD patients, accumulation 
of auto-oxidation byproducts of dopamine, and lack of or altered anti-oxidant enzyme 
glutathione peroxidase). Early mitochondrial dysfunction, oxidative stress, and protein 
mishandling seem to be common steps within PD cellular mechanism.  
Mitochondrial defects have been detected in Huntington‟s disease (HD), an autosomal 
dominant disease caused by increased levels of mutated the Huntington gene (Htt), in striatal, 
and cortical neurons. This mutation includes a CAG trinucleotide expansion which encodes a 
protein with long polyglutamine repeats. Polyglutamine repeats accumulate and aggregate as 
cytoplasmic and nuclear inclusions which are facilitating cell death. Extensive cell loss in 
striatum and cerebral cortex results in HD symptoms including impaired cognitive function and 
uncontrolled body movement. Although Htt is distributed in peripheral and central nervous 
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system, the function of both normal and mutated Htt is not fully understood. However, several 
studies suggest a toxic gain of function of the mutated form, resulting in selective degeneration 
in the striatal neurons
88,89
.Disrupted energy metabolism as well as mitochondrial dysfunction 
have been detected in pre-symptomatic HD patients
90
. In the basal ganglia and occipital cortex of 
HD patients, reductions in glucose metabolism as well as elevated lactate production have been 
measured
91
. However, increased lactate production is not found in all pre-symptomatic HD 
patients suggesting an early metabolic alteration before HD actual symptoms. Additionally, 
impaired energy metabolism and elevated ROS which results in mitochondrial dysfunction have 
been observed in cortical pre-symptomatic HD samples. Mitochondrial complex II activity is 
altered in HD patients. Interestingly enough, the pathological hallmarks of HD samples and 
selective degeneration of striatal neurons have been observed in animal models that are 
systemically injected with complex II inhibitor, 3-nitropropionic acid
92
. 
Ischemic stroke (one of the leading cause of disability and death worldwide) is another 
neuropathologic condition that includes severe cell loss. Although necrosis has long been 
considered as the main death form in ischemic stroke, apoptosis occurs in neurons of peri-infract 
zone (ischemic penumbra) after long times (several hours to weeks) of ischemic stroke
93
. The 
onset of ischemic stroke is followed by dramatic reduction of blood flow accompanied by loss of 
energy stores, release and inhibition of reuptake of neurotransmitters, and ionic imbalance 
leading ultimately to necrosis. The ischemic penumbra is a less severe zone that surrounds the 
necrotic core and has been found to possess apoptotic hallmarks including DNA fragmentation, 
caspase activation, expression of pro-apoptotic genes and cytochrome c release. Apoptosis 
through excitotoxicity occurs due to excess glutamate released from necrotic core. Stimulated 
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glutamate receptors, NMDA, promote calcium influx, an event which increases [Ca 
2+
] to the 
limit that induce cell death an event that is found to initiate intracellular activation of pro-
apoptotic proteins and signaling pathways 
94,95
. Loss of cellular energy, due to limited substrates 
(i.e. oxygen and glucose), along with prevention of reuptake excitatory neurotransmitters (by 
pre-synaptic neurons) lead to disrupted ionic homeostasis and compromise membrane 
potential
96,97
. Mitochondrial dysfunction is one of the key steps that facilitates post-stroke 
apoptosis; however, the complete mechanisms have yet to be fully identified. Also, mitochondria 
are recognition sites for pro-apoptotic proteins including Bax, Bad, and Bid that are activated 
upstream of mitochondrial dysfunction. The anti-apoptotic BcL-2 proteins play a key role in 
mediating apoptosis after stroke. Whereas, overexpression of the anti-apoptotic protein BcL-2 or 
administered BcL-xL to wild-type animals leads to stroke resistance in such animals 
98
.High 
mitochondrial ROS either due to various events (i.e. Ca
2+
 overload, excitotoxicity, and hypoxia) 
or lack of function of superoxide dismutase is one of the leading causes of apoptosis in ischemic 
brain injury 
93
.   
Although causes for neurodegenerative diseases seem to be divergent, their pathogenesis 
have a common convergent mechanism including oxidative stress, metabolic defects and 
mitochondrial dysfunction. The goal of my research is to determine the extent to which 
physiological apoptosis alters glucose metabolism and whether or not such metabolic changes 
are a cause or a consequence of apoptosis. 
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B. Apoptosis regulation and cellular mechanism 
The occurrence of apoptosis during development ina wide variety of animals from worms 
to human has supported the fact that it is regulated by an evolutionarily conserved genetic 
program. This genetic program works by turning the activity of specific genes on or off based on 
the prevailing extracellular or intracellular conditions. This program is greatly affected by, and 
tightly linked to, interconnected cellular signaling pathways. There are two distinct apoptotic 
pathways: extrinsic and intrinsic “mitochondrial” pathways. Both pathways converge on a 
common execution step that involves the release of some mitochondrial components (i.e. 
cytochrome c, Smac/DIABLO and endonuclease G) which in turn directly or indirectly cause 
fragmentation of DNA, and degradation of most cellular proteins. Both extrinsic and intrinsic 
pathways have been found to be recruited in neurodegenerative conditions, whereas intrinsic 
pathway is found to be the main mode of cell death during development. 
B.1. Extrinsic pathway 
This pathway is induced via interaction between transmembrane receptors (death 
receptors) and their corresponding ligands. The death receptors are members of tumor necrosis 
factor (TNF) family that share cysteine rich domains. Each member of the TNF family 
hastrimeric or multimeric functional receptor complexes that assemble by formation of disulfide 
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bonds between cysteine domains. The most characterized receptors and their corresponding 
ligands include TNFR1/TNF-α, FasR /FasL, DR3/Apo3L, DR4/Apo2L, DR5/Apo2L. Activation 
of death domain by its corresponding ligand leads to recruitment of receptor associated death 
domain, FADD (Fas receptor associated death domain) or TRADD (TNF receptor associated 
death domain) (Figure 3-A). Apoptosis in developing ratcerebral cortical neurons was found to 
be induced by recruitment of Fas/Apo1L 
99
. Additionally, Fas-induced apoptosis mediated by 
caspase-8 activation in human embryonic primary cultures has been reported
100
. However, 
apoptosis in trophic factors deprived sympathetic neurons and K
+
 deficient CGNs didn‟t include 
Fas-mediated signaling, despite its high expression in these cells. Caspases are aspartate-specific, 
cysteine-dependent proteases that are recruited during many apoptotic mechanisms. Seven 
caspases (four initiators and three executioners) are known to play key role in apoptosis in 
mammals 
101
. Caspase-8 and -10 are considered as initiator caspases that can further activate 
downstream executioner caspases-3,-6, and -7 which in turn initiate a point of no return in the 
extrinsic pathway in many apoptosis conditions 
102
. However, both initiator and executioner 
caspases can be inhibited by inhibitor of apoptosis (IAP) proteins which are in turn controlled by 
mitochondrial proteins(i.e. XAF1 (XIAP-associated factor1), Smac, and Omi (a.k.a HtrA2) that 
are released during apoptosis 
103
. Procaspase-8 is activated when it comes in close proximity to 
the dimerized death effector domain (DED) of receptor associated domains. The assembly of 
these proteins results in death-inducing signaling complex (DISC) formation which induces 
procaspase-8 autocatalytic activation (Figure 3-A). From this point, apoptosis may occur via two 
different paths. First path involves the direct activation and recruitment of caspase-3, -6, and -
7which facilitate the final apoptotic stages including proteolytic digestion of key cellular proteins 
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and DNA
104
. The second path, involves the activation of executioner caspases through a 
mitochondria-mediated rout. This rout started by cleavage of the full length of the pro-apoptotic 
BcL-2 protein, (P22) Bid, by caspases-8. The resulted cleaved Bid (c-terminal (P15) truncated 
Bid (tBid)) translocates to mitochondria leading to cytochrome c release into cytoplasm which in 
turn recruits the mitochondrial “intrinsic” apoptotic pathway105. This pathway considered as a 
cross-talk point between the receptor- mediated extrinsic pathway and the mitochondrial 
“intrinsic” pathway. 
B.2. Intrinsic pathway 
This pathway is recruited by various non-receptor mediated stimuli which affect 
mitochondrial targets (Figure 3-A). The mechanism of action of each stimulus may include 
positive or negative signaling events. Positive signaling events include stimuli such as free 
radicals, toxins, radiation, viral infections, and hypoxia. Whereas, negative stimuli include loss 
of factors that maintain apoptosis suppression such as deprivation of neurotrophic factors, 
cytokines and hormones
4
. The main cellular response to such stimuli is the release of cytochrome 
c from the mitochondrial intermembrane space to the cytoplasm. The released cytochrome c 
triggers formation of wheel like heptameric apoptosomes upon binding to apoptotic protease 
activating factor-1 (Apaf-1).  The apoptosome, a wheel of death, is a 1 MD a heptamer 
composed of seven molecules of each cytochrome c, Apaf-1, procaspase-9, and (d)ATP
106
. The 
apoptosome  
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Figure 3-A.The extrinsic and intrinsic pathways of apoptosis. The extrinsic pathway started by activation of the death 
domain FADD due to ligand/receptor interaction. Close proximity of procaspase-8to activated domains and the 
formation of death-inducing signaling complex lead to its auto-cleavage to caspae-8. Activated caspases-8 further 
activates executioner caspases-3 either directly or indirectly through mitochondria mediated rout. The mitochondria-
meditated route started with pro-apoptotic protein Bid cleavage and activation to tBid which translocates to 
mitochondria. Translocation of tBid facilitates the release of cytochrome c from intermitochndrial space to the cytoplasm 
where it can activate a series of downstream executioner caspases. The intrinsic pathway induced by various stimuli (i.e. 
loss of trophic factors, oxidative stress, DNA damage due to radiation or toxic chemicals). The pathway proceeds by the 
activation of BH-3only proteins which further activate pro-apoptotic BcL-2 proteins, Bax, Bak. Also, BH-3only proteins 
neutralize the activity of the anti-apoptotic proteins leading to formation of the mitochondrial outer membrane pore 
(MOMP) which facilitate the release of cytochrome c protein. The released Cytochrome c further activate the 
executioner caspases-3 which facilitate DNA and cellular proteins fragmentation leading to apoptosis. 
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activates procaspase-9 that  activates executioner caspases that catalyze hydrolysis of cysteinyl-
aspartyl peptide bonds found in many cellular proteins. Forebrain extrusions have been observed 
in Apaf-1, caspase-9, and caspase-3 deficient mice suggesting a crucial role of these apoptosome 
protein components in CNS development
2
. Cytochrome c release occurs upon formation of 
mitochondrial outer membrane pores (MOMP) that are controlled by Bcl-2 proteins. In health 
conditions, cytochrome cis located in the intermembrane space of mitochondria function to 
transfer electrons between complexes III and IV of ETC. The Bcl-2 family proteins are classified 
according to the presence of Bcl-2 homology domains (BH1-4) or according to their function 
into anti-apoptotic proteins and pro-apoptotic proteins (Figure 4-A)
107
. Chemical interaction 
between anti-and pro-apoptotic proteins is found to neutralize their function. 
B.2.1. Pro-apoptotic proteins 
The pro-apoptotic proteins facilitate apoptosis by inactivating anti-apoptotic proteins and 
allowing mitochondrial outer membrane permeability (MOMP) formation that facilitate 
cytochrome c release. Of this group the most characterized proteins are two death effector 
molecules, Bak and Bax that share four BH domains.  In healthy neurons, Bakis a cytosolic 
monomer associated with the cytoplasmic side of mitochondrial outer membrane (MOM), 
whereas, Bax is a cytosolic monomer that translocates to mitochondria upon induction of 
apoptosis where it aggregates, homoligomerizes and permeabilizes the MOM. During apoptosis, 
Bax and Bak are thought to be activated by BH3-only proteins, and undergo conformational 
changes that cause them to oligomerize and form MOMP
108
.Despite many years of research, the 
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exact mechanism through which Bax and Bak are activated during apoptosis as well as the 
molecular content of MOMP and how it is regulated is controversial 
109
. 
 
 
 
 
 
 
 
 
 
 
 Separate from their pro-apoptotic function, Bax and Bak are integrated in cellular 
homeostasis mechanisms. In healthy neurons, Bax and Bak are mediating processes of 
mitochondrial fission and fusion through their effect on mitochondrial tubule dynamics. Such 
processes are critical in regulation of Ca 
2+
 buffering, ATP synthesis, and respiration 
110
. In 
agreement with such findings, studies on non-apoptotic hepatocytes promote the crucial role of 
Figure 4-A. Bcl-2 family proteins. BcL-2 proteins can be classified according to their function into anti-apoptotic 
BcL-2 proteins (proteins that induce cell survival and sharing 4 BcL-2 homology domains (BH)), and pro-
apoptotic proteins (proteins that induce apoptosis). The pro-apoptotic proteins group is further subdivided 
according to BcL-2 homology domain (BH) content into BH3 only proteins (those which containing BH3 domain 
only) and death effector proteins (Bak and Bax, those that are sharing 4 BH domains).   [Adapted from
106
] 
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Bax in regulating mitochondrial bioenergetics 
111
. Furthermore, Bax is reported to regulate 
mitochondrial ROS production in healthy sympathetic neurons 
112
. This involvement of Bax and 
Bak in cellular housekeeping duties suggest critical quality control role if the cellular 
homeostasis is perturbed. 
Either pro-survival or pro-apoptotic, Bax and Bak are directly or indirectly activated by 
other BcL-2 proteins, BH3-only proteins. Activation of BH3-only proteins is linking the signal 
transduction of apoptosis to the formation of MOMP. 
B.2.3. BH3- only proteins 
 These proteins contain only one BcL-2 homology domain, the third domain (BH3), an 
amphipathic helical motif that is found in all Bcl-2 proteins. All identified BH3-only proteins are 
pro-apoptotic i.e. BAD, BID, BIM, BMF, Noxa, and PUMA. Of these proteins, Bid, Bim, Puma 
are critically important for pro-apoptotic Bak and Bax activation, however, their apoptotic effect 
is negligible in the absence of Bax and Bak suggesting that BH3-only proteins working upstream 
to Bax and Bak. In support of this idea, double knock out Bax/Bak cell lines that over-express 
BH3-only proteins survived apoptotic insults when compared to the wild type cells
113
. Although 
some of BH-3 only proteins seem to directly target Bax and Bak, others (i.e. BAD, NOXA, 
BMF, HRK, and BIK/BLK) display a strong preference in binding to anti-apoptotic proteins. For 
example, anti-apoptotic proteins Bcl-2 and Bcl-xL that prevent cytochrome c release from 
intermitochondrial space are neutralized and heterodimerized with Bad 
114
.  
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In the presence of growth factors, phosphorylated Bad (phosphorylation occurs at three 
serine sites; S155, S136, S112) allows docking of the cytoplasmic chaperone molecule14-3-
3which prevent its binding to anti-apoptotic proteins and ultimately prevent cell death. 
Dephosphorylation of one of the serine sites is sufficient to prevent growth-factors mediated 
survival of cerebellar granule neurons 
115
. Additionally, mutated S155 which mimics a 
phosphorylated Bad, mediates protection against apoptosis despite the phosphorylation status of 
S112 and S136, implying a critical role of S155 in Bad apoptotic function
115
.This 
phosphorylation status of Bad is regulated by cellular kinases depending upon the cellular status. 
For example, in presence of growth factor, the survival signaling pathway PI3K is targeting Bad 
at S136 whereas MAPK is targeting Bad at S112 and S155 sites. While in absence of growth 
factors, Bad is targeted by JNK (death signaling pathway belongs to MAPK) which prevents its 
docking to 14-3-3 protein promoting Bad apoptotic function by neutralizing anti-apoptotic 
proteins 
116
. Additionally, other BH3 proteins (i.e. Bim, Bmf) activities are modulated by death 
signaling pathway in response to apoptosis (i.e. UV radiation, oxidative stress)
116,59
. 
In addition to its phosphorylation status, the pro-apoptotic function of Bad can be directly 
regulated by initiator caspases through a mechanism mediated by death receptors activation. 
Similar to Bid response (see section B.1.), cleavage of Bad by activated initiator caspases 
produce truncated Bad which shows high affinity for BcL-xL and mitochondrial membrane 
allowing cytochrome c release 
117
. In addition to its apoptotic function, phosphorylated Bad 
(particularly at S155 site) plays a key role in glucose metabolism in β-cells118. During survival 
conditions, phosphorylated Bad translocates to mitochondria forms a protein complex with 
glucokinase enzyme, which catalyzes glucose phosphorylation and mitochondrial ATP 
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consumption. This complex is dissociated upon dephosphorylation of Bad (i.e. in absence of 
growth factors) which encourages the binding of Bad to the partner anti-apoptotic proteins 
118
.  
Similar to Bad activity, other BH-3 only proteins like Bim exhibit subcellular 
translocation during apoptosis, which is connected to the cytoskeletal component of dynein light 
chain 8(LC8) in healthy conditions. During apoptosis, Bim is dissociated from LC8 and 
translocated to mitochondria where it is suggested to interact with and neutralize the 
corresponding anti-apoptotic BcL-2 proteins
119
.As mentioned previously, Bid is thought to 
trigger oligomerization of Bak that facilitates MOMP during apoptosis 
105
.Noxa has been shown 
to interact with Bcl-2 at the cytosolic side of mitochondria leading to formation of MOMP and 
then activation of caspase-9
107
. Both Noxa and Puma are mediators of P53-induced apoptosis 
which is triggered in response to cellular stress or oncogene activation. Overexpression of Puma, 
in vitro, is shown to be associated with highly expressed Bax that translocates to mitochondria 
which in turn depolarizes leading to cytochrome c release
120
. Many practical and hypothical 
explanations proposed the mechanism through which Bcl-2 proteins interact to commit cell‟s 
fate, however, the exact mechanism remains poorly understood
109,121,109
.  
 B.2.4. Anti-apoptotic proteins 
Anti-apoptotic BcL-2 proteins contain four BcL-2 homology domains (BH1-4) and 
integrated within the outer membrane of some cellular organelles like mitochondria, endoplasmic 
reticulum and nucleus. The most characterized forms are Bcl-2, Bcl-xL, and Bcl-w. The main 
function of anti-apoptotic proteins is to preserve the cellular compartments membrane integrity 
by preventing the formation of MOMP. However, the exact molecular mechanism through which 
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anti-apoptotic proteins achieve this function is controversial. One model (unified model)
122
 
recently proposed both direct and indirect interactions between anti-apoptotic proteins (BcL-2 
and BcL-xL) and pro-apoptotic proteins Bax and Bak. The direct interaction includes direct 
inhibition of pro-apoptotic proteins (Bax and Bak) by anti-apoptotic proteins which explain some 
of the observed phenomena during apoptosis such as prevention of mitochondrial fusion 
122
.In 
healthy cells, Bak and/or Bax is proposed to mediate the process of mitochondria fusion 
123
.However, this mode cannot be applied in healthy cells due to the different subcellular 
compartmentalization of each protein (i.e. Bax is cytosolic)
124
. Most recently 
125,126
, Bax has 
been  proposed to be localized to mitochondria and retro-translocated to the cytosol of healthy 
cells through a BcL-xL-mediated mechanism. This retro-translocation activity of Bax is thought 
to be inhibited after an apoptotic stimulus leading to Bax accumulation on mitochondria which 
facilitating apoptosis progression.  
The indirect interaction (derepression mode), however, includes sequestration of BH3-
only proteins, Bid, Bim, and Puma, that are activating pro-apoptotic proteins. This unified 
mechanism which is the first to relate MOMP formation to mitochondrial dynamics 
(mitochondria tend to stop fusion during apoptosis), proposed that the direct interaction is 
dominant over the indirect one. Other mechanisms (i.e. embedded together, displacement model, 
etc) were evolved before the unified mechanism, that propose either direct or indirect interaction 
between pro-and anti-apoptotic proteins 
127
. The embedded together model, however, assume an 
equilibrium among both modes of interactions where one mode may dominate over the other 
according to the physiological status of the cell
127
.  
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In general, the balance between pro- and anti- apoptotic proteins of the Bcl-2 family and 
their activity status is important in determining the cell fate. The removal of one or more of Bcl-2 
family proteins may affect the cellular decision to commit apoptosis. For instance, in Bax (one of 
Bcl-2 family protein)-deficient sympathetic neurons, the release of cytochrome c is delayed 
following the removal of NGF (and hence delaying the process of apoptosis) implying the role of 
Bax in facilitating the release of cytochrome c 
128
.  In Bcl-XL–deficient mice, severe apoptosis is 
reported in the differentiated postmitotic immature neurons of the spinal cord, dorsal root 
ganglia, and brain, which leads to death of the embryos at day 13 
129
. Significant degeneration of 
sympathetic neurons, dorsal root ganglion neurons, and facial motor neurons have been observed 
in a Bcl-2 -/- mice implying the importance of Bcl-2 for PNS survival 
19
 
In addition to the prevention of pro-apoptotic proteins, anti-apoptotic proteins promote 
cell survival through different mechanisms of action. For example, BcL-xL enhances the 
efficiency of energy metabolism in hippocampal neurons 
130
. This activity was rendered to a 
possible interaction between BcL-xL and the beta subunite of the F0F1 ATP synthase a 
mechanism which may explain the enhanced synaptic metabolism in cells overexpressing BcL-
xL. Furthermore, BcL-xL is suggested to promote metabolites exchange in and out mitochondria 
through a voltage-gated anion channel (VDAC)-mediated mechanism
131
.Interestingly, the anti-
apoptotic proteins have antioxidant activity not only by preventing generation of free radicals but 
also by preventing oxidative damage of cellular components 
132,133
.Also, their anti-apoptotic 
mechanism includes maintenance and organelles sequestration of cellular anti-oxidants such as 
GSH. For example, cellular level of GSH and its nuclear localization is maintained in cells 
overexpressing BcL-2
134,135
.  
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B.2.5. Cellular Signaling pathways 
 Neurotrophic factors deprivation, the major trigger of apoptosis during development, 
inactivates the PI3K/Ak survival pathway as well as cAMP/protein kinase A(PKA) and Ras-
mitogen-activated protein kinase (MAPK) pathways that contribute to suppression of apoptosis. 
The neuronal cell type and survival factor are the major determinants of the type of signaling 
cascade that is recruited. The PI3K/Akt pathway has been found to be central for the survival of 
a wide variety of cell types.  Trophic factors such as NGF, BDNF, and insulin-like growth factor 
1 (ILG-1) bind to their tyrosine kinase receptors leading to activation of PI3K. Also, PI3K can be 
recruited by direct interaction with the proto-oncogene Ras. Active PI3K catalyzes 
phosphorylation of the plasma membrane phosphoinositides producing phospatidylinositol 3,4 
bisphosphate (PI3, 4P) and phosphatidylinositol 3,4,5 trisphosphate (PI3,4,5P)within the inner 
surface of the plasma membrane.Once this happens, the generated phospholipids activate several 
downstream serine/threonine kinases, including Akt. The PI3K/Akt pathway suppresses 
apoptosis in many different ways including transcriptional and post-translational mechanisms. 
The post-translational pathway has been proposed to act upstream and downstream of the release 
of cytochrome c by regulating the activity of Bcl-2 proteins and components of the apoptosome, 
respectively. In the presence of survival factors, Akt phosphorylates and inactivates the pro-
apoptotic protein Bad
136
 (see section B.2.3.). Similarly, removal of survival factors inactivates 
Akt which leads to Bad dephosphorylation, which neutralize the anti-apoptotic protein Bcl-xL, 
thereby preventing its pro-survival effect. GSK-3β, an isoform of the metabolic GSK-3 enzyme 
which negatively regulates glycogen synthase, is one of the downstream substrates of Akt 
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pathways that are activated upon removal of neurotrophins. Active GSK-3β regulates the activity 
of Bax through phosphorylation and facilitates cytochrome c release, which induces the intrinsic 
apoptotic pathway 
137
.Additionally, the Akt pathway can act downstream of cytochrome c 
release; however its substrates which are thought to be components of the apoptosome have yet 
to be identified. Human caspases-9 is an Akt substrate, however, this relationship has not been 
proven in rodent models
115,138
. 
On the transcriptional level, the PI3K-Akt pathway activates expression of genes 
encoding glucose transporter (Glut-4) which promotes cellular glucose uptake
139
.The 
transcription factor NF-kB is one of Akt substrates that is activated in response to survival 
signaling. NF-kB stimulates the transcription of the anti-apoptotic proteins, Mn-SOD, and the 
inhibitors of apoptosis (IAPs) 
140
.This pathway is inactivated upon removal of survival factors.  
Mitogen-activated protein kinase (MAPK) pathway is induced in response to a wide 
variety of cellular stimuli. This may result in diverse cellular activity including growth, 
differentiation and PCD. There are three major pathways included in the mammalian MAPK 
form: P38/MAPK, c-Jun N-terminal kinases/stress-activated protein kinases (JNKs/SAPKs), and 
extracellular signal-regulated kinases (ERKs). In the presence of survival factors, ERK/MAPK is 
activated and mediates the phosphorylation of Bad and the activation of CREB (transcription 
factor that induce anti-apoptotic Bcl-2 proteins transcription)
141
. Collectively, although both 
PI(3)K–Akt and MAP kinase survival pathways seem to be divergent, they are activating the 
same set of some proteins (i.e. BcL-2 proteins) to prevent apoptosis. 
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A shortage of neurotrophins during development as well as elevated ROS activates the 
JNK/SAPK pathway. JNK is one of the mitogen-activated protein kinases (MAPKs) that mediate 
intracellular signaling in response to various cellular activities. JNK induces apoptosis by both 
post-translational and transcriptional modifications. The post-translational modifications by 
activated JNK include phosphorylation of both pro-and anti-apoptotic proteins. The 
transcriptional modifications include upregulation of pro-apoptotic proteins through activation of 
the transcription factor c-Jun(one of the transcription factor activator protein-1(AP-1) family 
members)
116
.Additionally, c-Jun promotes Fas-L expression in motor neurons and CGNs
142,143
. 
 These findings provide evidence for JNKs/c-Jun participation in both intrinsic and 
extrinsic apoptotic pathways. JNK is activated not only due to lack of survival factors but also in 
response to UV radiation, and oxidative stress. P38 pathway is one of MAPK that is activated in 
response to cellular stress, or pro-inflammatory cytokines. Both JNK and P38 pathways have 
been found to be implicated in neurodegenerative diseases including AD and PD supporting the 
role of ROS in apoptosis induction. Studies on different JNK isoforms (JNK1-3 in human and 
murine) in hippocampal neurons provide supportive evidence of the critical role of JNK in 
regulating apoptosis
144
. 
The tumor suppressor gene, P53 plays an important role in regulating cell fate decision 
by promoting gene transcription leading to cell-cycle arrest, or by inducing apoptosis, and 
regulating cell differentiation. DNA damage and/or oxidative stress can activate P53 on both 
transcriptional and post-translational levels 
145
. Furthermore, P53 plays a crucial role in 
mediating apoptosis in developing neurons. During neural development, P53 is found to 
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participate in the clearance process of unwanted neurons that fail either to differentiate from 
progenitor to postmitotic state or to compete for the available neurotrophins. Evidence 
supporting the role of P53 in apoptosis in neuronal development provided by several studies on 
P53-/- mutated mice, showed craniofacial abnormalities, and exencephaly due to neural tissue 
overproduction 
146,147
. In sympathetic neurons, over-expressed P53 is found to be sufficient to 
induce death in presence of NGF 
148
. Interestingly, cultured P53-/- postnatal sympathetic neurons 
are survived in absence of NGF suggesting a crucial role of P53 in controlling cell cycle 
149
. 
However, in a P53-/- transgenic mice, cell death is found to be delayed but not prevented. In 
immature mice cerebellum, P53-mediated apoptosis due to gamma-irradiation but not 
developmental have been reported 
150
. 
P53 promotes apoptosis on both transcriptional and post-translational levels. On the 
transcriptional level, P53 induces expression of pro-apoptotic proteins such as Puma, Noxa, Bid, 
Bad, Bax, and apoptogenic proteins (i.e. cytochrome c andApaf1). Recently, there is a growing 
body of evidence for a post-translational effect of P53 mediated by mitochondrial and metabolic 
changes
145, 151, 152
.The post-translational effect of P53 involves its direct effect on mitochondria. 
The cytoplasmic P53 is translocated to MOM due to stress signaling where it directly interact 
with pro-and anti-apoptotic proteins in a way similar to BH3-only proteins 
145,153
.Such 
interactions consequently facilitate MOMP formation and cytochrome c release. In developing 
sympathetic neurons, P53 lie upstream to Bax activation and is a downstream substrate in 
MAPK/JNK which is activated by P75 neurotrophin receptors in response to neurotrophins 
withdrawal which in turn can be inhibited by active Trk
154
.  
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Oxidative stress (due to increased ROS, impaired anti-oxidant systems or both)not only 
causes oxidative damage of cellular components but also has signaling activity which facilitates 
cell death. Oxidative stress can induce activity of both kinases and phosphatases in different 
signaling pathways. Protein kinases either receptor dependent or independent are sensitive to 
redox status of the cell. The redox sensor, apoptosis-regulating signal kinase 1 (ASK1) which is 
activated in response to oxidative stress initiates the signaling cascade of JNK/Stress-activated 
protein kinases (SAPKs; also called c-un NH2-terminal kinases [JNKs]). In healthy conditions, 
ASK1 is held inactive and sequestered by thioredoxin (TRX) protein which promote ASK1 
ubiquitination
155
. However, this ASK1/TRX complex is dissociated due to redox modification of 
the Cysteine residue in TRX leading to liberation of ASK1 which activate a number of 
downstream kinases 
156
.Active JNK/SAPK inactivates and phosphorylates anti-apoptotic BcL-2 
proteins which facilitate the activation of pro-apoptotic proteins 
157
. Furthermore, the survival 
signaling pathway PI3K/Akt is sensitive to the redox status of the cell. In health conditions, Akt 
phosphorylates and inhibits ASK1 which further prevent stress-induced apoptosis. Modified 
redox status inactivates Akt and other downstream redox sensitive protein kinases 
68
. Activation 
of JNK as well as down-regulation of Akt pathway due to oxidative stress converges on the point 
of activation of pro-apoptotic proteins and inactivation of anti-apoptotic proteins.  
In addition to the signaling transduction, oxidative stress may induce apoptosis by 
directly modulating activity of redox sensitive molecules in the intrinsic or extrinsic pathways. 
One of those molecules is cytochrome c which is released to the cytosol in a mitochondria-
mediated mechanism. Due to its nature as an electron donor/acceptor protein in ETC, 
cytochrome c is highly sensitive to the cell‟s redox status. Oxidative stress induces the 
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peroxidation activity of cytochrome c which oxidizes cardiolipin (a molecule that interacts with 
and stabilizes cytochrome c in intra-mitochondrial space). Oxidized cardiolipin reduces its 
binding affinity to cytochrome c which increase cytochrome c dissociation and release 
68
. 
Cytochrome c release needs mitochondrial outer membrane permeabilization, the latter is 
facilitated in response to diverse array of stimuli including high ROS. Once it is released, 
cytochrome c can induce apoptosis only if it is oxidized. During oxidative stress conditions, the 
released inactive cytochrome c is oxidized and activated facilitating activation of downstream 
apoptotic molecules such as caspases 
158
. Additionally, high endogenous as well as exogenous 
ROS levels may directly or indirectly activate caspases. Caspases activation, a hallmark of 
apoptosis, in response to apoptotic stimuli occurred either through extrinsic or intrinsic pathways 
(see section B.2.). Active caspases involves activation of a series of downstream caspases 
(caspases cascade) which initiating cleavage of vital cellular macromolecules leading ultimately 
to degradation of DNA, and loss of plasma membrane integrity. Caspases are activated indirectly 
due to cytochrome c release or increased expression of FasL which lead to activation of 
caspases-8 upon docking to its receptors. Interestingly, expression of FasL and cytochrome c 
release is mediated by cellular redox status in the cell line of Jurkat T cells.
159
.Direct activation 
of Caspases is due to its sensitivity to redox cellular status which is rendered to the presence of 
the reduced Cysteine at the active site. It has been reported that H2O2introduced at low doses is 
enough to activate caspases and hence induce apoptosis, however, high doses induce oxidative 
inactivation of caspases leading to cell necrosis 
160
. 
Cellular metabolism is directly regulated by survival pathways and hence expected to be 
directly or indirectly targeted by apoptotic signaling. For example, the activation of GSK-3β 
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(mentioned earlier) which is involved in glycogen synthesis in hepatic cells occurs upstream to 
Bax activation during apoptosis. Active GSK-3β (due to absence of growth factors and inactive 
Akt) phosphorylates pyruvate dehydrogenase complex which basically converts pyruvate to 
acetyl-coA (the first step in citric acid cycle) 
161
.Additionally, the pro-apoptotic protein Bad 
which is considered as a convergence point for many signaling pathways, has shown to play an 
important role in the cellular metabolism in presence of growth factors in hepatic
162
 and 
pancreatic cells(see section B.2.3.).Interestingly, glucose metabolism is suggested to be 
controlled by Akt at multiple points through which Bax is controlled 
139,163
.Furthermore, Akt 
promotes glucose metabolism in neurons by inducing GLUT4 translocation to membrane and 
thus facilitating the process of glucose uptake. Glucose metabolism particularly in neurons could 
be one of the earlier events of apoptotic pathway (which expected to facilitate further 
downstream events) mainly due to its role in regulating the neuronal redox status and in energy 
supplementation. Perturbed glucose metabolism in apoptotic neurons (either due to pathological 
or developmental events)has long been determined 
164,58,141,161,165–167
, however, the molecular 
mechanism through which neuronal metabolism may facilitate apoptosis has to be determined.   
B.2.4. Neuronal metabolism and apoptosis 
 Neurons differ from most somatic cells as they mainly depend on glucose as an energy 
source for ATP generation. Neurons of CNS are highly energy demanding cells as they consume 
20% and 25% of the total body oxygen and glucose respectively, while they constitute only 2% 
of the total body weight
168
. The produced energy represented in ATP is required mainly for 
maintenance of ionic gradients and synaptic communication. Cellular ATP is synthesized mainly 
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by mitochondria, the process of oxidative phosphorylation, and by glycolysis, conversion of 
glucose into three carbon sugars. In neurons, mitochondria play a crucial role not only in energy 
production but also in Ca
2+
 buffering, maintaining plasma membrane potential, neurotransmitters 
release and reuptake at synapse, and their transportation through neuronal processes
169
. 
Mitochondrial membrane potential (ΔΨm) is generated due to proton pumping across the 
impermeable mitochondrial inner membrane. The higher proton concentration outside the 
mitochondrial matrix than inside establishes an electrochemical gradient, or the proton motive 
force (ΔP), which drives ATP formation, ATP/ADP exchange, proton leak and regulates the rate 
of mitochondrial substrate oxidation. In addition to its pivotal metabolic role, mitochondria are 
central in apoptosis commitment as they sequester the pro-apoptotic protein, cytochrome c and 
interact with the Bcl-2 protein family. As previously mentioned (Section A.3.), early metabolic 
defects and mitochondrial dysfunction have been found to be associated with inappropriate 
apoptosis in neurodegenerative diseases. Such defects are thought to facilitate or even be 
responsible for neuronal loss by apoptosis or necrosis. Inactivated citric acid cycle enzyme, 
complex I, as well as cytochrome c oxidase (complex IV) in AD cells may be one of the key 
factors that are facilitating neuronal loss
72
. Such inactivation of metabolic enzymes may directly 
perturb energy metabolism and  enhance the production of ROS
164
.  Elevated ROS due to 
inactive complex I in PD may directly affect some other ROS susceptible metabolic enzymes in 
and out mitochondria. Furthermore, the findings that the disruption in energy metabolism is an 
upstream event, which precedes the irreversible apoptotic events in HD are supportive to this 
hypothesis (see section A.3.).  
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In developing neurons, neurotrophin deprivation has been found to be associated with 
early metabolic disturbances, early mitochondrial dysfunction, and increased ROS level
141
. 
Apoptosis in hippocampal neurons triggered by oxidative stress is found to be mediated by the 
aldehydic product of membrane lipid peroxidation, 4-hydroxynonenal (HNE). This type of 
apoptosis is prevented by treatment with GSH and Bcl-2 implying the role of ROS as key 
mediator of cell death
170
. In sympathetic neurons cultures, ROS is suggested to have early 
signaling role in triggering apoptosis rather than a non-specific toxic role.
23,171
. Such signaling 
effect of ROS occurs prior to cytochrome c release. The mitochondrial cytochrome c protein is 
one of the early discovered points at which both cellular metabolism and apoptosis converge. Its 
well defined metabolic function as an electron carrier between the respiratory chain complex III 
and IV is lost during apoptosis. Although the release of cytochrome c is regulated basically by 
BcL-2 proteins, its apoptotic activity (induced right after the release) is even highly dependent on 
the neuronal redox status and hence glucose metabolism 
172,58
.In agreement with these findings, 
tumor cells, with Known up-regulated PPP, are resistant to cytochrome c-mediated apoptosis. 
Both neurons and tumor cells undergo cytochrome c-mediated apoptosis when PPP is inhibited 
by dihydroepiandrosteone (DHEA)
58
. This is implying a crucial role of glucose metabolism 
particularly PPP not only in regulating neuronal redox status but also in regulating the pro-
apoptotic activity of cytochrome c. 
Glycogen synthase kinase-3β (GSK-3β)which phosphorylates and inactivates the 
metabolic enzyme, pyruvate dehydrogenase complex (PDC)
161,165
, is one of the downstream 
substrates in both MAPK and PI (3) K pathways that is activated upon removal of neurotrophins. 
Active GSK-3β regulates the activity of Bax by phosphorylating it and facilitating cytochrome c 
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release which induces the intrinsic apoptotic pathway providing a potential link between 
apoptotic signaling and neuronal energy metabolism
137
. Activation of Bax is suggested to be an 
upstream event of high ROS produced in cytochrome c-mediated apoptosis 
173
. Another link 
between metabolic defects and apoptosis is provided by the pro-apoptotic protein Bad. 
Phosphorylated Bad in response to survival factors and activation of survival kinases (Akt and 
Ras/MAPK) cannot bind to the anti-apoptotic proteins BcL-xL (see secion B.2.3.) allowing cell 
survival. In addition to be targeted by signaling pathways, phosphorylated Bad binds to 
glucokinase (a hexokinase (HK) isozyme, HKIV) in hepatocytes and pancreatic β-cells at its 
BH3 domain revealing a metabolic activity of Bad. The metabolic activity of Bad through the 
association of glucokinase (GK) is critical to maintain mitochondrial respiration and ATP 
production through GK activation
118
. In neurons, hexokinase II (HKII)was recently 
166
 found to 
act as a molecular switch that determines the cell‟s fate according to the metabolic status. 
Interestingly, mitochondrial HKII promotes neuronal survival through a GSK-3β-dependent 
mechanism suggesting another link between neuronal metabolism and apoptosis signaling 
167
.  
Hexokinases are normally bound to the cytosolic side of the MOM at VDAC by an Akt- 
mediated mechanism. Surprisingly, the pro-survival effect of Akt pathway is found to be tightly 
dependent on the activity of the first step in glucose catabolism (conversion of glucose into 
glucose 6 phosphate catalyzed by hexokinase)
174
. The mitochondrial location of HK allows rapid 
access to mitochondrial ATP pool which is transported through VDAC 
175
.This is suggesting a 
tight coupling between the pro-survival signaling and metabolic activity of HK. Consistent with 
these findings, forced dissociation of HK and MOM is found to inhibit the pro-survival activity 
of Akt and induce cytochrome c release and hence, apoptosis
176
. Furthermore, MOM 
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permeability occurs in response to HK and MOM dissociation in Bax and Bak deficient cells 
implying a dual function of HK as a key signaling and metabolic effector. Complementary to the 
role of HK in apoptosis, HK II is highly expressed in rapidly growing tumors that exhibit a high 
rate of anaerobic glycolysis
177,178
. Both cancer cells and healthy neurons show tight control of the 
intracellular redox status through high GSH provided by PPP 
58
. A mechanism proved to prevent 
cytochrome c-mediated apoptosis and hence allowing cancer cell evasion of apoptosis and life-
long survival of neurons 
58
. In addition to Bad, some of anti-apoptotic proteins provide more 
links between apoptosis and metabolism regulation. For example, in healthy neurons, BcL-xL 
interacts with F0F1 ATP synthase and regulates metabolite exchange from and to mitochondria 
(see section B.2.4.). Furthermore, the crucial role of BcL-xL in promoting ATP/ADP 
transportation through VDAC in healthy cells support the hypothesis that Bcl-xL has a metabolic 
function in addition to its ant-apoptotic function. In addition to its role in transporting the 
metabolic solutes in and out the MOM, VDAC regulates the activity of some pro-apoptotic 
proteins (i.e. Bax and Bak)
179,180
 in healthy neurons implying another role of VDAC in 
preventing apoptosis through blocking MOMP-dependent formation. The same dual nature of 
BcL-2 proteins is reported for Noxa, a pro-apoptotic BH-3 only protein. In non-neuronal 
apoptotic cells, the pro-apoptitic function of Noxa is suppressed in presence of high glucose due 
to posttranslational modifications
181
. Strikingly, this protective role of Noxa in presence of high 
glucose is rendered to its ability to promote glucose conversion into ribose-5-phosphate and its 
glycolytic recycling through pentose phosphate pathway (PPP) which generates NADPH and 
prevent oxidative damage by elevated ROS
181, 182
.  
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To date, despite the growing body of evidence of early metabolic alterations in apoptotic 
neurons, the question of which reaction(s) in glucose catabolism is (are)controlling these 
alterations has to be answered. Furthermore, whether this alteration is a cause or a consequence 
of an apoptotic stimulus hasn‟t been confirmed yet. For example, early mitochondrial 
dysfunction has have been observed with reduction in ATP synthesis and basal cell respiration 
rate in potassium/ serum deprived cultured CGNs
26
.This reduction of ATP synthesis was 
rendered to altered utilization of ATP. Both synthesis and utilization of ATP establish the 
cellular ATP level which is maintained in healthy conditions. Accordingly, the cellular ATP 
level is not only a function of its production but also of its utilization. Altered ATP utilization is 
expected to directly affect the rate of glycolysis (glycolytic flux) partly due to the fact that 
glycolysis is one of the cellular sources of ATP. Also, the first step of glycolysis which involves 
utilization of ATP (glucose phosphorylation by HK) is suspected to be a direct target by 
apoptosis signaling that may occur upstream the BcL-2 proteins recruitment. This means that 
altered ATP utilization as well as changes in other metabolic enzymes within the glucose 
catabolic pathway may facilitate and propagate the apoptotic stimulus cell-wide. However, these 
alterations of metabolic sites may superimpose on or be masked by the observed alteration in 
ATP utilization. 
Although the contribution of glycolysis to total ATP production is known (8-12%) which 
cannot explain the reported ATP reduction 
26
, the degree to which glycolysis may exert a control 
over ATP utilization as well as the degree to which glycolysis (and other metabolic reactions) is 
sensitive to early changes in ATP levels has to be determined. Furthermore, whether or not HK 
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and/or other reactions within the glucose catabolic pathway (in addition to altered ATP 
utilization) in CGNs are directly targeted by apoptotic stimulus has to be answered.  
The metabolic changes within the energy metabolism during apoptosis may be due to 
direct post-translational changes resulted in alterations in enzymes kinetics (that may affect their 
catalytic activity (Kcat) or their affinity toward their substrates (Km)), or due to indirect changes 
in metabolites concentrations to which they are sensitive. Accordingly, by taking into account 
the participation and effect of other reactions embedded in the neuronal metabolic flux on the 
glycolytic flux and on the whole catabolic flux, more informative map of the primary sites 
targeted by apoptotic signaling will be obtained.  
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C. CGNs as a model 
Cerebellar granule neurons (CGNs) constitute the most homogenous population of 
neurons in the mammalian brain (~90% of cerebellum neurons)
183
. In the developing cerebellum, 
CGNs are initially located in the outer layer of the cerebellar cortex but then migrate into the 
deepest internal granular layer during development. In general, the developing brain undergoes 
two major steps: 1) neurogenesis followed by migration, and 2) formation of neural circuits and 
synapses
184
. In small rodents as well as humans, development of granular neurons is mostly 
postnatal (Figure 4-A) and starts with neurogenesis and proliferation in the external granular 
layer primarily during the first postnatal week (P0-P7)
185
. By the beginning of the third postnatal 
week (P14) a large pool of immature CGNs exit the cell cycle, differentiate, and migrate to their 
final destination (internal granular layer) where they innervate Purkinje cells, and are in turn 
innervated by mossy fibers terminals originating from brain stem interneurons
184
. A large 
number of immature CGNs undergo apoptosis during their migration to the internal granular 
layer. The process of developmental death precedes the maximal synaptogenesis that takes place 
during the third postnatal week supporting its role in adjusting the number of neurons to the 
available synaptic endings. Primary CGNs cultures are successfully shown to recapitulate such 
cerebellar developmental events and have been advantageously used for over 30 years
186–
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188
.Since then, CGNs have become widely used as the most common in vitro system in all studies 
of neuronal death, whether developmental or pathological.  
CGNs survival in vitro requires the presence of fetal bovine serum (FBS), as a source of 
growth factors, and non-physiological depolarizing levels of K
+
 (25 mM, high K) in the culture 
media
40,42
.  Upon removal of FBS as well as the reduction of potassium concentration to (3.5-
5mM), CGNs show the morphological and biochemical hallmarks of apoptosis such as DNA 
fragmentation, cell shrinkage, chromatin condensation and formation of apoptotic 
bodies
189
.Depolarizing conditions are unnecessary for the first 2-3 days of CGNs culture; 
however, high K is vital beyond 3-4 days in vitro as the neurons are fully differentiated. This is 
consistent with the in vivo invasion of mossy fibers into the internal granular layer and 
establishment of excitatory synapses with the differentiated CGNs. The incidence of apoptotic 
elimination of the differentiated CGNs in vivo closely matches the formation of mossy fiber 
synapses with CGNs
185
. High potassium promotes the opening of the voltage-gated L-type Ca
2+
 
channels by depolarizing the plasma membrane potential (ΔΨp) from ≈ -75 mv (resting potential) 
to ≈ -35 mv and so raises the intracellular Ca2+ concentration ([Ca2+]c)
40
.In low K a decrease in 
respiration occurs which parallels changes in [Ca
2+
]c where the majority of L-type Ca
2+
 channels 
are closed due to hyperpolarized plasma membrane. It has been found that an immediate 
reduction in respiration occurs upon exposure to low K with additive effects of combined 
K/serum removal
26
.The reduction in respiration is mainly affected by [Ca
2+
]c, as lowering 
external [Ca
2+
]e to 0.02mM in high K, a condition that lowers [Ca
2+
]c to mimic that which occurs 
in low K, results in a similar decrease in respiration
26
. 
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The reduction in [Ca
2+
]c results in decreased Ca
2+
-ATPase pumps activity, an important regulator 
in maintaining low [Ca
2+
]c, which in turn affect the cellular ATP level. As mentioned in section 
B.2.4., cellular ATP level is a function of both ATP production and consumption (i.e. through 
Ca
2+
-ATPase pumps). In addition to affecting the cellular level of ATP, [Ca 
2+
]c plays a pivotal 
role in controlling neural metabolism, axon extension and neuronal elimination by apoptosis 
during development
190
.Some of the regulatory enzymes and/or protein kinases in survival 
signaling pathways targeting metabolic enzymes are sensitive to [Ca
2+
]c level as well. For 
example, PI3-K/Akt, P38 MAPK, and calcium calmodulin-dependent signaling pathways 
involved in cell survival and directly regulate certain metabolic enzymes are Ca
2+
-dependent 
Figure. 5-A. Cerebellum developmental stages characterized by metamorphosis in cerebellar circuitry: (a) 1
st
 postnatal 
week, (b) 2
nd
 postnatal week, (c) adult in rodent. (a) During the 1
st
 postnatal week, progenitor cells differentiate to a 
large population of immature CGNs (in blue) in the external granular layer (EGL). In (b) reduced number of 
differentiated CGNs migrate to internal granular layerthrough the molecular layer (ML) and purkinje cell layer 
(orange oval). In (c) mature CGNs receive synaptic inputs from mossy fibers (green lines) and form axons to synapse 
with purkinje cells. [Adapted from 
164] 
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kinases 
191,192
. Furthermore, the neuronal energy metabolism has many [Ca
+2
]c responsive sites 
that may be affected. Mitochondrial metabolic enzymes such as isocitrate dehydrogenase, and α-
keto-glutarate dehydrogenase complex are directly regulated by [Ca
2+
]c whereas, pyruvate 
dehydrogenase complex (PDC) is indirectly affected by Ca
2+
-dependent phosphatases
193,194
. 
Interestingly, these mitochondrial dehydrogenases are critically regulated by the mitochondrial 
levels of ADP/ATP and NAD/NADH suggesting another link between [Ca
2+
]c and cellular ATP 
level. The F0-F1 ATP synthase is also activated by [Ca
2+
]c which strongly correlates the cellular 
bioenergetics to the [Ca
2+
]c level
169
. Low ATP demand,  due to reduced activity of Ca
2+
-ATPase 
pumps, may directly affect the glucose metabolism of CGNs by targeting certain pathways (i.e. 
glycolysis, see section B.2.4.). Additionally, it can indirectly down-regulate the metabolic 
enzymes via changes in their intermediate concentrations. To date, the degree to which each 
mechanism mentioned above contributes to the observed decrease in glycolysis and 
mitochondrial oxidative phosphorylation (approximately by 20% and 40%, 
respectively)
26
remains unclear. 
In addition to K
+
-mediated, Ca
2+
 dependent changes in metabolism, growth factor 
withdrawal may have further effects on metabolism. Growth factors induce activation of receptor 
tyrosin kinase (RTKs) which activate several cellular signaling pathways, most important of 
which are PI3-K/Akt and MAPK. Both pathways include activation of many metabolic enzymes 
(see section B.2.4.). In sympathetic neurons both NGF and KCl synergistically promote Akt 
activity suggesting a cross-talk between NGF and KCl signaling pathways
195
. Interestingly, 
glycolytic flux is targeted by PI-3K/Akt
163,196
 (see section B.2.4.) which may partly explain the 
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measured apoptosis and even cancer-associated flux changes within glycolysis. Glycolytic 
changes, as well as the suspected changes in mitochondrial metabolic enzymes, during apoptosis 
may partly explain the observed alterations in glucose metabolism. However, the extent to which 
each may participate to the observed change is unclear.  
Assuming alterations in ATP demand (due to survival factors/K deprivation) are the only 
direct effect of apoptotic signaling so that changes propagated throughout the metabolic pathway 
are considered as secondary (indirect) changes (i.e. changes in metabolite concentrations) to the 
apoptotic signaling. Such changes in metabolites concentrations may occur in healthy cells 
metabolism. However, activated phosphatases and kinases mentioned above during apoptosis 
(survival factors/K deprivation) are important pieces of the puzzle that are suspected to directly 
target metabolic enzymes in CGNs. The resulted direct changes may be superimposed by the 
indirect ones, those due to changes in intermediates concentration. For this reason, it is critical 
that the changes in flux resulting from kinetic defects are distinguished from those resulting from 
changes in metabolite concentrations (either due to a kinetic defect, or simply to a change in 
ATP demand), which can be considered as secondary effects. The control a reaction has on the 
flux of another reaction within a multi-step pathway (i.e. glycolysis on glucose catabolism), as 
well as the dependence of fluxes on the concentrations of substrates and products, have not been 
considered in studies on the link between apoptosis and metabolism. Metabolic control analysis 
(MCA) is an approach which quantifies the sensitivities of reaction fluxes to small changes in 
substrates and products. By quantifying these sensitivities, it is also possible to determine the 
control a reaction has on the flux through other reactions in the pathway
197
. Application of MCA 
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on CGNs during both health and apoptosis conditions will be used to differentiate early changes 
(primary targets) due to post-translational modifications in metabolic enzymes from those due to 
changes (secondary changes)in intermediates concentrations.  The goal of this work is to identify 
and rank the reactions whose fluxes are altered because of direct kinetic changes after accounting 
for indirect flux changes due to the metabolites after induction of apoptosis in cerebellar granule 
neurons.  
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A. Introduction 
Metabolic control analysis (MCA) is a means of quantitatively understanding the 
behavior of a system through identifying the interactions occurring among the components of the 
system It provides the mathematical and theoretical framework for describing any system at any 
given degree of complexity and architecture. Metabolic control analysis was initially developed 
in the 1970s by two independent groups of Kacser and Burns
1
and Heinrich and Rapoport
2
.  
Application of MCA has changed the old assumption that a single “rate-limiting step” 
determines the flux through a multi-step pathway, to the conclusion that the control of flux is 
distributed among multiple reactions. This was supported by the findings that overexpression 
3
 of 
what were considered rate limiting enzymes within different pathways had marginal effects on 
flux, whereas over-expression of many enzymes within a system leads to many-fold flux 
increment 
4
. These findings lead to the replacement of the intuitive qualitative description of rate 
limiting steps with a quantitative measure of how multiple enzymes contribute to establishing a 
system flux. The main advantage of MCA is that it relates the local behavior of the system‟s 
components (i.e. how enzyme velocities are affected by substrates, products, and allosteric 
effectors) to the global behavior of the whole system (i.e. how changes in the kinetics of an 
enzyme propagate throughout a system to affect pathway flux). The information gained from 
MCA is essential to understanding how an unknown parameter (e.g. an apoptosis trigger) acts to 
perturb a metabolic system. 
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To successfully apply MCA, the system must meet the following criteria: 1) the system is 
a single connected unit (i.e., all the reactions comprising the system must be linked together 
through a common set of metabolites); 2) reaction velocities (i.e., reaction rates) are affected by 
changes in the concentrations of explicit metabolites (those linking the reactions together), but 
not by metabolites which reside within a reaction (a situation which occurs with top-down MCA, 
where a reaction may consists of two or more enzymatic steps that are linked by one or more 
„implicit‟ metabolites; 3) individual reactions interact with one another only through the explicit 
metabolites (i.e. an enzyme affects the rate of another enzyme by altering the concentration of an 
explicit metabolite, and does not affect the rate through effects such as protein-protein 
interactions); 4) the system is at a steady state such that the fluxes and metabolite levels do not 
change over
5
. The variables within a metabolic system are the metabolite concentrations and 
reaction fluxes, both of which can be affected by the parameters of the system (e.g., the amount 
of an enzyme, the kinetics of an enzyme, the temperature, the concentration of a hormone). 
Given a fixed collection of parameters, the concentrations of metabolites are the critical variables 
that establish the system‟s steady state fluxes. 
For a simple pathway (Figure 1-B, A)
6
, composed of two reactions catalyzed by enzymes E1 and 
E2, the source of metabolite X (a parameter) is converted to the variable metabolite M which in 
turn is converted to the sink metabolite Y (a parameter). The steady state of the system is reached 
when the rate of M supply equals the rate of its consumption so that the flux from X to Y is 
constant and the concentration of M is stable. If fluxes E1 and E2 are plotted against the 
concentration of M (Figure 1-B, B), the steady state occurs at the intersection of lines reflecting 
the kinetics of each enzyme to metabolite M.  
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The system‟s variables (concentration of metabolite M, and rates of its production and 
consumption) change (i.e., a new steady-state occurs)when a parameter either internal (e.g., the 
kinetics or amount of E1 or E2) or external (e.g., pH, temperature, availability of  or hormones) 
to the system changes. For example, addition of a specific inhibitor of E1will result in reduction 
of the enzyme‟s velocity (Figure 2). Consequently, the rate of M consumption will exceed the 
rate of its production. This will cause a decrease in the concentration of M, which will lower the 
rate of E2 thereby reducing feedback inhibition of E1 until a new steady-state is achieved. This 
new steady state will be at a new intersection point based on the inhibitor-induced change in 
Figure 1-B. Steady state of a simple metabolic pathway. A, For a two step metabolic pathway catalyzed by enzymes 
E1 and E2, metabolites X and Y are considered parameters external to the system, and thus are considered as infinite 
sources and sinks whose levels remain constant as the system proceeds to the steady-state, as well as after it has 
reached  the steady-state. The first step of the pathway (catalyzed by E1) includes the formation of M metabolite and 
consumption of X. The second step of the pathway (catalyzed by E2) involves consumption of M and production of 
Y. B, The hypothetical kinetics of E1 and E2 to M depicted by the red lines illustrate that E1 is subject to product 
inhibition as M accumulates, while E2 is subject to substrate activation in a Michaelis-Menten-type fashion. The 
steady state is reached at a point in which the rate of M production equals rate of M consumption. 
[Adapted.Brand.J.Exp. Biology. 1997
5
].
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kinetics of E1 (an internal parameter change that can be considered a direct kinetic change to 
e.g., the enzyme's catalytic rate constant), and the metabolite-induced changes in the kinetics of 
both E1 and E2 (a change in a system variable that indirectly changes the enzymes‟ kinetics). 
From this example, it can be seen that a parameter which perturbs a metabolic system does so by 
first directly affecting the kinetics of one or more reactions, and secondly by indirectly affecting 
other reaction fluxes because of the changes in concentrations of metabolites connecting the 
reactions. In this way, reactions sharing a metabolite exert control over each another by affecting 
the concentration of the shared metabolite. A system evolving to a steady-state therefore does so 
through both local enzymatic properties(i.e. the dependence of an enzyme‟s velocity on the 
concentrations of its substrate and product, as well as any other explicit metabolites which have 
allosteric effects), which involve parameters such as Km and Kcat constants that occur 
independent of the system, and global system interactions that are dependent on the system‟s 
structure and variables (i.e. the control that a reaction has on establishing the concentration of 
another reaction‟s substrate , product, or allosteric effector).  
The essential feature of control analysis is to quantitatively describe the enzymatic 
system properties of a multi-step metabolic pathway whose structure and stoichiometric 
relationships are known. With this information, the processes most important in controlling a 
system flux or metabolite concentration can be determined. The use of MCA has significant 
advantages; first, it provides quantitative understanding of the interactions occurring between the 
system components, which provides objective insight into the behavior of the system, and 
second, it provides a means to identify and rank those reactions whose kinetics are directly  
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affected by parameters that perturb the system in ways that are not apparent by inspection of the 
new  state Such advantages are important in identifying enzymes or target sites affected by 
chemical or genetic factors which cause pathophysiological states. This can be done using MCA 
as a tool to extensively characterize how the behavior of a metabolic system in a disease state 
differs from that in a healthy state (e.g., forms of diabetes, cancer and neurodegenerative 
diseases)
7
. For example, a strong association has been found between the high control coefficient 
glucokinase (GK) and a specific form of diabetes (the monogenic diabetes)
8
. This diabetes form 
occurs due to a mutation in a GK allele that results in autosomal dominant inheritance. 
Application of MCA provided insight into how the single mutated GK (with high control 
coefficient) affects the synthesis of hepatic glycogen in monogenic diabetic individuals. 
Figure 2-B. Steady state change due to kinetic inhibition of producer. Progressive addition of an M-producer 
inhibitor causes changes in its kinetic parameters, which are reflected by the parallel lines. Successive new steady 
states evolve that correspond to different intersections of the lines representing the kinetics of the M producer. 
[Adapted.Brand.J.Exp. Biology. 1997 
5
]. 
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Additionally, MCA relates dominance of mutant alleles to the control coefficients of the 
enzymes that they encode 
9
. Furthermore, targeting certain enzymes that exert high control over 
the metabolism of parasites that cause incurable fatal diseases such as trypanosomes (causing 
sleeping sickness) may kill the parasite without threatening the host‟s life (corresponding forms 
of targeted enzymes in host must have low control over human metabolism)
10
. Understanding the 
metabolic nature of cells under certain pathological conditions using MCA could ultimately open 
the door to identify new drug targets. Using MCA, the control structure of a system is 
quantitatively expressed in a few key coefficients which are described below in Sections A.1-
A.3. 
A.1.Concentration control coefficients 
Concentration control coefficients are global features of a system as they measure the 
extent to which each reaction determines the concentration of a specific metabolite M change 
(within the system boundaries) in response to changes in reaction rate (𝐶𝐸1
𝑀 ).  
 𝐶𝐸1
𝑀 =
𝑑𝑀 𝑀 
𝑑𝑉𝐸1 𝑉𝐸1 
 
Where, dV is the change in enzyme velocity VE. According to the summation theorem
11,12
 there 
is no net change in a metabolite concentration in the steady-state, as production and consumption 
are equal. Accordingly, it follows that: 
 𝐶𝐸𝑖
𝑀𝑛
𝑖=1 = 0 
 Where n is the number of reactions within a system. According to the summation theorem, the 
level of metabolite M is affected by all enzymes in the system indicating a positive and negative 
control. 
(1) 
(2) 
70 
 
A.2.Flux control coefficients 
Flux control coefficients are a system feature as they reflect the interactions occurring 
among the reactions within the metabolic network because of their connectedness through the 
explicit metabolites. Flux control coefficients 
13
, previously known as sensitivity coefficients
1
, or 
control strengths 
14
, quantify the extent to which a reaction/ enzyme dictates flux through another 
reaction in the pathway. This concept can be illustrated with the following example of a 
hypothetical, linear series of reactions forming a metabolic pathway. 
 
 
 
 
 In this pathway, assume that X and Y are infinite source and sink metabolites, respectively, such 
that their concentrations do not significantly change, while M and N are the variable metabolites 
explicitly considered.  
Since M is the product of the reaction catalyzed by enzyme E1,but is also the substrate of 
enzyme E2, the concentration of M is partly determined by activities of both E1 and E2. Thus E2 
exerts partial control over the flux through E1 by virtue of E2‟s effect on consuming M, thereby 
relieving feedback inhibition on E1. Reactions that do not share a common metabolite can still 
exert control over their respective fluxes. In this example, E3 consumes N, and so affects the 
extent of product inhibition on E2, which in turn influences the rate of M consumption. Thus, by 
indirectly affecting the concentration of M, E3 exerts some degree of control over the flux 
Scheme 1 
E2  E1 E3 
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through E1. The control that E2 exerts over flux through E1 is quantified as the flux control 
coefficient 𝐶𝐸2
𝐸1: 
𝐶𝐸2
𝐸1 =
𝑑𝐽𝐸1
𝐽𝐸1
 
𝑑𝑉𝐸2
𝑉𝐸2
 
 
From the equation above, the flux control coefficient mathematically equals the fractional 
change in a specific flux (JE1) in response to a fractional change in the velocity of another 
enzyme (VE2). The rate of E2 is denoted V indicating that it has been manipulated by an external 
effector, while, the rate of E1 is denoted J indicating the measured flux rate is a function of the 
changes in metabolite concentrations in the system. Fractional changes are used to make the 
coefficients unitless and dimensionless. It should be emphasized that dJE1 reflects the change in 
flux from the original steady-state to a new steady-state upon addition of an effector (specific for 
E2) that causes an infinitesimally small change in the rate of E2 (dVE2). Flux control coefficients 
are thus valid only around the infinitesimal change in flux from the original steady-state. 
Because of the non-linear nature of enzyme reaction rates as a function of their metabolite 
concentrations, an effector that produces large changes in VE2 (VE2) will cause a proportionally 
different perturbation in JE1 (JE1), and thus a change in the flux control coefficient. In practice, 
flux control coefficients are often approximated by making a perturbation that is sufficiently 
large to produce an experimentally measurable change in flux. 
According to the summation theorem
11,12
, the sum of the flux control coefficients of each of the 
enzymes (E1, E2, and E3) on the flux catalyzed by E1 at a given steady state is unity,  
𝐶𝐸1
𝐸1 + 𝐶𝐸2
𝐸1 + 𝐶𝐸3 
𝐸1 = 1 (4) 
(3) 
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This means that a change in the control that a specific reaction exerts over flux through another 
reaction leads to compensatory changes in the control exerted by one or more reactions within 
the same pathway. If the control coefficient of a specific enzyme were close to one, this would 
indicate that the enzyme is rate limiting while the control coefficient for the other enzymes will 
be close to zero. However, the extensive application of MCA indicates that most pathways do 
not have a rate-limiting enzyme 
15
. This means that most of reactions within a linear pathway 
have values range from 0 to less than 1. However, in the case of pathways containing branches 
(where two reactions compete for the same substrate) and cycles, negative control coefficients 
will occur. 
The global properties of the system, including both concentration and flux control 
coefficients, are dependent primarily on the system‟s status. Indeed, quantitative measurements 
of control coefficients provide valuable information about the distribution of enzymes with the 
highest control over a given flux within a metabolic network. This allows further manipulation of 
such enzymes to control the outcome of the metabolic flux. For example, quantifying flux 
control coefficient was beneficial in studying regulation in many metabolic pathways such as the 
respiration flux, and oxidative phosphorylation in isolated mitochondria 
16
, in vitro identification 
of activities of enzymes isoforms in living Drosophila
17
, and enzymes within the glycolytic 
pathway of in vitro liver extracts
18
.  
Metabolic control analysis relates the overall system properties (global properties) to its 
local properties of its component parts (enzymatic properties). Unlike global properties, the local 
properties are dependent mainly on the kinetic response of each enzyme to each metabolite.  
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A.3. Elasticity coefficients  
The Elasticity coefficient (ε) quantifies the degree to which an enzyme‟s velocity is 
affected by a change in the concentration of a metabolite (substrate, product, or allosteric 
effector), as all other metabolites within the system are held constant. Elasticities are inherent 
features of enzymes, but can be modified by factors such as covalent modification and protein-
protein interactions. Mathematically, the elasticity coefficient is the fractional change in rate of a 
reaction in response to an infinitesimal change in the concentration of a metabolite (dM). 
Accordingly, it is equivalent to the normalized slope of the relationship between an enzyme‟s 
reaction rate and the concentration of the metabolite M (figure 1). For the multistep reaction 
above (Scheme 1) the elasticity of E2 to M is  
𝜀𝑀     
𝐸2 =
𝑑𝑉𝐸2/𝑉𝐸2
𝑑𝑀/𝑀
 
where dV is the change in enzyme velocity (V) resulting from an infinitesimal change (dM) is 
the metabolite M concentration. The values of ε are positive for metabolites that are substrates or 
allosteric activators, while they are negative for metabolites that are products or allosteric 
inhibitors. 
The local properties of a system (i.e. elasticity coefficients) was related to its global 
properties (i.e. flux and concentration control coefficients) through the connectivity theorem
19
. 
The connectivity theorem is one of the most important MCA theories as it provides explanation 
on how local enzymes features (elasticity coefficients) can affect the systemic behavior (flux and 
concentration control coefficients). For example, the flux control coefficient of a specific enzyme 
(5) 
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(i.e. E1 from Scheme 1 above), tends to be relatively small if its elasticity to the pathway 
metabolites (i.e. X and M) is high
13
. This can viewed as an increase in the enzyme E2 activity 
(i.e. due to external stimulator) will cause reduction in substrate X and increase in product M. 
Assuming high elasticity of E2 to X and M, the preceding change in their concentrations will 
compensate for the increased activity of E2. In this sense, the increased activity of E2 due to 
external perturbation will exert a small effect over the steady state flux meaning that E2 has low 
flux control coefficient. Likewise, if E2 elasticity to X and M is low, its flux control coefficient 
will be high. An effect that can be rendered to the low effect (low elasticity) of X and M in 
maintaining the steady state flux of E2. Consequently, E2 has high flux control coefficient. This 
relationship between flux control coefficient and elasticity coefficient was derived by Kacser and 
Burns
1
 as follows 
 𝐶𝑖
𝐽𝜀𝑚
𝑖𝑛
𝑖=1   =0 
Using the bases of summation and connectivity theories, the systemic properties (flux and 
concentration control coefficients) can be determined in terms of the components features 
(elasticity coefficients) for any given system. Reder
20
 has developed proofs of the matrix 
relationships that exist between the elasticity coefficients, concentration control coefficients, and 
flux control coefficients for a system of any complexity, provided that the structure of the system 
and the corresponding stoichiometric relationships between the reactions are known. 
In a more complex metabolic system like CGNs where metabolic pathways consist of 
many reactions, elasticity and flux control coefficients cannot practically be measured for all 
reactions, but can be measured by simplifying the number of explicit reactions considered using 
(6) 
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a top-down approach. Our goal is to quantify the enzymology of blocks of reactions to a limited 
number of metabolites, and the important interactions that occur between the blocks which 
establish the steady-state catabolism of glucose in healthy CGNs using a modified, top-down 
approach to MCA. The information gained will be used to identify how metabolism is perturbed 
in trophic factor derived CGNs. 
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B. Top-down control analysis 
The top-down approach considers the system behavior without having to account for all 
the reactions that are involved in metabolizing glucose. Conversely, the complementary “bottom 
up” analysis explicitly considers every reaction within a metabolic pathway. The top-down 
approach is much favored for MCA application to complex systems having a large number of 
metabolites and enzymes as occurs in intact cells. In the top-down approach, the complexity of a 
system composed of many reactions (enzymatic/ non-enzymatic) that may include feedback 
loops, cycles, and branches can be simplified by grouping such reactions into a relatively small 
numbers of blocks
21,22
. The control distribution among blocks of the system can be calculated 
using the connectivity and summation theorems from elasticity coefficients of such blocks to the 
common metabolites to which they are responding (see Section D). 
Top-down control analysis was first applied by Brand and his group in 1988 on a simple 
system (isolated mitochondria) of two blocks (producers and consumers) interconnected with 
single metabolite (proton motive force)
23
. Years later, producers block of this system (isolated 
mitochondria) was further broken into respiratory chain and phosphorylation blocks to describe 
the control of mitochondrial respiration
24
. More detailed picture of the control pattern of 
mitochondrial respiration has been obtained by further subdividing the respiratory chain block 
into succinate consumers and cytochrome oxidase and considering two intermediates 
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(cytochrome c redox state and proton motive force)
25
. The use of top-down analysis has been 
extended to analyze the energy metabolism in intact cells (i.e. hepatocytes) with limited number 
of blocks and metabolites
26
. Furthermore, it has been advantageously used to study control of 
metabolism in perfused whole organs (i.e. liver, heat)
27,28
.The control of ATP turnover, 
glycolysis, and oxidative phosphorylation have been mapped in hepatocytes where metabolism 
was grouped into 9 blocks connected with 5 explicit metabolites
29
. 
This approach makes the application of control analysis within cells experimentally 
feasible so that the behavior of metabolism within healthy neurons can be described 
quantitatively, and the primary kinetic changes perturbing the metabolism of apoptotic neurons 
can be identified and ranked.  
In the simplest case glucose metabolism can be divided into reactions that produce and 
consume ATP
30
. Since the function of the ATP producers is closely associated with neuronal 
viability, more detailed information about the kinetic state of the producers is desired by 
partitioning them into eleven blocks connected by six explicit metabolites (Figure 3). The 
reactions are grouped so that kinetic information on mitochondrial function (blocks 3, 4, 6, and 
7), on substrate supply to mitochondria (blocks 1, 2, and 11), and on substrate supply for 
antioxidant defenses (blocks 9 and 10) will be obtained. The blocks are grouped similar to the 
model developed by Ainscow and Brand 
29
 for hepatocytes with a few important exceptions due 
to differences in the metabolic nature of each cell. First, the oxidative pentose phosphate 
pathway  and NADPH oxidation blocks are included  because apoptosis in neurons is associated 
with oxidative stress, which has the potential to cause significant glucose consumption through 
this pathway. Second, the non-oxidative pentose phosphate pathway is included as recent 
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evidence indicates that recycling of carbon through this pathway may be substantial, which will 
affect calculation of glycolytic flux as well as the yield of glycolytic ATP. Third, media glucose 
is consumed by neurons, unlike hepatocytes that release glucose into the media from internal 
glycogen stores. Fourth, the transport and subsequent cytoplasmic oxidation of malate from the 
tricarboxylic acid cycle through cytoplasmic malic enzyme is included, as this block serves as an 
alternative source of NADPH for protection against oxidative stress. Additionally, inclusion of 
the malic enzyme block was necessary to account for the 
13
C-lactate labeling pattern (which was 
used to determine non-oxidative pentose phosphate pathway flux) with CGNs consuming 1,2-
13
C 
glucose (See Section B.1.9). 
Our metabolic model fulfills the MCA requirements in that all the blocks (reactions) are 
interconnected by explicit metabolites, so the system is a single interconnected unit. Substrates 
out of the system boundaries (glucose, lactate, and oxygen) change minimally over the 
experimental time frame (See Chapter 3) and thus have little effect on the system. Glucose and 
oxygen are considered as the source substrates while lactate is the sink product (i.e., these are the 
„edge‟ metabolites that are not variables within the system). A second important requirement for 
the analysis to be valid is that the system maintains a steady state. Indeed, cultured CGNs 
triggered to undergo apoptosis by serum/K
+
 deprivation have been shown to maintain a steady 
state in early phases of apoptosis (i.e. respiration rate maintained constant for 3-5 hours before 
cells undergoing apoptosis  
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morphological changes) 
30,31
. The explicit metabolites connecting the blocks, as well as the 
implicit ones within the blocks will change in response to a parameter that perturbs the original 
steady-state, but the implicit metabolites within a block are presumed to not affect the flux 
through other blocks. The system contains 6 explicit metabolites that connect twelve blocks 
together as follows: (1) glucose-6-phosphate (G6P) product of  the glucose transport and 
phosphorylation block and substrate for both the glycolytic and oxidative pentose phosphate 
pathway blocks; (2) pyruvate (Pyr), product of the glycolysis and malic enzyme blocks and 
Figure 3-B. A simplified model of cerebellar granule neurons energy metabolism. Dashed and bold blue arrows refer 
to explicit reaction blocks where Jx denotes the flux occurring through the respective blocks and x is the number of 
the block as follows; 1) glucose transport and phosphorylation; 2) glycolysis; 3) pyruvate oxidation; 4) NADH 
oxidation; 5) lactate production; 6) mitochondrial phosphorylation; 7) proton leak; 8) ATP consumption; 9) 
oxidative pentose phosphate pathway; 10) NADPH oxidation; 11) non-oxidative pentose phosphate pathway; 12) 
malic enzyme. Asterisks refer to explicit metabolites including; glucose-6-phosphate (G6P), pyruvate (Pyr), 
mitochondrial membrane potential (ΔΨm), ATP/ADP ratio, NADH/NAD ratio, and NADPH/NADP ratio. Ribulose-
5-phosphate (R5P) is not considered as an explicit metabolite, as NADPH is the primary product regulating the 
oxidative pentose phosphate pathway. Fructose-6-phosphate (F6P) is not included as an explicit metabolite, but is 
assumed to rapidly equilibrate with G6P to form a single pool of hexose phosphates. 
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substrate for both the lactate production/export and pyruvate oxidation blocks; (3) NADH/NAD 
ratio , product of the glycolysis block, and substrate for both the lactate production/export and 
NADH oxidation blocks; (4) mitochondrial membrane potential (ΔΨm),product of both the 
pyruvate and NADH oxidation blocks, and substrate for both the mitochondrial H
+
 leak and 
oxidative phosphorylation blocks; (5) ATP/ADP ratio, product of the glycolysis, pyruvate 
oxidation, and oxidative phosphorylation blocks, and substrate for both the ATP consumers and 
glucose transport/phosphorylation blocks; and (6) NADPH/NADP ratio, product of the oxidative 
pentose phosphate pathway and malic enzyme blocks, and substrate for the NADPH oxidation 
block. Metabolites shown in Figure 3, but not measured in these experiments are: fructose-6-
phosphate (F6P), ribulose-5-phosphate (R5P), and the triose-phosphates (TrP, including 
glyceraldehyde-3-phosphate and dihydroxyacetone phosphate). Fructose-6-phosphate (F6P) and 
G6P are rapidly interconverted due to the near-equilibrium reaction catalyzed by hexose 
phosphate isomerase
32
; thus, G6P and F6P are assumed to form a single functional hexose 
phosphate pool whose level is reflected by G6P.Ribulose-5-phosphate and NADPH are products 
of the oxidative pentose phosphate pathway, but NADPH is considered to exert most, if not all, 
of the feedback inhibition through effects on glucose-6-phosphate dehydrogenase (the first step 
in PPP)
33
. For this reason, R5P was not measured in this study. However, R5P is substrate for the 
non-oxidative pentose phosphate pathway, and so the inability to assess the elasticity of this 
pathway to its substrate is a limitation of this study, and will introduce some error into the 
elasticities of the non-oxidative pentose phosphate pathway to the explicit metabolites.  The 
triose phosphates were not measured, as these metabolites are not the final products of glycolysis 
and are not known to exert significant allosteric effects on the remaining blocks; these implicit 
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metabolites are shown to indicate the point of entry of carbon from the non-oxidative pentose 
phosphate pathway to glycolysis. Malate, the substrate for the malic enzyme block, was not 
measured, as this block was not originally included in the system. It was only after the 
experiments were performed that it became apparent through mathematical modeling of 
13
C-
lactate labeling that inclusion of this reaction was necessary. Consequently, the loss of 
information on the elasticity of the malic enzyme block to its substrate will introduce errors into 
the elasticities of this block to the explicit metabolites. For this block, the errors introduced are 
expected to be small, as malic enzyme is likely to be regulated primarily by feedback inhibition 
through its products NADPH and pyruvate. In contrast to the unmeasured metabolites shown in 
Figure 3, each of the explicit metabolites is located at critical branch points between the reaction 
blocks and have, in vitro, been shown to be important regulators of glucose metabolism.  
The blocks considered important to glucose metabolism in CGNs include: 1) glucose transport 
and phosphorylation (GTP); 2) glycolysis (GLY); 3) pyruvate oxidation (PYR); 4) NADH 
oxidation (NAO); 5) lactate production and export (LAC); 6) mitochondrial phosphorylation 
(PHO); 7) mitochondrial proton leak (PRL); 8) ATP consumption (ATC); 9) oxidative pentose 
phosphate pathway (OXPPP); 10) NADPH oxidation (NPO); 11) non-oxidative PPP (NonPPP); 
12) mitochondrial export and cytoplasmic decarboxylation of malate by malic enzyme (ME). 
 
 
 
 
 
82 
 
 
 
C. Organization of reactions blocks and their Stoichiometric relationships 
The metabolic system consisting of those reactions involved in the catabolism of glucose 
was simplified into 12 reaction blocks. The organization of each block, and their known 
stoichiometric relationships is detailed below. 
C.1. Glucose uptake/phosphorylation (GTP) 
The GTP block (Fig. 3, J1) includes glucose transport primarily through GLUT-3 
transporters (provide reference) and phosphorylation by hexokinase to G6P. For each glucose 
molecule taken up from the external buffer, one ATP is consumed and one G6P is produced. The 
flux (in glucose units) was measured as the rate of media glucose depletion over 120 min (See 
Chapter III Methods).  
C.2. Glycolytic (GLY) 
The GLY block (Fig. 3, J2) includes the eight reactions from phosphofructokinase to 
pyruvate kinase that produce two pyruvate for each G6P consumed. This block also produces 
three ATP and two reducing equivalents (NADH). The flux in (G6P units) was calculated as one-
half the rate of glycolytic pyruvate production. Glycolytic pyruvate production was calculated as 
the difference between the total rate of LAC and PYR fluxes (i.e. J3+J5) and the sum of 
production by the NonPPP and E fluxes (i.e. 1/3(J11+J12)). 
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C.3. Lactate production and export (LAC)  
The LAC block (Fig. 3, J5) includes lactate production from the reduction of pyruvate 
(one lactate produced from one pyruvate with one NADH oxidized) by lactate dehydrogenase 
and lactate export through the plasma membrane by the monocarboxylate transporters. The flux 
(in pyruvate units) was measured as the rate of media lactate accumulation over 120 min (See 
Chapter III Methods). 
C.4. NADH oxidation (NAO)  
This block (Fig. 4, J4) includes the malate-aspartate shuttle reactions that transfer 
glycolytic NADH from the cytosol to the mitochondrial matrix where the redox reactions of 
respiratory chain take place. For each NADH oxidized by complex I of the respiratory chain, ten 
H
+
 are translocated to the intermembrane space (thus generating m). However, since the 
uptake of glutamate into the matrix in exchange for the efflux of aspartate from the matrix is 
coupled with the influx of one H
+
, the NAO results in the net transport of nine H
+ 
and 
consumption of one oxygen atom from the oxidation of one NADH. It was assumed that the 
NADH not oxidized by lactate dehydrogenase in the cytosol was oxidized strictly by the NAO 
block. Thus, this flux was calculated as the difference between mitochondrial respiration rate and 
5 x PYR flux (where PYR flux = J3; i.e., J4 = respiration rate – 5J3; See Section C.5). Note that 
this calculation had to agree with mass-balance for NADH: the rate of NADH oxidized by the 
NAO was the difference between the rate of NADH produced which is the sum of 2x GLYflux 
and one-third NonPPP flux (i.e., 2J2 + 1/3J11) and the rate of NADH consumed via the LAC 
block (equal to lactate production). 
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C.5. Pyruvate oxidation (PYR)  
This block (Fig. 3, J3) includes pyruvate transport into the matrix via the 
monocarboxylate transporter oxidation into acetyl CoA, all reactions of the tricarboxylic acid 
cycle, and reactions of the respiratory chain. Each pyruvate oxidized in this way results in the 
transport of forty-six H
+
 to the intermembrane space from the resulting four NADH and one 
FADH2 produced by the TCA cycle. The TCA cycle also produces one GTP by substrate level 
phosphorylation, which was assumed to be converted to ATP by nucleoside diphosphate kinase, 
with the ATP subsequently exported from the matrix by the adenine nucleotide transporter. The 
latter reaction results in the influx of one H
+
 from the intermembrane space to the matrix, so the 
oxidation of one pyruvate results in a net yield of forty-five H
+
 transported (thus generating 
m) and the synthesis of one cytoplasmic ATP for five oxygen atoms consumed. This flux (in 
pyruvate unite) was optimized within a mathematical model that exploited the solver function of 
Microsoft Excel (see Table 1). This optimization was based on the stoichiometric constraint 
between respiration rate and PYR/NADH, and the malic enzyme rate using the stoichiometry of 
oxygen consumed by each block (i.e. five oxygen atoms are consumed for each pyruvate 
oxidized by PYR, and one oxygen atom is consumed for each NADH oxidized by NAP such that 
respiration rate=5J3+J4).  
C.6. Mitochondrial phosphorylation (PHO)  
The PHO block (Fig. 3, J6) includes the phosphorylation of matrix ADP catalyzed by 
ATP synthase, and the exchange of matrix ATP with cytoplasmic ADP and Pi through the 
phosphate and adenine nucleotide transporters. Recent evidence
34
 indicates that 2.7 H
+
 are 
required for the synthesis of each ATP by ATP synthase, and another H
+
 is required for its export 
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to the cytosol, thus resulting in a stoichiometry of 3.7 H
+
 used per ATP produced. The flux 
calculation depends on knowledge of the H
+
 leak rate, as this must be subtracted for total rate of 
H
+
 returning to the matrix to assess H
+
 used for ATP synthesis. Cell respiration (RC) can be 
divided into the non-mitochondrial (Rnm) and mitochondrial (Rm) reactions, the latter of which 
can be further divided into that used for ATP synthesis (RATP) and for (RL) H
+
 leak. Accordingly, 
RATP is calculated as Rm-RL. The stoichiometry between oxygen consumed for pyruvate and 
NADH oxidation and H
+ 
produced (9.0 for pyruvate and NADH) was used to convert the rates 
into ATP units (see Sections C.4 and C.5).   
C.7. H
+ 
leak (PRL)  
The PRL block (Fig. 3, J7) involves all routes that allow H
+
 return to the matrix without 
ATP synthesis (resulting in heat as the product). In principle, the leak rate in oligomycin treated 
CGNs is equal to the rate of H
+
 pumping, which can be determined as product of mitochondrial 
respiration rate and the known stoichiometry of H
+
 pumped for each pyruvate and NADH 
oxidized by the respective blocks. However, inhibition of ATP-synthase (by oligomycin) 
perturbs the steady-state due to reducing H
+
 re-entry into the matrix via ATP-synthase. The 
resulting imbalance causes ΔΨm to increase and so leak flux increases, as the leak rate is strongly 
dependent on the magnitude of m. The leak rate can be determined at lower ΔΨm (equal to 
that of the original steady-state) by titrating the respiratory chain with an inhibitor (myxothiazol) 
that produces successive new steady states
35
. The elasticities of the H
+
 leak block to the explicit 
intermediates other than ΔΨm are assumed to be zero since oligomycin will perturb the levels of 
the other explicit metabolites in the system. The determined leak flux/ ΔΨm relationship in 
25K/FBS was used to calculate the leak flux for all modulations (excluding FCCP) once the ΔΨm 
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for each modulation has been measured. In the case of FCCP and 3.5K (apoptotic cells), the 
leak/ΔΨm relationship was re-measured (i.e. the H
+
 leak kinetics were determined by titration 
with myxothiazol). 
C.8. ATP consumers(ATC)  
At any steady-state, ATP consumption rate (Fig. 3, J8) equals the ATP synthesis rate, 
where the rate of ATP production is the sum of ATP produced from the GLY,PHO, PYR, and 
NonPPP blocks. The rates of ATP synthesis by these blocks were calculated from the known 
stoichiometries: three ATP are produced for each G6P consumed by GLY; one ATP is produced 
for each pyruvate oxidized by PYR; 0.272 ATP are produced for each H
+ 
consumed by the PHO 
block; and 0.67 ATP are produced for each R5P consumed by the NonPPP. Note that the GTP 
block consumes one ATP per G6P produced, but this block is not included as part of the ATP 
consumers. Consequently, ATP consumer flux was calculated as the difference between the rate 
of ATP synthesis by all blocks and its rate of consumption by the GTP block. 
C.9. Fluxes modeled from analysis of 
13
C-lactate labeling with CGNs 
catabolizing 1,2
13
C-glucose 
A mathematical model was developed to determine OxPPP, NonPPP, and ME fluxes 
from the measured fluxes through GTP, LAC, and the combined PYR/NAO (i.e., respiration 
rate), and the measured 
13
C lactate labeling pattern from CGNs metabolizing1,2
13
C glucose. The 
model was developed based on the theoretical pyruvate (and thus lactate) labeling pattern as 1,2 
13
C glucose is processed through GLY, the OxPPP, the NonPPP, and further through the TCA 
cycle of the PYR block, and the ME block. From analysis of the carbon atom transitions and the 
recycling of carbons in the PPP, the processing of 1,2
13
C-glucose through the OxPPP and 
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NonPPP will produce eight differentially labeled hexose phosphates (i.e., 
13
C at positions 1, 2, 3, 
1,2, 1,3, 2,3, 1,2,3, and unlabeled) of variable fractional amounts; thus, eight differentially 
labeled pyruvates of variable abundance are produced when these hexose phosphates are 
subsequently processed through glycolysis. By contrast, the processing of 1,2
13
C-glucose strictly 
through glycolysis produces a constant 0.5 fractional amount of unlabeled pyruvate and 2,3 
13
C 
pyruvate. From analysis of the carbon atom transitions in the TCA cycle, sixteen differentially 
labeled malates will be generated, which will generate eight differentially labeled pyruvates 
when processed by ME. These carbon atom transitions were used to establish a model in which 
the solver function of Microsoft Excel optimized two flux ratios (Table 1). These ratios reflect 
the contributions of (a) the NonPPP block to the steady-state labeling of the hexose phosphate 
pool (Ratio 1) and (b) the ME block to labeling of the pyruvate pool (Ratio 2). The ratios were 
optimized so that the 
13
C lactate labeling pattern calculated by the mathematical model agreed 
with the observed 
13
C lactate labeling pattern. 
C.9.1. Non-oxidative pentose phosphate pathway (NonPPP) 
This block (Figure 3-B, J11) is organized in a way that differs from the standard NonPPP, 
as it shares some reactions that are found within the GLY block (similar to the PYR and NAO 
blocks that share reactions of the respiratory chain). It includes the reactions (a) that interconvert 
the pentose phosphates (ribulose-5-phosphate isomerase and ribulose-5-phosphate epimerase),(b) 
that link the pentose phosphates to glycolysis (transketolase and transaldolase) via F6P and TrP, 
and (c) that convert the TrP generated by this block to pyruvate (i.e., the last five enzymes of 
glycolysis are also included in the NonPPP). Since the TrP were not considered as an explicit 
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metabolite, it was necessary to group some of the glycolytic enzymes into the NonPPP, so that 
the resultant pyruvate, NADH, and ATP arising from these TrP were accounted for in the flux 
calculations. Thus, the consumption of three R5P yields two F6P, two ATP, one NADH, and one 
pyruvate (the latter three products resulting from one TrP processed in glycolysis). In this 
respect, the rate of ATP, NADH, and pyruvate production by glycolysis (J2) does not include that 
generated from the glycolytic processing of TrP derived from the NonPPP.  
Table 1-B. Flux parameters optimized by the solver function of Microsoft Excel. Parameter 1 reflects the 
contribution of the NonPPP (J11) and the GTP (J1)to the total 
13
C labeling pattern of the hexose phosphate pool (G6P 
+ F6P). Parameter 2 reflects the contribution of ME (J12) and GLY (J2) to the total 
13
C labeling pattern of the 
pyruvate pool. Measurement of LAC flux (J5) is necessary to calculate J12.Parameter 3 is the contribution of the PYR 
block (J3), and thus the NAO block (J4) to mitochondrial respiration, with the constraint that the PYR consumes 
five-times more oxygen per substrate oxidized than does the NAO. 
 
Solver-optimized 
parameter Purpose 
𝐽11
(𝐽11 + 𝐽1)
    (1) 
This ratio was used to determine the probability of the nine different hexose 
phosphates reacting in the PPP, which in turn was necessary to calculate the 
labeling pattern of F6Ps produced by the PPP. Once optimized, this ratio was 
used to calculate J11since J1was measured. 
𝐽12
(𝐽12 + 2 ∗ 𝐽2)
    (2) 
This ratio was used to calculate the contribution of ME flux to labeling of the 
pyruvate pool. The carbon atom transitions were assessed through four turns of 
the TCA cycle to yield a predicted malate 
13
C labeling pattern. Once the ratio 
was optimized by the solver, it was used to calculate J12, given that J12 + 2*J2 = 
J3 + J5.  
𝐽3   (3) 
This flux was optimized within the stoichiometric and flux constraints that 
mitochondrial respiration rate = 5*J3 + J4 and J3 J4. 
 
 
The reactions traditionally defining the NonPPP (i.e., those within items (a) and (b) of the 
previous paragraph) are near equilibrium and thus reversible depending on the prevailing 
conditions within the cell. For this study, it was assumed that the flux through these reactions 
was unidirectional towards the production of F6P and TrP. This assumption is based on studies 
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of cortical neurons demonstrating net lactate production from hexose phosphates derived from 
the PPP 
36,37
or extensive recycling of R5P into the hexose phosphate pool
38
.The unidirectional 
assumption also seems logical from the perspective that neurons are terminally differentiated and 
so have a relatively low R5P requirement for nucleotide biosynthesis, but are more critically 
dependent on PPP-derived NADPH to protect against oxidative stress
36
. Thus, R5P in excess of 
that needed for nucleotide synthesis is likely produced by the OxPPP, causing the return of these 
carbons to glycolysis. The NonPPP flux was calculated from optimized Ratio 1 (Table 1) and the 
measured GTP flux (J1) as X*J1/(1 – X), where X is the solver-optimized Ratio 1. 
C.9.2. Matrix export and cytoplasmic oxidation of malate by malic enzyme 
(ME) 
This block (Fig. 3, J12) includes the electroneutral exchange of matrix malate with 
cytoplasmic dicarboxylates (e.g., succinate, -ketoglutarate, aspartate) and the oxidative 
decarboxylation of carbon four to produce pyruvate and NADPH. This flux is calculated from 
optimized Ratio 2 (Table X), given that LAC and PYR fluxes (J3 and J5) are known (i.e., J12= X 
* (J3 + J5), where X is the solver-optimized Ratio 2). 
C.9.3. Oxidative pentose phosphate pathway (OxPPP) 
This block (Fig. 3, J9) includes the oxidative decarboxylation of G6P by glucose-6-
phosphate dehydrogenase and 6-phosphogluconate dehydrogenase, . For each G6P oxidized, two 
NADPH and one ribulose-5-phosphate are produced. This flux was calculated as the difference 
between the total rate of hexose-6-phosphate production (J1+2/3*J11) and its consumption by 
GLY (J2) 
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C.9.4.  NADPH oxidation (NPO) 
This block (Fig. 3, J10) includes all reactions consuming NADPH. An important subset of 
this block is those reactions that contribute to maintenance of the cellular redox state via 
reduction of oxidized thiols and removal of reactive oxygen species. Protein thiols are 
susceptible to oxidation by a number of reaction oxygen species (ROS). Thioredoxin and 
glutaredoxin catalyze the reduction of a number of these oxidized protein thiols, either through 
electrons donated by internal cys residues (thioredoxin) or by cys residues from glutathione 
(glutaredoxin). Glutathione peroxidase catalyzes the reduction of H2O2 to H2O using electrons 
from glutathione, and so helps protect cells from oxidative stress. The protection afforded by 
these enzymes is only possible if the cys residues are re-reduced so that they can continue to act 
as catalysts. The reduction of glutathione disulfide or thioredoxin disulfide is accomplished by 
glutathione reductase and thioredoxin reductase, respectively. Both of these enzymes use 
NADPH as the electron donor; in this way the NADPH consumers act as a defense against 
oxidative stress. It has been demonstrated
36
 that exogenous addition of an oxidant such as H2O2 
to neurons substantially stimulates OxPPP flux, and so links the NADPH consumers to the 
OxPPP via the NADPH/NADP ratio. The flux is calculated as the sum of twice the OxPPP and 
ME fluxes (i.e., 2J9 + J12). 
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D. Flux control coefficients and elasticity coefficients of the system’s blocks 
Control coefficient and elasticity equations discussed in Section A.2 and A.3.apply 
equally well to blocks of reactions
21
. The control over a process K (where K can be a flux J or a 
metabolite concentration M) by a block is the sum of all control coefficients of the individual 
reactions within that block over process K: 
𝐶𝑏𝑙𝑜𝑐𝑘
𝐾 =  𝐶 𝑖
𝐾𝑛
𝑖=1  
where i is one of n total reactions within the block contains n. 
Similarly, elasticity coefficients for a block having n reactions is the sum of the product of all 
elasticities of each reaction i to the explicit metabolite M and the control each reaction has over 
flux through the block 
21
: 
𝜀𝑀
𝑏𝑙𝑜𝑐𝑘 =  𝐶𝑖
𝑏𝑙𝑜𝑐𝑘 ∙ 𝜀𝑀
𝑖𝑛
𝑖=1  
 
 
 
 
 
 
 
(7) 
(8) 
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E. In situ block elasticities to the intermediates 
When considering a complex system having multiple reactions and metabolites, it is not 
possible to directly determine the elasticity of a reaction to each metabolite given that it is 
impossible to vary one metabolite while holding the others constant. In the past, a double-
modulation method of Kacser and Burns
11
 was used to facilitate analysis of a segment in a 
pathway that results in determining elasticities to the intermediates within the system. The basis 
of that method involved perturbation of the enzymes under investigation by addition of a specific 
inhibitor/activator for each enzyme. The resultant perturbation is dependent on the flux control 
coefficient of the affected enzyme and the distal enzymes that are responsive to changes in the 
intermediates due to their elasticities. This method has been generalized by Giersch
39
into a 
multiple-modulation approach that was applied on a reconstructed enzyme system. However, the 
structural information (stoichiometric relationships) of the system wasn‟t considered. The 
combined use of top-down control analysis and the multiple modulation approach, along with 
complete information about the system‟s structure provide the necessary means to analyze the 
control of metabolism in an intact cell 
40
.  
Top-down control analysis has been used by Ainscow and Brand
29 
for hepatocytes having 
five explicit metabolites. They calculated the elasticities and control coefficients for the reaction 
blocks by applying the multiple modulation approach, which involves perturbing the original 
steady state of a specific block using inhibitors or alternative substrates. A new steady state 
develops each time a modulation is applied, thus yielding a set of equations for each block that 
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can be solved for the unknown elasticities. As an example, consider a block (b) that responds to a 
metabolite M, which will exert a change in the velocity of b (ΔVb) as a result of a finite change 
in M (ΔM). The elasticity of b to M is estimated as 𝜀𝑀
𝑏  
𝜀𝑀
𝑏  ≈  
∆𝑉𝑏
𝑉𝑏
 
∆𝑀
𝑀 
  
 
If the block responds to another metabolite (N), then its elasticity toward a finite change in N 
while holding M constant can be estimated.   
𝜀𝑁
𝑏  ≈  
∆𝑉𝑣
𝑉𝑏
 
∆𝑁
𝑁 
 
If the concentration of (M) and (N) both change, block b flux will be affected according to the 
magnitude of the metabolite changes and the elasticities of b to M and N. Thus, the flux change 
in block b resulting from simultaneous changes in M and N is given by combining equations 10 
and 11 and rearranging: 
 
∆𝐽𝑏
𝐽𝑏
≈
∆𝑀
𝑀
∙  𝜀𝑀
𝑏 + 
∆𝑁
𝑁
∙  𝜀𝑁
𝑏  
The change in rate of b is denoted as a flux (J) rather than velocity (V) to indicate that more than 
one metabolite is changing, as when b is embedded within a larger metabolic pathway. In this 
way the change in velocity of a block (e.g., glycolysis) embedded in a larger system such as 
energy metabolism in situ (Fig. 3) is the sum of changes induced by the 6 explicit intermediates 
(assuming no changes to the kinetics of the block).  
(9) 
(10) 
(11) 
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∆𝐽𝐺𝑙𝑦
𝐽𝐺𝑙𝑦
≈ 𝜀𝑔6𝑝
𝐺𝑙𝑦 ∙
∆𝑔6𝑝
𝑔6𝑝
+ 𝜀𝑃𝑦𝑟
𝐺𝑙𝑦 ∙
∆𝑃𝑦𝑟
𝑃𝑦𝑟
+ 𝜀𝐴𝑇𝑃
𝐴𝐷𝑃
𝐺𝑙𝑦 ∙
∆𝐴𝑇𝑃
𝐴𝐷𝑃 
𝐴𝑇𝑃
𝐴𝐷𝑃 
+ 𝜀𝑁𝐴𝐷𝐻
𝑁𝐴𝐷
𝐺𝑙𝑦 ∙
∆𝑁𝐴𝐷𝐻
𝑁𝐴𝐷 
𝑁𝐴𝐷𝐻
𝑁𝐴𝐷 
+ 𝜀𝑁𝐴𝐷𝑃𝐻
𝑁𝐴𝐷𝑃
𝐺𝑙𝑦 ∙
∆𝑁𝐴𝐷𝑃𝐻
𝑁𝐴𝐷𝑃 
𝑁𝐴𝐷𝑃𝐻
𝑁𝐴𝐷𝑃 
+ 𝜀∆𝜓𝑚
𝐺𝑙𝑦 ∙
Δ(∆𝜑𝑚 )
∆𝜓𝑚
 
The unknown elasticities of each block can be solved from a set of 6 different equations, 
each produced from a modulation that perturbs the original steady state without directly affecting 
the kinetics of the block. The new steady states can be reached by applying different external 
manipulations by using the multiple modulation approach
39
. It is essential to use modulations 
that are highly specific to one or more blocks (i.e. specific inhibitor or alternative substrate) 
whose elasticities are not being measured. A major goal of this research is to perturb the 
metabolism of healthy CGNs in at least six independent ways and to measure the resulting 
changes in the metabolite levels and reaction fluxes. By substituting the measured metabolite 
concentrations and reaction fluxes in equation 6 for each reaction block at each new steady state, 
at least six equations per block will be developed from which the six elasticities can be solved. 
From this analysis, six different elasticities for each block (72 total, since the model contains 12 
blocks), representing the block‟s responsiveness to changes in the six explicit metabolites within 
our CGNs model system, will be determined. Because this method involves making relatively 
large, finite perturbations to the system, while elasticity coefficients are strictly defined for 
infinitesimally small changes, the calculated elasticites are approximations of the true ones. 
The control coefficients for each block can be determined from the elasticities. Since the 
structural features of a multi-step metabolic pathway are necessary for calculations of control 
coefficients,  known values of elasticities, known stoichiometric relationships, and measured 
fluxes are used to calculate control coefficients using Reder‟s linear algebra- based method as 
follows, 
 
(12) 
      S= - (N. dJ
o. ε)-1. N. dJ              (13)                  C = I +  ε.S                      (14) 
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Where S, N, dJ, I, ε, and C are matrices as follows: 
S is 12 column, 6 row concentration control coefficient matrix 
N is 12 column, 6 row matrix of reaction stoichiometries 
dJ is 12 column, 12 row diagonal matrix of the basal fluxes through each block 
ε is 6 column, 12 row elasticities matrix 
I is 12 column, 12 row identity matrix 
C is 12 column, 12 row of flux control coefficient matrix 
The control exerted by a specific block over the flux through other blocks is reflected in a set of 
12 control coefficients (total of 144 coefficients) as there are twelve blocks within the system. 
Also, the control that each block exerts over each explicit metabolites within the system is 
reflected in a set of 6 concentration control coefficients ( total of 72 coefficients) as there are 6 
explicit metabolites affected by the twelve blocks of the system. The control coefficients provide 
extensive quantitative information regarding the metabolic behavior of healthy CGNs. This 
information includes insights into the most important processes controlling mitochondrial 
substrate oxidation and ATP synthesis, reducing equivalent production, glycolysis, and cellular 
glucose uptake. This deep understanding of CGNs metabolic behavior will then be used to 
elucidate the major apoptotic targets within the energy metabolic pathway of CGNs. Also, it can 
be considered as scientific record for further investigation of the effect of chemical treatments 
(i.e. hormones, hypoxia, and low glucose content in blood) on neurons in general.  
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E.1. Modulations to perturb the steady state of the CGNs: 
Nine different modulators with known sites of actions were used to affect the metabolic 
steady state. The fluxes through each block and metabolite concentrations were determined for 
each modulator-treated neurons and healthy neurons. The number of modulations is greater than 
the minimal required theoretical set in order to reduce the error in the calculations of elasticities 
and control coefficients.  
E.1.1. FCCP (0.5 M) 
FCCP is a proton ionophoreuncoupler that dissipates ΔΨm by increasing the rate at which 
protons leak back into the mitochondrial matrix. This modulation directly affects the kinetics of 
the proton leak block, so the data obtained from this modulation cannot be used to calculate the 
elasticity of the H
+
 leak block to m. The metabolite most immediately affected is ΔΨm, which 
is predicted to decrease. 
E.1.2. Oligomycin (10ng/ml with reduced extracellular Ca
2+
) 
Oligomycin directly affects the kinetics of the mitochondrial phosphorylation block via 
inhibition of the Fo proton channel subunit of the ATP synthase. CGNs do not survive for 
extended periods with oligomycin, as glycolysis is insufficient to provide ATP at a rate sufficient 
to meet the demand. Consequently, [Ca
+2
]e was reduced from 1.3 mM to 25µM. This has the 
effect of reducing ATP demand by lowering Ca
+2
-ATPase activity. Under these conditions of 
lower ATP demand, neurons survive in the presence of oligomycin. Because this modulation 
directly affects both the ATC and PHO blocks, the data obtained from this modulation cannot be 
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used to calculate the elasticities of these blocks to the metabolites. The metabolites most 
immediately affected are ΔΨm (increase) and ATP/ADP (decrease). 
E.1.3. Low glucose (0.4 mM) 
Under normal conditions the incubation buffer contains a saturating concentration of 
glucose (10 mM). CGNs primarily express Glut-3 and 4 transporters with a Km for glucose of 1-
3 mM, so the transport rate should not be limited by the media glucose concentration (and thus is 
considered an infinite source whose level does not change sufficiently to affect the GLUT-
mediated transport rate). Reduction in media glucose concentration to 0.4 mM should 
significantly impede glucose transport, and thus will directly affect the kinetics of the GTP block 
(in this case glucose is not an infinite source, but a restricted source which does affect GTP 
kinetics). The data obtained from this modulation cannot be used to calculate the elasticities of 
GTP block to the metabolites. The metabolite most immediately affected is G6P, which is 
predicted to decrease. 
E.1.4. Lactate (2 mM) 
Under normal conditions there is no exogenous lactate added to the media. The addition 
of exogenous lactate affects the kinetics of the lactate production and export block by making 
transport across the plasma membrane less favorable. The data obtained from this modulation 
cannot be used to calculate the elasticities of the lactate block to the metabolites. The metabolites 
most immediately affected are pyruvate (increase) and NADH/NAD (increase). 
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E.1.5. Trans-androsterone (50 μM) 
Trans-androsterone is a competitive inhibitor of the PPP enzyme, glucose-6-phosphate 
dehydrogenase (G6PDH)
41
and therefore directly affects the kinetics of the Ox-PPP block. The 
data obtained from this modulation cannot be used to calculate the elasticities of PPP block to 
metabolites. The metabolites most immediately affected are G6P (increase) and NADPH/NADP 
(decrease). 
E.1.6. Dichloroacetate (0.5 mM) 
Dichloroacetateis an analoge of acetic acid that inhibits pyruvate dehydrogenase kinase 
which inactivates pyruvate dehydrogenase (PDH). This should lead to dephosphorylation and 
activation of PDH. The PYR block is thus directly affected. Because the NAO block shares 
many of the same enzymes as the PYR block, the kinetics of the NAO block are also directly 
affected. The data obtained from this modulation cannot be used to calculate the elasticities of 
the PYRand NAO blocks to the metabolites. The metabolite most immediately affected is 
pyruvate (decrease) and ΔΨm(increase). 
E.1.7. β-hydroxybutyrate(BHB) (2 mM)  
β-hydroxybutyrate is the predominant blood ketone body that can be oxidized in the 
mitochondrial matrix during times of low glucose in the brain. For these experiments, -
hydroxybutyrate was added to a final concentration of 2mM as a 50% D/L racemic mixture, so 
the metabolizable concentration to which the CGNs were exposed was 1mM (as the L form is 
not oxidized).The first step in the oxidation is by -hydroxybutyrate dehydrogenase, which 
produces acetoacetate and NADH. Acetoacetate can be further metabolized by 3-oxoacid-CoA 
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transferase and acetyl-CoA acetyl transferase 1 to yield two molecules of acetyl-CoA, which can 
then enter the TCA cycle (Maurer et al BMC Cancer 2011). Thus, the complete oxidation of -
hydroxybutyrate generates nine reducing equivalents which, when oxidized by the respiratory 
chain, consumes nine oxygen atoms. However, it is well established that not all acetoacetate 
generated by -hydroxybutyrate dehydrogenase is further processed, as some acetoacetate is 
known to exit cells. The inclusion of-hydroxybutyrate means that mitochondrial respiration rate 
is now a function of three substrates instead of two. Partitioning the measured respiration rate 
into that due to each of the substrates required modification of the original mathematical model 
used to determine PYR and NAO fluxes (see Sections C.4, C.5, and C.9) such that the fraction of 
-hydroxybutyrate completely oxidized was now included as a solver-optimized parameter. 
Since the oxidation of -hydroxybutyrate leads to an alternative source of NADH, this 
modulation will perturb the kinetics of the pyruvate and NADH oxidation blocks. The data 
obtained from this modulation cannot be used to calculate the elasticities of the pyruvate and 
NADH oxidation blocks to the metabolites. The metabolites most immediately affected are 
NADH/NAD (increase), pyruvate (increase), and ΔΨm(increase). 
E.1.8. Tert-butyl hydroperoxide (tBHP)  (25μM) 
Tert-butyl hydroperoxide is a source of exogenous ROS that is an excellent substrate for 
glutathione peroxidase. This should cause increased oxidation of GSH, which in turn will 
increase NADPH consumption via glutathione reductase. Consequently, tBHP will directly affect 
the NADPH consumer block. The data obtained from this block cannot be used to calculate 
elasticities of NADPH consumer block to metabolites. 
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E.1.9. Cyanide (100 μM) 
Cyanide inhibits complex IV (cytochrom c oxidase) of the respiratory chain, and so 
directly affects the kinetics of the PYR and NAO blocks. The data obtained from this modulation 
cannot be used in calculating the elasticities of these blocks to the metabolites. 
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F. Assessing In situ apoptotic stimuli target in CGNs energy metabolism 
Trophic factor (serum and high K) deprivation is an apoptotic stimulus that is a 
modulator of CGN metabolism
31
, but with an unknown number of blocks targeted. These blocks 
can be identified with knowledge of the elasticities of the blocks to the explicit metabolites. 
CGNs deprived of trophic factors undergo a rapid decrease in energy metabolism (as indicated 
by decreased mitochondrial respiration), but then maintain a preserved metabolic steady state for 
at least 4 hours (unpublished and
31
).If the kinetics of a block are directly affected (e.g. change in 
kcat, or Km to an explicit metabolite), then its flux will change in a way that is independent of 
changes in the concentrations of the explicit metabolites. Thus, once the fluxes and metabolites 
levels are re-measured after trophic factor deprivation, the elasticities can be used to predict flux 
changes based on the new metabolite levels. If the predicted fluxes differ from those measured, it 
can be inferred that the kinetics of a block have changed, thus implicating the block as a target. 
F.1. Direct effects: 
The fractional flux changes of the block(s) directly affected by apoptosis will not equal 
the predicted changes. The degree to which a block is affected by trophic factor deprivation 
(which is a parameter change designated as Δq) can be estimated by the integrated elasticity 
coefficient (IE)
29
 
𝐼𝐸∆𝑞
𝑏𝑙𝑜𝑐𝑘 =
∆𝐽𝑏𝑙𝑜𝑐𝑘
𝐽𝑏𝑙𝑜𝑐𝑘
−  𝜀𝑥𝑖
𝑏𝑙𝑜𝑐𝑘𝑛
𝑖=1 ∙
∆𝑥𝑖
𝑥𝑖
 (15) 
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where n=number of  explicit metabolites, 𝜀𝑥𝑖
𝑏𝑙𝑜𝑐𝑘  are the elasticities (determined in healthy 
CGNs) of a block to each metabolite (x), and 
∆𝐽𝑏𝑙𝑜𝑐𝑘
𝐽𝑏𝑙𝑜𝑐𝑘
 is the measured flux change induced by 
trophic factor deprivation, which includes both direct and indirect effects. Hence, the summation 
term 𝜀𝑥𝑖
𝑏𝑙𝑜𝑐𝑘 ∙
∆𝑥𝑖
𝑥𝑖
𝑛
𝑖=1   represents the combined indirect effects of the changed metabolites on the 
flux. Therefore, IE is the fractional flux change which cannot be attributed to the changes in 
metabolites and thus reflects direct kinetic changes mediated by other effects such as post- 
translational or allosteric modifications (which can affect kcat or Km).  
F.2. Indirect effects 
The indirect effects represent the propagation of a direct kinetic change on a block to 
other blocks in the system. Such propagation results from the change in metabolite 
concentrations that are affected by kinetic changes of the primary target(s). The indirect effect 
that each metabolite (x) has on a block is quantified as the partial integrated response coefficient 
x𝐼𝑅∆𝑞
𝑏𝑙𝑜𝑐𝑘  and can be compared to the overall measured response  
∆𝐽𝑏𝑙𝑜𝑐𝑘
𝐽𝑏𝑙𝑜𝑐𝑘
 , which is known as the 
integrated response coefficient (𝐼𝑅∆𝑞
𝑏𝑙𝑜𝑐𝑘 =  
∆𝐽𝑏𝑙𝑜𝑐𝑘
𝐽𝑏𝑙𝑜𝑐𝑘
). The partial integrated response coefficient 
acting through a metabolite (x) is calculated as: 
𝑥𝐼𝑅∆𝑞
𝑏𝑙𝑜𝑐𝑘 = 𝜀𝑥
𝑏𝑙𝑜𝑐𝑘 ∙
∆𝑥
𝑥
 
Each of these coefficients gives the theoretical fractional flux change of a block due to the 
change in a single metabolite caused by q (where all other metabolite concentrations remain 
constant). Furthermore, the effect that direct kinetic changes on a block (e.g., block 1) have on 
the flux through another block (e.g., block2) can be quantified from the known control that block 
(16) 
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1 exerts on the flux through block2. This is known as the partial integrated response of block2 to 
trophic factor deprivation (Δq) mediated by direct kinetic changes in block1 
21 block
q
block IR  
𝐼𝑅∆𝑞
𝑏𝑙𝑜𝑐𝑘 2𝑏𝑙𝑜𝑐𝑘 1 = 𝐶𝑏𝑙𝑜𝑐𝑘 1
𝑏𝑙𝑜𝑐𝑘 2 ∙ 𝐼𝐸∆𝑞
𝑏𝑙𝑜𝑐𝑘 1
 
The partial integrated response acting through a block provides a theoretical measure of the 
extent to which block2 flux is changed due to direct kinetic effects on block1 caused by a change 
in some parameter (under the condition where no other blocks are affected). The partial response 
coefficients are important to understanding how the measured perturbation of different variables 
within the system (e.g., the change in the concentration of a particular metabolite, the change in 
the kinetics of another block)contribute to the overall change in flux through a block in the 
system. 
Thus a change in reaction flux due to trophic factor deprivation 
∆𝐽𝑏𝑙𝑜𝑐𝑘
𝐽𝑏𝑙𝑜𝑐𝑘
, can be partitioned into 
direct kinetic changes 𝐼𝐸∆𝑞
𝑏𝑙𝑜𝑐𝑘
and indirect changes  𝜀𝑥𝑖
𝑏𝑙𝑜𝑐𝑘 ∙ ∆𝑥𝑖
𝑥𝑖
𝑛
𝑖=1   mediated by n metabolites. 
The indirect changes can be dissected into those mediated by other blocks in the pathway whose 
kinetics have been directly affected by apoptosis 𝐼𝑅∆𝑞
𝑏𝑙𝑜𝑐𝑘 2𝑏𝑙𝑜𝑐𝑘 1
 , and those mediated by changes 
in each of the metabolites
𝑥𝐼𝑅∆𝑞
𝑏𝑙𝑜𝑐𝑘 = 𝜀𝑥
𝑏𝑙𝑜𝑐𝑘 ∙
∆𝑥
𝑥  
In this way, the measured changes in CGN energy metabolism due to apoptotic signaling 
can be viewed as a result of a mixture of direct and indirect changes occurring within the system. 
Distinguishing and quantifying such changes leads to identification of primary apoptotic targets 
within CGNs energy metabolism. For instance, if glycolytic flux is affected by apoptosis through 
direct kinetic changes in either GTP or PPP or both, the rate of ATP synthesis could adversely be 
(17) 
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affected, but only because of the metabolite changes (i.e. G6P and NADPH) due to kinetic 
targeting of GTP and /or PPP. In this case, the flux change in glycolysis, while critical to ATP 
levels, would not be the important mechanistic change to investigate further, as the alteration in 
GTP or PPP are the primary sites. Accordingly, comprehensive analysis of the metabolic 
behavior of healthy CGNs provides a tool to explain, quantify, and rank most of the observed 
metabolic changes that accompany the early stages of apoptosis. 
Locating the link between metabolism of neurons and apoptotic signaling opens the door 
for research to completely identify the major sites in energy metabolism that facilitate the 
occurrence of neurodegenerative diseases and provide a tool for therapeutic strategies for many 
neuronal diseases that are associated with disrupted apoptosis regulation.   
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A. Introduction 
Apoptosis plays a crucial role in sculpting the developing central nervous system (CNS) 
and in maintaining the structure and function of the mature CNS
1
.Approximately half of 
developing CNS neurons die by apoptosis in the process of fine tuning the neuronal circuits
2
. In 
contrast to its beneficial role in the developing CNS, apoptosis in the mature CNS results in loss 
of function in many neuronal circuits that ultimately characterize neurodegenerative diseases. 
Outside the nervous system, dysfunctional apoptosis increases the probability that genetically 
damaged cells survive to become cancerous 
3
. Regulation of apoptosis therefore has a substantial 
impact on both nervous system development and function. The balance of activities of pro- and 
anti-apoptotic Bcl-2 proteins are essential to determining whether a cell remains viable or dies, 
but the upstream processes which affect this balance remain unclear. Metabolic changes have 
long been known to be associated with apoptosis (physiological and pathological)but it remains 
uncertain how important this is to the balance of Bcl-2 protein activities. Additionally, the 
mechanisms underlying the metabolic changes have yet to be determined
4,5
. Understanding how 
metabolism is perturbed is fundamental to determining whether such changes might facilitate 
apoptosis. 
In the CNS, glucose is the major source of energy where neurons consume approximately 
25% of total body glucose content
6
. Glucose metabolism is critical for neuronal survival not only 
to provide ATP at a rate sufficient to meet their high energy demand, but also to help defend 
against oxidative stress
5
. In the early stages of neuronal apoptosis (whether physiological or 
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pathological), there is a general consensus that glucose metabolism decreases while oxidative 
stress occurs due to higher levels of reactive oxygen species (ROS)and/or reduced ROS 
scavenging. The changes are thought to be related to one another in many cases of physiological 
and pathological apoptosis because mitochondria are the main ROS producer while the OxPPP is 
a main source of reducing equivalents used to protect against ROS. In some situations, oxidative 
stress (e.g., due to exposure to redox compounds such as paraquat, or to abnormal Fe
2+
 handling) 
can result in oxidative modification to metabolic enzymes and organelles (i.e., mitochondria), 
which can perturb metabolism to further promote oxidative stress, and activate apoptosis. In 
other cases, metabolic changes (e.g., from xenobiotics or genetic mutations) can affect ROS 
production and/or scavenging, which in turn induces apoptosis
7
.The fact that the relative balance 
of pro- and anti-apoptotic protein activities can be influenced by ROS levels and metabolism, 
each of which is intimately linked with the other, suggests that metabolic changes, in at least 
some instances, may trigger and/or facilitate apoptosis.
3,4,8
.  
There are a number of proposed metabolic processes that may directly or indirectly affect 
the balance of pro- and anti-apoptotic protein activities and/or ROS levels. One of these targets is 
the proton leak rate which may function as a negative feedback mechanism to limit ROS 
production by the mitochondrial respiratory chain
9
. In general, there are two proposed routes 
through which ROS-mediated leak may occur. One of which is the non-protein mediated leak 
which includes conformational changes to adenine nucleotide translocase (ANT) at 
mitochondrial sites
9
. The conformational changes in ANT have been suggested to convert ANT 
into proton permeable pore. The other route, is an inducible protein-mediated leak, including the 
activation of one or more uncoupling proteins (i.e. UCP2, UCP3) and /or conformational changes 
to ANT
10
.  
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The other metabolic target is the voltage dependant anion channel (VDAC). A major 
function of VDAC is to allow metabolite exchange between the cytoplasm and mitochondrial 
compartments and so plays an important role in energy metabolism, but it also has been shown to 
interact with Bcl-2 family proteins (particularly pro-apoptotic Bax and Bak; 
11
) and thus may 
have a role in apoptosis 
12
.  
Hexokinase (HK)catalyzes the first step of glucose metabolism but may also function as a 
pro-survival protein in a manner that is independent of catalytic activity. It has been reported as a 
downstream target of the pro-survival kinaseAkt
13
, which is inhibited during apoptosis triggered 
by trophic factor deprivation. There is some evidence that Akt-mediated phosphorylation of HK 
is important to maintain metabolite exchange across the mitochondrial outer membrane(MOM) 
by promoting the physical association of HK, the pro-apoptotic protein Bad, and VDAC on the 
cytosolic surface of the MOM
14
. Additionally, this physical association was found to be 
prevented by glycogen synthase kinase (GSK 3β)-mediated VDAC phosphorylation in tumor 
cells
15
. The association of HK and VDAC that may facilitate metabolite exchange and 
preferential access of HK to mitochondrial ATP, has been suggested to impede, either directly or 
indirectly, the binding of pro-apoptotic proteins to the MOM 
16
.Hexokinase is also up-regulated 
and predominately associated with mitochondria in rapidly growing tumor cells, which are 
characterized as having a high glycolytic rate and a high resistance to apoptosis 
17,18
. The strong 
association of HK with mitochondria is thought to contribute to the high resistance of tumor cells 
to apoptosis, possibly by antagonizing Bax/Bak interaction with, or oligomerization within, the 
MOM. These findings suggest that HK plays a role in signaling cell survival, although the 
mechanism is unclear. One possibility is that HK promotes protection against ROS by increasing 
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G6P availability for the pentose phosphate pathway (and thus increasing NADPH/NADP ratio) 
or in some way promotes survival by enhancing glycolysis.  
Despite extensive research on the mechanisms underlying apoptosis, it remains debatable 
whether the metabolic changes associated with physiological and pathological apoptosis are a 
central feature driving neuronal cell death. A limitation to most of the mechanistic studies 
implicating a specific process (e.g., the phosphorylation state of hexokinase or VDAC; the 
interaction of a pro-apoptotic protein with a glycolytic or mitochondrial protein) to a change in 
metabolism upon induction of apoptosis is the lack of quantitative information on how important 
one or more particular processes are to causing the metabolic change. Moreover, the rate of 
cellular ATP consumption is an important determinant of the rate of metabolism by virtue of 
affecting the ATP/ADP ratio, which importantly affects both glycolytic and mitochondrial 
metabolism. Despite this, changes in ATP demand are uniformly disregarded as a possible 
mechanism to account for the metabolic change. This becomes particularly important for models 
of physiological apoptosis in the developing nervous system, where the neurons are triggered to 
die by trophic factor deprivation. 
In apoptotic cerebellar granule neurons (CGNs), decreased cellular ATP demand was 
suggested as the primary cause driving the decrease in mitochondrial respiration rate 
8
.The 
decrease in respiration did not appear to be caused by mitochondrial dysfunction due to previous 
mechanisms that have been put forward- closure of VDAC and inhibition of the respiratory 
chain. Thus, it seemed that physiological apoptosis due to trophic factor deprivation in the 
developing nervous system might not be associated with mitochondrial defects, but simply to 
decreased ATP demand, which is arguably a change that would not be important in facilitating 
apoptosis. Despite this finding, the previous study was limited to investigation of mitochondrial 
113 
 
function and did not directly measure total cellular ATP consumption; possible defects to other 
processes critical to neuronal survival, including glucose catabolism through glycolysis and the 
pentose phosphate pathway were not investigated. To understand the role that glucose 
metabolism may play in facilitating apoptosis, it is necessary to identify the reactions that are 
directly affected by the apoptosis inducer (i.e., to identify sites of metabolic dysfunction).This 
requires knowledge of the control the reactions exert over one another, as well as the effect that 
key metabolites have on affecting the reaction rates. In this study, MCA was applied to healthy 
CGNs to determine the sensitivities of the primary reaction blocks metabolizing glucose to 
changes in six key metabolites (i.e., the elasticities were determined).With this information, the 
extent to which the reactions control one another was assessed (i.e., the flux control coefficients 
were determined). The control structure of healthy neurons was used to quantify and rank the 
reactions directly targeted by depriving CGNs of trophic factors to induce apoptosis. 
Understanding the routes through which apoptotic signaling acts to perturb energy metabolism 
may open a new era for therapeutic strategies for current incurable diseases (i.e. 
neurodegenerative diseases, and cancer).  
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B. Top-down metabolic control analysis applied to neurons 
B.1. A simplified model of glucose metabolism  
As described in Chapter 2, CGN glucose metabolism was simplified (Figure 1-C) by 
grouping reactions into 12 blocks connected by 6 explicit metabolites. Accordingly, the 
distribution of the control among blocks can be feasibly analyzed. 
B.2. The reaction stoichiometries of the system (matrix N) 
The system‟s structural features are expressed in the stoichiometric relationships (Table 
1-C) of the blocks. These relationships were assumed to be a constant feature of the system, 
affected by neither the modulations nor trophic factor deprivation. A detailed explanation of the 
stoichiometries is provided in Chapter 2, Section C.  
B.3. Modulations to perturb the steady state of healthy CGNs: 
To determine the elasticities of the blocks to the metabolites, healthy CGNs were exposed 
to eight different modulations to perturb the metabolite concentrations and block fluxes. Details 
on the modulations used are given in Chapter 2,Section D.1.andsummarized below in Table 2-C. 
Table 2-C shows which modulations were used in calculating the elasticities of each block to the 
metabolites.  
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Figure 1-C. A simplified model of cerebellar granule neurons energy metabolism. Dashed and bold blue arrows 
refer to explicit reaction blocks where Jx denotes the flux occurring through the respective blocks and x is the 
number of the block as follows; 1) glucose transport and phosphorylation; 2) glycolysis; 3) pyruvate oxidation; 4) 
NADH oxidation; 5) lactate production; 6) mitochondrial phosphorylation; 7) proton leak; 8) ATP consumption; 9) 
oxidative pentose phosphate pathway; 10) NADPH oxidation; 11) non-oxidative pentose phosphate pathway; 12) 
malic enzyme. Asterisks refer to explicit metabolites including; glucose-6-phosphate (G6P), pyruvate (Pyr), 
mitochondrial membrane potential (ΔΨm), ATP/ADP ratio, NADH/NAD ratio, and NADPH/NADP ratio. Ribulose-5-
phosphate (R5P) was not considered as an explicit metabolite, as NADPH is the primary product regulating the 
oxidative pentose phosphate pathway. Fructose-6-phosphate (F6P) is not included as an explicit metabolite, but is 
assumed to rapidly equilibrate with G6P to form a single pool of hexose phosphates. 
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Blocks Metabolites 
G6P NADPH 
NADP 
NADH 
NAD 
Pyr ΔΨm ATP 
ADP 
GTP 1 0 0 0 0 -1 
GLY -1 0 2 2 0 3 
LAC 0 0 -1 -1 0 0 
NAO 0 0 -1 0 9 0 
PYR 0 0 0 -1 45 1 
PHO 0 0 0 0 -3.67 1 
PRL 0 0 0 0 -1 0 
ATC 0 0 0 0 0 -1 
OxPPP -1 2 0 0 0 0 
NonPPP 0.667 0 0.333 0.333 0 0.667 
ME 0 1 0 1 0 0 
 
  
Table 1-C.The stoichiometric relationships of the blocks to the metabolites. The organization of the blocks is shown in 
Fig. 1. The abbreviations are: GTP, glucose uptake and phosphorylation; GLY, glycolysis; LAC, lactate production and 
export; NAO, glycolytic NADH oxidation; PYR, pyruvate oxidation; PHO, mitochondrial phosphorylation; PRL, 
mitochondrial proton leak; ATC,ATP consumers; OxPPP, oxidative pentose phosphate pathway; NonPPP, non-oxidative 
pentose phosphate pathway; ME, export and oxidation of matrix malate by cytoplasmic malic enzyme. The explicit 
metabolites are glucose-6-phosphate (G6P), NADPH/NADP ratio, NADH/NAD ratio, pyruvate (Pyr), mitochondrial 
membrane potential (ΔΨm), and ATP/ADP ratio. Positive numbers denote production of a metabolite, negative numbers 
denote consumption of a metabolite, and zeroes denote that block neither consumes nor produces the metabolite.  
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Table 2-C. The modulations used to calculate the elasticities of each block to the explicit metabolites. B, β-
hydroxybutyrate (2mM); C, Cyanide (100µM); D, Dicholoroacetate (0.5mM); F, FCCP (0.5µM); G, low glucose 
(4mM); L, lactate (2mM); O, Oligomycin (10ng/L); T, Tert-butyhydroperoxide (25µM). obtained from modulations 
(modulations not used) that directly affecting certain fluxes are not used in calculating elasticities of those fluxes. 
Fluxes Modulations used Modulations not used 
GTP O, L, D, B, T, C G, F 
GLY F,O, G, L, B, T, C D 
LAC F, G,  D, B, T, C L, O 
NAO F,O, G,  L, T, D, C, B 
PYR F,O, G, L,  T D, C, B 
PHO  G, D, B, T, C O, F, L 
PRL O, G, L, D, B, T, C F 
ATC G, L, D, B, T, C O, F 
OxPPP F,O, G, L, D, B, T, C  
NonPPP F,O, G, L, D, B, T, C D 
NPO F,O, G, L, D, T, C B 
ME F,O, G, L, D, B, T, C L, B 
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C. Experimental approach 
C.1. Cell culture preparation and incubation conditions 
Cerebellar granule neurons were obtained from the cerebella of 5-7 day old Wistar rat 
pups (Harlan, Indianapolis, IN) killed by decapitation. Cells were dissociated from freshly 
dissected cerebella by mechanical disruption in the presence of trypsin and DNase, then washed 
and filtered through a 70 μm cell strainer (Becton-Dickinson, Franklin Lakes, NJ) to remove 
undissociated tissue. Neurons were plated on either 4-well (1.5 x 10
6 
cells/well) or 2-well (7 x 
10
6
 cells/well) (depending on the condition of the experiment) LabTek II chambers (Nunc, 
ThermoFisher Scientific, Pittsburgh, PA) previously coated with polyethyleneimine. Cells were 
incubated at 37 
o
C humidified atmosphere of 5% CO2/95% air in a Minimum Essential Media 
supplemented with Earl‟s salts (Mediatech, Manassas, VA), 2 mM glutamine, 10% fetal bovine 
serum (Hyclone, Logan, UT), and 25 mMKCl. 1β-arabinofuranosyl cytosine (Ara C;10μM) was 
added to the culture medium 24 hrs after plating to prevent the proliferation of non neuronal cells 
i.e. glial cells. On day 6 cultures were supplemented with 5 mM D-glucose, and the mature 
neurons (7 to 10 days) utilized in the experiments.  
C.2. Experimental media 
For the experiments, healthy cells were exposed to a high K buffer which contained the 
following components (in mM unless otherwise noted):  
116 NaCl, 25 KCl, 20 TES pH 7.35, 10 glucose, 1.3 MgCl2, 1.3 CaCl2, 1.2 Na2SO4, 0.4 KH2PO4, 
0.2 NaHCO3, and 10% v/v heat inactivated 10 kDa dialyzed fetal bovine serum (FBS). Apoptosis 
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was induced using buffer lacking trophic factors (hereafter referred to as low K). This differed 
from the high K buffer in the following components: 3.5 mM KCl, 137.5 mM NaCl, and 0.3% 
w/v fatty acid-free bovine serum albumin (BSA) instead of FBS. For the modulations, the high K 
buffer was supplemented with each compound as detailed in Chapter 2, Section D. 
C.3. Measurement of the source and sink metabolites external to the system 
Neurons seeded in 2-well chambers were incubated in high K buffer a modulation, or in 
low K, for 60 min at 37
o
C, and then used to measure the rates of glucose consumption, lactate 
production, and respiration for the same preparation. The measurements were conducted as 
paired experiments so that the results of a modulation or low K could be normalized to that of the 
high K control. 
C.3.1. Respiration rate  
Jekabsons
19
 developed a novel technique that allows measuring of respiration, glucose 
consumption and lactate production rates in attached neurons in 2-well Lab-Tek chambers 
(Figure 2-C). A custom-made acrylic lid fitted with an oxygen microelectrode (Clark-type) was 
used to seal the 2-well Lab-Tek chamber, which contained 2.1 mL of experimental buffer. 
 
 
 
 
 
Figure 2-C. Cover slip mode respiration measurement. Schematic diagram showing the respirometer used for the in 
situ measurement of CGN respiration rate in 2-well LabTek chambers. The chamber is sealed with an acrylic lid with 
an inserted micro-oxygen electrode. The magnetic stirrer required for accurate measurement of dissolved oxygen by 
the electrode was positioned above the chamber to keep the stir bar from disturbing the cells. [Adapted from 
Jekabsons
15
]. 
acrylic lid 
cells 
O
2
 electrode 
stirrer 
stir bar 
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A stir bar suspended against the lid was used for continuous stirring of the buffer to avoid 
oxygen depletion at the electrode tip using a rotating magnet positioned above the lid. The entire 
assembly was maintained within a 37
o
C incubator and the depletion of oxygen in the chamber 
(typically 20-40%) was monitored over 30-40 min. With this system, once respiration rate has 
been measured, the cells can be used to determine the rate of glucose consumption and lactate 
production. 
C.3.2. Glucose consumption rate  
Immediately following the respiration measurements, the cells were washed once and 
incubated in 350 μL of buffer ± modulation for two sequential 60 min intervals at 37oC. To 
correct for the evaporation that occurred during the incubation periods, control chambers without 
cells were run in parallel. The collected samples were centrifuged for 2 min, 21,000xg at 4
o
C and 
the supernatants stored at -20
o
C. Triplicate 15 μL aliquots were assayed in 485 μL reaction 
buffer containing 100mM triethanolamine pH 7.6, 7mM MgCl2, 2mM ATP, 2mM NADP, 
1U/mL hexokinase (HK), and 1U/mL glucose-6-phosphate dehydrogenase (G6PDH). The 
reaction mixture was incubated 8 min, and then the change in absorbance at 340nm was 
determined with a spectrophotometer (Amersham Ultrospec 3300 pro). Glucose standards (9.0, 
9.2, 9.4, 9.6, 9.8, and 10 mM) dissolved in the experimental buffer were run with each assay. 
C.3.3. Lactate production rate  
Lactate was assayed enzymatically by detecting NADH produced from lactate 
dehydrogenase. Triplicate 20 μL aliquots were assayed in 480 μL of reaction buffer containing 
100mM glycylglycine, pH 9.0, 100mM glutamate, 1mM NAD, 1 U/mL lactate dehydrogenase, 
and 1 U/mL glutamate-pyruvate transaminase. Samples were incubated 70min, then the 
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fluorescence was determined (λex = 340nm, λem = 460nm) with a 
spectrofluorophotometer(Shimadzu RF-1501). Lactate standards (0, 0.2, 0.4, 0.6, 0.8, 1.0, and 
1.2 mM) dissolved in the experimental buffer were run with each assay. 
C.3.4. 
13
C lactate labeling from 1,2
13
C glucose 
For some experiments, 1,2
13
C glucose was used in the high K buffer  modulation, or 
low K buffer. The resulting 
13
C lactate labeling pattern was used to determine OxPPP, NonPPP, 
and ME fluxes from the measured rates of glucose consumption, lactate production, and 
respiration (See Chapter 2, Section C.9) 
C.3.4a) 
13
C lactate labeling with 1, 2 
13
C glucose 
Cerebellar granule neurons (7x10
6
 cells per well plated in 2-well Lab-Tek chambers) 
were incubated for 1h at 37
o
C with 600L high K or low K buffer with 9.6mM 1,2 13C glucose. 
Cells were then incubated 2h 15min at 37
o
C with 800L of high K 13C glucose  a modulation or 
low K to further equilibrate the central metabolite pools with 
13
C while perturbing metabolism. 
The cells were washed once, and then incubated 1h, 37
o
C with 350L of the same buffer. 
Parallel controls were run in each experiment and included wells without cells incubated with 
each modulation, and cells incubated with each modulation in standard 
12
C glucose. The samples 
were centrifuged 2min, 21,000 xg, 4
o
C and the supernatants stored at -20
o
C until processed for 
LC-MS/MS.  
C.3.4b) Lactate derivatization for LC-MS/MS 
Samples and lactate standards (prepared in high K) were derivatized with 3-
nitrophenylhydrazine as previously described
20
, with minor modifications. The samples (50L) 
were extracted with 100L cold methanol for 30min at -20oC, then centrifuged at 21,000 xg, -
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2
o
C for 10 min. Supernatants were supplemented with 75L 50mM N-(3-dimethylaminopropyl)-
N′-ethylcarbodiimide hydrochloride (prepared fresh in 98.5% ethanol, 1.5% pyridine) and 75L 
140mM 3-nitrophenylhydrazine (3-NPH) hydrochloride (prepared fresh in 50% ethanol) and 
incubated for 2h, 37
o
C. The derivatized samples were stored at -20
o
C. 
C.3.4c) LC-MS/MS of derivatized lactate 
The derivatized samples (10L) were separated on a Waters ACQUITY UHPLC system 
using a Synergi Hydro-RP C18 100Å column (100mm × 2.0 mm i.d., 2.5 µm; Phenomenex, 
Torrance, CA) maintained at 35
o
C. Samples were eluted over 5min with a linear gradient of 
water (A) /acetonitrile (B) (both with 0.05% formic acid) from 80% A/20% B to 20% A/80% B 
using a flow rate of 0.30 mL/min. Each run was followed by a 2min wash with 100% B, and a 
3.5min equilibration time in 80% A/20% B. A Waters ACQUITY™ XEVO QTOF Mass 
Spectrometer connected to the UHPLC system via an ESI interface (in negative ionization mode, 
capillary voltage 2.0 kV; cone voltage 25V). The temperatures of the source and desolvation 
were 150
o
C and 450
o
C, respectively. Leucine-enkephalin was used as the lock mass, generating 
an [M-H]
+
 ion (m/z 554.2615 Da) and its fragment ions (m/z 236.1035 Da) at a concentration of 
2 ng/mL and flow rate of 5 µL/min to ensure accuracy during the MS analysis. Tandem MS/MS 
was used with collision energies of 10, 20, 30 and 40 V. Fragment intensities corresponding to 
ions 224, 225 and 226 Da (the expected masses for M, M+1, and M+2 derivatized lactate, 
respectively) were confirmed, and peak areas of fragment ions 152 Da (3-NPH; 10V collision 
energy) corresponding to these masses, were calculated. This analysis yielded linear standard 
curves with the 
12
C lactate standards. Corrections for background 
13
C labeling were applied 
based on the results from the controls where the cells were metabolizing 
12
C glucose. 
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C.4. Preparation of cell extracts for measurement of explicit metabolites 
The reduced forms of pyridine nucleotides (NADPH, and NADH) are stable in strong 
basic media (pH 12.2-12.6) while the oxidized forms are not, so the cells were extracted in 
25mM NaOH, 1mM EDTA pH12.4. The oxidized pyridine nucleotides and other metabolites 
G6P, Pyr, ATP, and ADP are stable in strong acidic media such as 0.2M perchloric acid. For 
both treatments, 7x10
6
 CGNs incubated 4hrs (in 25K± modulation and /or 3.5K buffer) were 
rapidly washed with cold PBS containing 10mM glucose. For acidic extraction, 300μL of 0.2M 
perchloric acid was added to each well, then the cells were scraped and transferred to microfuge 
tubes. The suspensions were homogenized with a battery-powered pestle then centrifuged at 4 
o
C 
for 10mins at 18,000xg. The supernatant was partially neutralized with 4M KOH for 10min on 
ice then centrifuged 2 min, 18,000 xg to pellet the precipitate. The supernatant was further 
neutralized with 0.5M Tris base to pH 6.6-6.8. The final extract volumes were measured then the 
samples were stored at -80 
o
C. 
In parallel, the basic extraction was performed by adding 300 μL of 25mM NaOH, 1mM 
EDTA to the cells, scraping the extract into microfuge tubes, homogenizing with a battery-
powered pestle, then heating to 60
o
C for 10 min (to decompose NADP and NAD). The extract 
was centrifuged 10 min at 18,000xg at 4
o
C and the supernatant was partially neutralized with 1 
M glycylglycine (pH 5.9) and then titrated to a final pH of 8-8.2 with 1M HCl. The extract 
volumes were measured and the samples stored at -80
o
C.The samples were assayed for NADH 
immediately, and for NADPH within 24h.  
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C.5. Measurement of the explicit metabolites 
C.5.1. Nicotinamide adenine dinucleotide phosphate (NADP and NADPH) 
Both NADP (in acidic extraction) and NAPDH (in basic extraction) were assayed by the 
same procedure, however NADPH must be assayed within 24h after the extracts prepared to 
avoid degradation. Since the concentration of either NADPH or NADP is inherently low in the 
extract, an enzymatic reaction with a signal amplification loop based on the reduction of MTT 
(3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium Bromide) to a purple formazan 
(detected spectrophotometrically at 578nm) in presence of phenazinemethosulphate (PMS) was 
used. Duplicate 5 μL (for NADPH) or 20 μL (for NADP) were assayed in 55 μL (1.11X) or in 40 
μL (1.5X) reaction buffer respectively. The final reaction buffer contained 70mM 
triethanolamine pH 7.2, 1mM EDTA, 5mM MgCl2, 1mM isocitrate, 0.25mM MTT, and 2mM 
PMS. To start the reaction, 0.12 units ofyeast NADP specific isocitrate dehydrogenase (to avoid 
interference with NAD)was then added to the reaction mixture at 1 min time interval. Samples 
were then incubated either for 75 min (NADP), or 22 min (NADPH), and then the absorbance 
was read at 578nm. NADPH standards (0, 50, 100, 200, 350, 500, and 650 nM) were prepared 
fresh in glycylglycine and HCl-neutralized 25 mMNaOH, 1 mM EDTA. NADP standards (0, 5, 
10, 20, 40, 70, and 100 nM) were prepared in KOH and Tris-neutralized 0.2 M perchloric acid 
and stored at -80
o
C. 
C.5.2. ATP and ADP 
The concentration of ATP was detected in the neutralized perchloric acid extracts by 
measuring the resulting luminescence, produced from the oxidation of luciferinto oxyluciferinin 
the presence of ATP and luciferase. The concentration of ADP was further detected in the same 
samples by adding pyruvate kinase which catalyzes the conversion of ADP and PEP 
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(phosphoenolpyruvate) to pyruvate and ATP. Triplicate 10 μL aliquots were assayed in 40 μL of 
1.25x buffer containing 87.5mM Tris acetate, 94mM KCl, 1.25mM EDTA, 12.5mM Mg acetate, 
75 μM DTT, 0.125% BSA, supplemented with 1:25 luciferin/luciferase reagent (Sigma, St. 
Louis, MO). The resulting luminescence was determined over 60 sec using a tube luminometer 
(Turner Biosystems). The reaction mixture wasthen supplemented with 0.7mM 
phophoenolpyruvate and 1U/ml pyruvate kinase. The increase in luminescence above the 
residual ATP signalwas determined over 160 sec, and the peak increase used to quantitate ADP. 
Individual ATP (0, 2.5, 5, 10, 15, 20, 25, and 30 M) and ADP (0, 0.3, 0.6, 1.0, 1.5, 2.0, 3.0, and 
4.0M) standards prepared in neutralized perchloric acid were combined and assayed in parallel. 
C.5.3. Glucose-6-phosphate (G6P)  
The enzymatic oxidation of G6P by G6PDH and subsequent reduction of NADP to 
NADPH was coupled to reduction of resazurin (Abs 601nm) to resorufin (Abs 574nm). 
Resorufin is typically measured by fluorescence, but we found greater consistency and 
sensitivity evaluating the ratio of resorufin to resazurin by absorbance at 574 and 601 nm, 
respectively. Duplicate 40 μLperchloric acid aliquots were assayed in 20 μL 3x assay buffer 
containing 300mM triethanolamine (pH 7.3), 0.6mM EDTA, 3mM MgCl2, 0.9mM NAD, 3U/ml 
superoxide dismutase, 1.2U/ml glucose-6-phosphate dehydrogenase from  L. mesenteroides, 1.2 
U/ml 6-phosphogluconate dehydrogenase, 1.2 U/ml diaphorase, and 22.5 μMresazurin. Inclusion 
of superoxide dismutase was found to reduce the background and improve the detection 
limit.Glucose-6-phosphate standards (0, 0.3, 0.6, 1.0, 2.0, 4.0, and 6.0 M) dissolved in 
neutralized perchloric acid were run with the extracts.The reaction was incubated 2h and 20min 
in the dark and then the absorbance ratios were determined. 
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C.5.4. Pyruvate 
Intracellular pyruvate was measured in the presence of pyruvate oxidase which catalyzes 
conversion of pyruvate in the presence of phosphate buffer to acetyl-phosphate and H2O2. 
Hydrogen peroxide is reduced to water by horseradish peroxidase (HRP) in the presence of the 
electron donor luminol, which is oxidized to the unstable form of 3-aminophthalate (3APA, 
unstable excited state) that decomposes to a low energy state with resultant emission of light at 
425 nm (detected via a tube luminometer). Triplicate 30μL aliquots were assayed in 30μL (2x) 
buffers containing 200mM KH2PO4/K2HPO4 (pH 6.8), 4mM MgSO4, 0.8mM EDTA, 100μM 
flavin adenine dinucleotide (FAD), 400μM thiamine pyrophosphate, 2mM luminol, 2 U/ml 
superoxide dismutase, and 0.4 U/mL horseradish peroxidase. The superoxide dismutase was 
included to reduce the background luminescence observed in the cell extracts. Addition of the 
extracts (but not the standards) to the assay buffer typically caused a strong but variable increase 
in luminescence that decreased to background within 30-45 sec; this artifactual signal was 
always monitored to ensure that it fell to background prior to beginning the assay. The 
luminescence was then monitored for 60 sec after addition of vehicle (100 mM 
KH2PO4/K2HPO4, 1% BSA, pH 6.8- the solvent in which pyruvate oxidase was dissolved) 
because this caused variable artifactual signals that were subtracted from the signal measured 
over 60 sec upon addition of 0.3 U/ml of pyruvate oxidase to start the reaction. 
C.5.5. NADH and NAD 
Both NADH (in basic extract) and NAD (in acidic extract) were assayed with the same 
procedure. The reaction was initiated by oxidation of ethanol into acetaldehyde in the presence 
of alcohol dehydrogenase (ADH). The resulting NADH was then reoxidized in presence of 
resazurin and diaphorase to resorufin. For the basic extracts, the oxidation of NADH by 
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diaphorase/resazurin provided the source of NAD for use by ADH. The ratio of reduced to 
oxidized resorufin/resazurin was detected by absorbance at 574 and 601 nm, respectively. 
Duplicate 5μL aliquots were assayed in 55 μL of 100mM glycylglycine (pH 8.8), 0.2mM EDTA, 
1mM MgCl2, 250mM ethanol, 1 U/mL superoxide dismutase, 0.4 U/mL diaphorase, and 10μM 
resazurin. The reaction was started by addition of 0.24 U of alcohol dehydrogenase, and the 
ratiometric detection of reduced/oxidized resazurin was measured by absorbance at 574 and 
601nm, respectively after 20min.NADH standards (0, 0.2, 0.4, 0.6, 0.8, 1.0, and 1.5M) were 
prepared fresh in glycylglycine/HCl neutralized 25mM NaOH/1 mM EDTA. NAD standards (0, 
0.3, 0.6, 1.0, 1.5, 2.0, and 4.0 M) were prepared in KOH/Tris neutralized perchloric acid and 
stored at -80
o
C. 
C.5.6. Mitochondrial membrane potential (ΔΨm) 
The fluorescent lipophilic cation tetramethylrhodamine methyl ester (TMRM) was used 
to determine ΔΨm. TMRM accumulates in the cytoplasm [TMRM]cyto and mitochondria 
[TMRM]mito in a Nernstian fashion according to ΔΨp, and ΔΨm respectively
21
.Mitochondrial 
membrane potential is a function of the following ; cytoplasmic and mitochondrial volumes (Vc, 
Vm) that have been determined by fluorescence microscopy (unpublished), activity coefficients 
(ac, am) which represents non-specific binding of TMRM to cell components, have been 
experimentally determined (unpublished), plasma membrane potential ΔΨp (assumed ΔΨp=-
35mVfor 25K, and -70mV for 3.5K)
22
, and the free concentrations of TMRM in the cell 
[TMRM
+
]cell and extracellular space [TMRM
+
]e, (see section D.1.). 
Healthy and/or apoptotic neurons were incubated in 1.2mL (1nM TMRM) in 25K/FBS or 
3.5K/BSA for 2h, then 600µL aliquots were collected for each sample for initial readings. Cells 
were incubated for another 1hr in 700µL (0.8nM TMRM) with treatment (any modulation or 
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3.5K/BSA), then 600µL aliquots were collected for final readings. Samples were centrifuged for 
2 min at 18,000 xg and the supernatant fluorescence was determined (λex = 550nm, λem = 580nm) 
with a spectrofluorophotometer (Shimadzu RF-1501). The total TMRM taken by cells 
[TMRM]cellwas calculated by subtracting the initial and final readings. Using the known 
cytoplasmic and mitochondrial volumes (Vc, Vm), activity coefficients (ac, am), plasma 
membrane potential ΔΨp (assumed ΔΨp=-35mv for 25K, and -70mv for 3.5K)
22
, and the free 
concentrations of TMRM
+
 in the cell [TMRM
+
]cell and extracellular space [TMRM
+
]e, the 
ΔΨm(Eq.1)can be determined (see Section D.1.) 
m = 61.5*log ([TMRM
+
]mitofree/[TMRM
+
]cytofree)                                                                     (1) 
C.6. Determining mitochondrial H
+
leak,  
Proton leak involves all pathways of H
+
 influx through the mitochondrial inner 
membrane that are not coupled to ATP synthesis. The leak occurs through one or more ill-
defined influx pathways that are strongly affected by the magnitude of ΔΨm
23
. Practically, the 
leak rate can be measured by blocking ATP synthase with oligomycin then determining the new 
steady-state respiration rate, which reflects H
+
 pumping that exactly opposes the leak rate. Since 
oligomycin increases ΔΨm, which increases the leak rate more than without oligomycin, 
progressive inhibition of the respiratory chain, with the complex III inhibitor myxothiazol (22, 
28, and 34nM), was used to reduce H
+ pumping and therefore reduce ΔΨm back to the basal state. 
For theseexperiments, respiration rate of 4 x 10
6
 CGNs plated on 22 x 40 mm coverslips was 
determined using an RC-30 closed bath chamber (Warner Instruments) with a perfusion-mode 
micro-oxygen electrode (Microelectrodes, Inc.) on the downstream side of the chamber for 
improved sensitivity, as developed by Jekabsons and Nicholls (2004)
19
.The cells were 
equilibrated in the chamber with high K media for 30-45 min at 37
o
C to establish basal 
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respiration. The perfusate was switched to a high K media supplemented with 1 g/mL 
oligomycinand 25 M Ca2+rather than the standard 1.3 mMCa2+(which prevented Ca2+ 
deregulation from occurring).In a preliminary experiment, it was found that 25 M Ca2+ was the 
concentration which kept the cytoplasmic [Ca
2+
] (as monitored with FURA PE3) in the presence 
of oligomycin similar to that measured in the absence of oligomycin. The cells were allowed 25-
40 min to establish a new steady-state respiration, and were then sequentially titrated with 
myxothiazol (22, 28, and 34 nM) in the continued presence of 1µg/mL oligomycin (with 25µM 
Ca
+2
). Parallel experiments with TMRM were run in 2 well LabTek chambers as described in 
Section C.5.6 to measure ΔΨm under the same conditions. The resulting plot of leak rate 
againstm were used to determine the leak flux for CGNs in high K, as well as the leak flux in 
CGNs exposed to all modulations except FCCP (once m for each modulation was measured). 
For cells exposed to FCCP or low K, similar titrations with oligomycin and myxothiazol were 
performed, except that for low K the media [Ca
2+
] was kept at 1.3 mM during the titration 
because the cells did not Ca
2+
 deregulate upon addition of oligomycin. The elasticities of the H
+
 
leak block to the explicit metabolites other than ΔΨm were assumed to be zero since oligomycin 
perturbs the levels of the other explicit metabolites in the system. 
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D. Preliminary results for determination of m and H
+
 leak 
D.1. Determination of cytoplasmic and mitochondrial volumesand TMRM
+
 
activity coefficients to assess m 
To determine ΔΨm from TMRM
+
 uptake experiments, the cytoplasmic and mitochondrial 
volumes (Vc, Vm, respectively), and TMRM
+
 activity coefficients (ac, am, respectively) must be 
known.These parameters were measured as detailed below. It should be noted that p is also 
required, and was assumed from previously published work
22
. 
Cytoplasmic and mitochondrial volumes were determined by fluorescence microscopy 
(similar to a technique developed by Ward et al
21
). Images of CGNs double-labeled with 
TMRM
+
 and FURA PE3 (the latter as a cytoplasmic marker) were acquired as a series of Z 
stacks, in which optical slices were taken through the cells every 0.25 m (typically 30-40 
slices). The FURA, TMRM
+
, and colocalized are asin each slice were determined using the co-
localization feature of the Axiovision software to calculate the volumes (Table 3). The volumes 
were restricted to the cell bodies (i.e., the neurites were not included) from at least 20 neurons 
from three independent preparations exposed to high Koligomycin, or low Koligomycin. The 
volume of cells in high K plus oligomycin were determined (but not for the other modulations) 
because preliminary studies indicated this modulation caused significant swelling, most likely 
due to altered ionic homeostasis from compromised ATP synthesis. For analysis of the 
oligomycin effect, single bright field images were taken rather than fluorescent Z-stacks, so it 
was assumed that the increase in volume was due to a change in Vc but not Vm. In this case, the 
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volume of each cell was calculated from the measured radius, assuming the cells were perfect 
spheres. Oligomycin caused the cell volume to increase 1.680.04 (meanSD from two 
experiments) fold above that of the controls, and this change was applied to the volumes 
measured for the high K controls by double-label Z-stack analysis (Table 3).In contrast, 
oligomycin did not affect the cell volume in low K (1.020.11 fold of low K controls from two 
independent experiments). 
The TMRM
+
 activity coefficients ac, and am reflect the non-specific binding of the 
lipophilic cation to hydrophobic cytoplasmic and mitochondrial components. Assessment of the 
free vs. bound TMRM
+
 is important because the Nernst equation used to calculate m is based 
strictly on the free concentration. The cytoplasmic activity coefficient (ac) was measured by the 
uptake of TMRM
+ 
in CGNs treated with 0.4g/mL oligomycin, 3M FCCP, and 2M 
myxothiazol to abolish m. Assuming that Vc, Vm, and p remain constant, then  
ac = [TMRM
+
]cytofree/([TMRM
+
]cytofree + [TMRM
+
]cytobound)                                                                   (2) 
where the amount of cytoplasmic free TMRM
+
 (TMRM
+
cytofree) can be calculated as 
TMRM
+
cytofree=[TMRM
+
]buffer/10^(∆Ѱp/61.5) * Vc                                                                                                                             (3)  
Since m=0, [TMRM
+
]cytofree = [TMRM
+
]mitofree,  
so the amount of cytoplasmic bound TMRM
+
 is, 
TMRM
+
cytobound={(TMRM
+
cell-TMRM
+
cytofree-TMRM
+
mitofree)* (Vc/(Vc+Vm))}                                (4)  
From three independent preparations, it was determined that 10.06.9% of cytoplasmic TMRM 
was free while the remaining 90% was non-specifically bound (Table 3).The mitochondrial 
activity coefficient (am) was assessed in CGNs having a m, but no p. This was 
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accomplished by selectively permeabilizing the plasma membrane with40g/mL digitonin in 1.2 
mL mitochondrial buffer (120mM KCl, 20mM TES, 1mM EGTA, 2mM MgSO4, 2mM KH2PO4, 
5mM malate, 5mM pyruvate, 0.4g/mL oligomycin, and 0.3% fatty acid free BSA, pH 7.3). In 
this condition, the mitochondria are in State 4 and thus generate a maximalm, which was 
assumed to be 170mV based on previous studies
24–26
 with isolated mitochondria under similar 
conditions (i.e., oxidizing complex I substrates, with phosphate and oligomycin present). The 
amount of TMRM
+
 accumulated in mitochondria can be assessed by measuring the difference in 
fluorescence of extracellular buffer between permeabilized cells and control using 
spectrofluorophotometer (Shimadzu RF-1501).  
sincep = 0, [TMRM
+
]cytofree = [TMRM
+
]buffer                                                                                                            (5) 
From this the matrix free concentration of TMRM
+
 can be calculated 
[TMRM
+
]mitofree = [TMRM
+
]cytofree * 10^(m/61.5)                                                                   (6) 
The total amount of TMRM in the cytoplasmis 
TMRM
+
cytototal = [TMRM
+
]cytofree*Vc/ac                                                                                        (7) 
Therefore, the total (bound and free) TMRM
+
 in the mitochondria is  
TMRM
+
mitototal = TMRM
+
cell – TMRM
+
cytototal                                                                                                             (8) 
Where TMRM
+
cell = [TMRM
+
]media no cells – [TMRM
+
]media with cells * Vmedia                                                 (9) 
The amount of TMRM
+
 non-specifically bound to the mitochondria is 
TMRM
+
mitobound = TMRM
+
 mitototal – [TMRM
+
]mitofree * Vm                                                        (10) 
So the mitochondrial TMRM
+
 activity coefficient am is calculated 
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am = TMRM
+
mitofree/(TMRM
+
mitofree + TMRM
+
mitobound)                                                              (11) 
D.2. The kinetics of H
+
 leak to m for CGNs in high K 
The leak kinetics to m were determined in high K by titrating oligomycin-treated 
CGNs with myxothiazol(Fig.3).Oligomycin increased m from 1696 to 1895 mV (n=4), 
while decreasing mitochondrial respiration to 22.31.8 % of the basal rate (which was 
1198124pmol O/min x 106 cells, n=3).The H+ leak kinetics became apparent upon titrations 
with myxothiazol. From the titration with myxothiazol, 6.7% of high K basal mitochondrial 
respiration rate was used to support H
+
 leak while 93.3% was used for ATP synthesis. For all 
subsequent experiments with CGNs in high K, the H
+
 leak rate was calculated as 6.7% of the 
measured mitochondrial respiration rate, which was converted to units of H
+
 using the H
+
/O 
Stoichiometries for the oxidation of pyruvate and NADH (See Chapter 2, Sections C.4 and 
C.5).The kinetic relationship between H
+
 leak rate and m in high K was used to determine the 
leak rate for all modulations used to perturb the metabolism of CGNs in high K, except FCCP. 
For each modulation, m was measured, which allowed calculation of the fraction of 
mitochondrial respiration driving the leak. Since most of the modulations had minimal effect on 
m, the percent of respiration driving the leak was minimally affected (i.e. BHB: 6.5%, CN: 
5.0%, DCA: 5.8%, Lac: 7.1%, Low glc: 6.2%, tBHP: 5.0%). 
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Treatment Vt (fL) Vm (fL) Vc (fL) ac am 
      
High K 433±8 19±2 414±8 0.10±0.07 0.16±0.05 
Low K 443±8 19±1 424±8 nd nd 
High K + oligo 728 
 
19 709 nd nd 
Low K + oligo 443 
 
19 424 nd nd 
Table 3-C. Measured parameters (cell volumes and TMRM
+
 activity coefficients) for ΔΨm calculation. 
Cytoplasmic (Vc) and mitochondrial (Vm) volumes of FURA-PE3AM and TMRM
+
 loaded CGNs in high or 
low K were determined using colocalization analysis of Z stacks. The total cell volume (Vt) represents the 
sum Vc+Vm. Data are mean ± S.E.M. of 49 (high K) or 56 (low K)cells  from 3 independent preparations. 
Brightfield images were used to determine the effect of 1 g/mL oligomycin on Vt from analysis of 84 cells 
in both high and low K(from two independent preparations). Oligomycin affected Vt in high (1.680.04 fold 
increase) but not low (1.020.11 fold increase) K. In high K, it was assumed that Vc was the only parameter 
affected by oligomycin. The cytoplasmic activity coefficient (ac) was measured by assessing the 
sequestration of TMRM
+
 in CGNs without a ΔΨm(treated with oligomycin, FCCP, and myxothiazol) (n=3). 
The mitochondrial TMRM
+
 activity coefficient (am) was measured by assessing TMRM
+
 sequestration in 
CGNs without a ΔΨp(permeabilized with digitonin and having a maximal ΔΨmby addition of oligomycin 
and complex I substrates) (n=3).      
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Figure 3-C. Cerebellar granule neuron mitochondrial H
+
 leak kinetics in high K .The respiration rate was measured 
with a perfusion mode oxygen electrode downstream to an RC-30 chamber. After establishing the basal rate in high 
K, the cells were perfused with 1µg/L oligomycin and then titrated with myxothiazol (22, 28, and 34 nM). 
Respiration rates were normalized to the basal rate. In parallel, ΔΨm was measured by the uptake of TMRM
+ 
into 
cells seeded in Lab-Tek chambers which were treated with the same concentrations of oligomycin and myxothiazol. 
The red vertical line represents the respiration used for ATP synthesis, whereas the purple line represents to the 
respiration rate used for H
+
 leak flux. Data are meanSEM of three (for respiration measurements) or four (for m 
measurements) experiments. 
 
D.3. The fraction of respiration rate used for H
+
 leak with 10 ng/mL 
oligomycin 
For the H
+
 leak experiments in Section D.2, a saturating concentration (1 g/mL) of 
oligomycin was used to ensure complete inhibition of ATP synthase. However, when oligomycin 
was used as a modulation to perturb metabolism, a 100-fold lower concentration (10 ng/mL) was 
used to minimize possible toxic effects over the longer exposure times which were required for 
the modulation experiments. At this lower dose, respiration rate was greater (32.90.8% vs. 
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22.31.8% of basal) while m was less (1.090.03 vs. 1.120.02 fold of basal) than with 1 
g/mL oligomycin, indicating that some ATP synthase remained active at the lower dose. The 
fraction of respiration rate driving proton leak with 10ng/mL oligomycin was determined from 
the original leak kinetics (Figure 3-C ) superimposed upon the kinetics of the substrate oxidation 
reactions to m, which is indicated by the linear regression using the basal, low, and high dose 
oligomycin conditions (Figure 4-C).  With 10 ng/mL oligomycin, the deviation from the 
regression line could be because of error in measurements of respiration rate, m, or both. 
Accordingly, the fraction of respiration that drives proton leak with 10ng/L oligomycin could be 
from 51-67 %, depending on whether the error is assumed to be in respiration or m, 
respectively. For the calculations, it was assumed that the error was with respiration, so 51% of 
respiration was for H
+
 leak and 49% was for ATP synthesis. This fraction was then used in the 
calculation of proton leak rate for all 10ng/mL oligomycin-treated neurons. 
D.4. The kinetics of H
+
 leak to m in CGNs treated with 0.5µM FCCP  
The protonophore FCCP was used as a modulation to perturb the metabolism of healthy 
CGNs. It does so by increasing the mitochondrial inner membrane permeability to H
+
, and thus 
directly affects the kinetics of the H
+
 leak block to m. As a result, the kinetics of proton leak 
to m were re-measured in the presence of FCCP (Figure 5-C).With 0.5 M FCCP, basal 
respiration increased 1.420.01-fold (from 645167 to 910232 pmol O/min x 106 cells, n=4) 
while m decreased from 1673 to 1584 mV (n=9). Addition of 1 g/mL oligomycin 
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Figure 4-C.The fraction of mitochondrial respiration rate used for H
+
 leak in CGNs treated with 10 ng/mL 
oligomycin. The basal and 10 ng/mL respiration rates (meanSEM of three experiments, normalized to the basal 
state) were determined with a perfusion-mode oxygen electrode as described in the Fig. 3 legend. Parallel 
experiments in 2-well Lab-Tek chambers for measuring TMRM uptake were used to determine basal and 10 ng/mL 
oligomycinm (meanSEM of four experiments). The high K H+ leak kinetics (Fig. 3)were superimposed with 
this data, but adjusted for differences in the mean basal m between the experiments. The regression line (black) 
reflects the kinetic response of the mitochondrial substrate oxidation reactions to m with increasing oligomycin. 
The red vertical line extended from the substrate oxidation kinetics to the H
+
 leak kinetics reflects the fraction of 
respiration for ATP synthesis (49%)and the purple line represents the fraction used for proton leak (51%). 
 
decreased respiration to 0.630.01 of the basal state (to 406109 pmol O/min x 106 cells, 
n=4) and increased m to 1702 mV (n=4). Subsequent titration with myxothiazol resulted in 
the expected ohmic-relationship between the leak rate and m (Figure 4-C). From this 
relationship, the fraction of respiration rate used for proton leak increased to 37.4%. This fraction 
was used for the calculation of proton leak rate for all flux experiments with FCCP-treated 
neurons. 
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D.5. The kinetics of H
+
 leak to m in apoptotic CGNs  
Due to the unknown effects of low K
+ 
on the kinetics of the leak to m, the leak rate 
was re-measured using the oligomycin-myxothiazol titration as detailed for healthy neurons in 
high K. Oligomycin increased m from 1725 to 1808 mV (n=7), while decreasing 
mitochondrial respiration to 41.43.9 % of the basal low K rate (which was 556111pmol O/min 
x 10
6
 cells, n=6). Titration with myxothiazol resulted in a surprisingly ohmic response of the leak 
to m (similar to FCCP), indicating that low K directly affects mitochondrial H+ leak. From 
the kinetics, the fraction of the basal low K respiration used for proton leak increased to 32.4% in 
apoptotic neurons compared to 6.7%in healthy neurons. This fraction was used for the 
calculation of proton leak rate for all flux experiments with apoptotic neurons. 
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Figure 5-C. The fraction of mitochondrial respiration rate used for H
+
 leak in CGNs treated with 0.5 M FCCP. 
Basal respiration rate in high K was measured with a perfusion mode oxygen electrode as described in Fig. 3. The 
respiration rates were then measured in presence of 0.5 M FCCP and FCCP with 1µg/L oligomycin. Titration with 
myxothiazol (8, 16, 20, 22, and 28nM) was then performed. In parallel, m was measured by TMRM uptake of 
CGNs seeded in Lab-Tek chambers and treated with the same concentrations of FCCP, oligomycin, and 
myxothiazol. Data are meanSEM of four to nine experiments. The regression line (blue) reflects the ohmic kinetics 
of the H
+
 leak to m with FCCP. The vertical red line indicates the fraction of respiration used for ATP synthesis 
(62.6%) and the purple line indicates the fraction of respiration used for H
+
 leak (37.3%). 
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Figure 6-C.The fraction of mitochondrial respiration rate used for H
+
 leak in CGNs exposed to low K. Basal 
respiration rate was measured with a perfusion mode oxygen electrode after 35-45 min equilibration in low K (see 
Fig. 3). The respiration rate was measured after perfusion with1µg/L oligomycin and then sequential titrations with 
myxothiazol (24, 30, and 36nM). In parallel, m  was measured by TMRM uptake of CGNs seeded in Lab-Tek 
chambers and treated with the same concentrations of oligomycin and myxothiazol. 
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E. Results and Discussion 
E.1. The metabolic steady-state of healthy neurons 
The metabolic steady-state of healthy CGNs was determined in high K buffer containing 
10 mM glucose as the sole exogenous substrate. In other experiments, the high K buffer was 
modified by addition of inhibitors, activators, or alternative substrates designed to perturb the 
original steady-state in different waysso that metabolic control analysis could be performed. The 
system variables (i.e., block fluxes and metabolite levels) in high K were assessed in parallel 
with each modulation so that the effect on the variables could be normalizedto the high K 
condition to minimize the variability between cell preparations. It should be noted that the rates 
of glucose uptake, lactate production, and mitochondrial respiration were measured for all flux 
experiments, while
13
C-lactate labeling and the fraction of respiration used for H
+
 leak were 
measured in separate experiments. The mean 
13
C labeling pattern and fraction of respiration used 
for H
+
 leak for each respective condition were applied to the individual measurements of glucose 
uptake, lactate production, and respiration to calculate the block fluxes. 
E.1.1.
13
C-lactate labeling from 1,2
13
C-glucose 
Table 4-C represents data of mass fractions of the released derivatized lactate from 
healthy neurons (control) with or without modulation and apoptotic neurons.  
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Table 4-C. Measured labeling pattern of lactate released from 1,2
13 
C-glucose treated neurons. Tandem MS/MS was 
used to determine the mass of lactate isotopomers that were confirmed as; unlabeled (M), single labeled (M1), and 
double labeled (M2)derivatized lactate. The fraction of each isotopomerto total lactate released are represented as 
M/total, M1/total, and M2/total. Data are mean of fraction± S.E.M. of three independent preparations. Fractions 
were measured for healthy (high K) neurons± modulation and apoptotic neurons (low K). Modulations are Tert-
butyl hydroperoxide (tBHP), FCCP, dichloroacetate (DCA), β-hydroxybutyrate (BHB), cyanide (CN), oligo 
(oligomycin), low glucose (Glc), and lactate. 
 
 
 
 
 
 
In healthy neurons, 57.81.1% of the lactate excreted was unlabeled, while 18.20.8% 
and 24.01.3% contained one or two, respectively 13Catoms. In principle, if neurons metabolized 
glucose only through glycolysis, then 50% of the lactate excreted should be unlabeled and 50% 
should be double labeled. These results indicate that other pathways are involved in metabolizing 
glucose to pyruvate. One of these pathways is the oxidative and non-oxidative pentose phosphate 
pathway (PPP) which play an important role in neuronal viability by regulating the cellular redox 
state 
27
. Accordingly, the Ox- and Non-PPP may be a significant pathway for metabolizing 
glucose to pyruvate. In the OxPPP, glucose is decarboxylated at the C1 position leading to 
formation of single labeled 1 
13
C-ribulose-5-phosphate (R5P) from 1,2
13
C-Glc. In the NonPPP, 
carbons are exchanged between three moles of R5Pto produce two moles of six carbon fructose-
6-phosphate (F6P) labeled at carbon 1 and carbons 1 and 3 with 
13
C and one mole of unlabeled 
three carbon glyceraldehyde-3-phosphate/dihydroxyacetone phosphate (the glycolytic triose 
phosphates; TrP). The F6P can be rapidly converted back to G6P through the rapid equilibrium 
condition M/total M1/total M2/total 
High K 0.577±0.011 0.181±0.008 0.240±0.013 
25µM tBHP 0.577±0.010 0.179±0.012 0.242±0.022 
0.5µM FCCP 0.613±0.020 0.169±0.009 0.216±0.011 
0.5mM DCA 0.578±0.012 0.157±0.014 0.263±0.027 
2mM BHB 0.618±0.111 0.172±0.016 0.208±0.005 
100 µM CN 0.592±0.016 0.169±0.012 0.233±0.021 
10ng/L Oligo 0.604±0.026 0.165±0.021 0.229±0.004 
0.4mM Glc 0.543±0.020 0.199±0.019 0.257±0.015 
2mM Lactate 0.493±0.063 0.188±0.011 0.318±0.052 
Low K 0.579±0.008 0.192±0.017 0.227±0.015 
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reaction catalyzed by hexose phosphate isomerase and thus recycle back through the PPP, 
generating addition allabeling of R5P which can exchange carbons again through the NonPPP. In 
total, the exchange of carbons between recycled G6P and 1,2 
13
C G6P from the external media 
can generate eight differentially labeled forms of F6P (than range from unlabeled to tripled 
labeled) which can be metabolized through glycolysis to contribute to the lactate labeling. The 
three carbon (TrP) from the NonPPP is metabolized by glycolysis and thus also contributes to the 
lactate labeling. According to the recycling of F6P and carbon exchange in the NonPPP,a 
mathematical model was created which varied the contribution of glycolysis and the Ox/NonPPP 
in metabolizing glucose until the calculated lactate labeling pattern matched the measured 
labeling pattern (see Chapter 2, Section C.9).However, the model proved incomplete, as it could 
not adequately account for the measured lactate labeling pattern. Cytoplasmic malic enzyme, 
which oxidizes malate from the TCA cycle to generate pyruvate, is known to be expressed in 
neurons, and thus could constitute an additional pathway contributing to the pyruvate (and thus 
lactate) labeling pattern. The theoretical labeling of lactate from malic enzyme was incorporated 
into the mathematical model such that the solver function in Microsoft Excel varied the 
contribution of glycolysis, the Ox/Non-PPP, and malic enzyme to the pyruvate pool, within the 
stoichiometric and flux constraints of the system. This was sufficient for the model to precisely 
calculate the measured lactate labeling pattern. Most of the modulations had relatively minor 
effects on the labeling pattern, suggesting that they did not substantially affect the proportion of 
glucose metabolized by each of the three pathways. This was particularly surprising for tBHP, 
which was expected to cause a rather substantial increase in single labeled lactate, as the OxPPP 
is a major source of this label. A greater concentration of tBHP may have produced more 
substantial changes in the labeling pattern, but higher concentrations also increase the likelihood 
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of the neurons dying prematurely. Conversely, oligomycin had dramatic effects on increasing 
lactate production, and this was expected to reflect a much greater proportion of glucose 
metabolized through glycolysis rather than the OxPPP; the expectation was that the proportion of 
single-labeled lactate should have fallenmore substantially than it did. Whilelow K has been 
associated with oxidative stress, only a minor increase in single-labeled lactatewas observed, 
similar to the oxidant tBHP. These data, however, do not indicate the absolute fluxes occurring 
through the reactions. To determine the fluxes, the labeling patterns must be used within the 
context of the measured rates of glucose uptake, lactate production, and mitochondrial 
respiration.  
E.2. Fluxes and metabolites in healthy neurons  
Table 5 below shows the fluxes for all blocks in healthy neurons as well as those treated 
with each modulation. The values were normalized to the paired high K control to reduce the 
variability between different cell preparations. The fluxes in control neurons are expressed as the 
rate of substrate consumed, except for the phosphorylation block (PHO) which is expressed as 
the rate of product (ATP) formed. For the first time, these results provide a comprehensive 
metabolic profile of healthy attached monolayer neurons.  
According to our results, only 53.7±1.3% of glucose transported into the cell from the 
media was metabolized via glycolysis. This percentage is higher than that found in detached 
differentiated rat cortical neurons
28
. Conversely, this is lower than that found by Brekke et al
29
 
(glycolysis is 94% of net glucose metabolism) a finding which was recently described as an over 
estimation of glycolysis in intact neurons
30
. The discrepancy in estimating glycolysis was 
attributed to the method used in Brekke et al 
29
that may underestimate glucose metabolism 
through the PPP (i.e. isotopic labeling of acetyl-CoA at carbon one from 2-
13
C glucose is not 
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exclusively from glycolysis, as the recycling of G6P through the PPP can produce this label). In 
this study, assessing the labeling pattern of lactate from 1, 2-
13
Cglucose as well as the absolute 
rates of glucose consumption, lactate production, and mitochondrial pyruvate oxidized provided 
a more accurate way to assess glycolytic and PPP fluxes . Our results showed that OxPPP flux 
was 87.30.3 % of the rate of glucose uptake, indicating that OxPPP flux was 1.630.05-fold 
greater than glycolytic flux.. Of the G6P metabolized through the OxPPP,  48.31.3% % was 
returned to the hexose phosphate pool through the NonPPP, leaving 51.71.3% net use by the 
pentose cycle (PC; combined Ox- and NonPPP) as well as by nucleotide synthesis. Thus, of the 
glucose take up by the neurons, 20.60.5% was used by the PC, 25.71.8% was used for 
nucleotide synthesis, and 53.71.3% was used by glycolysis. The glucose used by the PC is 
higher than that recently determined in intact primary neurons (PPP is 14% of glucose 
metabolized)
30
, in primary cortical neurons (6% of glucose metabolized)
29
, and cerebellar 
neurons (4% of glucose metabolized)
29
. Also, it is higher than that reported in in vivo studies on 
basal forebrain and intracerebral glioma (3.5% and 6.2%, of glucose metabolized respectively)
31
. 
Furthermore, this ratio (PC/GM) is remarkably lower than that in neuronal suspension (70%)
28
. 
The considerable contribution of the PC to glucose metabolism indicates that glutathione 
turnover/recycling may be quite high
32
 making the production of NADPH via the PPP critical for 
maintenance of the redox status of neurons
27,31
. 
The sources of pyruvate in our system are glycolysis, the NonPPP, and cytoplasmic malic 
enzyme. Of these, glycolysis was the major source of pyruvate (74.2 ± 0.10%), whereas the 
NonPPP, and ME reactions contributions were relatively small (14.3 ± 0.03 % and 11.6 ± 0.13 
%, respectively). The production of pyruvate and NADPH from malate and the re-oxidation of 
pyruvate by mitochondria, pyruvate recycling, was first reported in 1990 by Cerdan and 
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colleagues in brain
33
. This pathway may be important to maintain neuronal energy demand 
during limited substrate (i.e. glucose, ketone bodies, and lactate) supply. McKenna and her group 
initially found that the activity of malic enzyme was limited to astrocytes not neurons in cerebral 
hemisphere tissue
34
. Five years later, they found detectable mitochondrial malic enzyme activity 
in cerebellar neurons
35
. Furthermore, the activity of mitochondrial malic enzyme was confirmed 
in neurons of perfusion-fixed rat brain
36
. In agreement with previous studies, our results indicate 
that malic enzyme and pyruvate recycling contributes to the NADPH cytosolic pool (data 
discussed later in this section) that is important for redox status maintenance
35,36
. 
 Interestingly, a substantial amount of the pyruvate produced (74.2± 0.7%) was reduced 
to lactate and only 25.8 ± 0.65 % was oxidized by mitochondria. This is substantially higher than 
for some in vivo studies (3.5% 
37
and 7% 
38
 of glucose uptake). The percentage of glucose 
converted to lactate was suggested to be regional in human brain (i.e. lower in cerebellum and 
medial temporal lobes than medial and lateral parietal and prefrontal cortices)
39
.These findings 
support the recent findings that in cultured glutamatergic neurons (i.e. CGNs), glucose utilization 
in presence of glucose and glucose plus lactate is correlated with the level of intracellular 
calcium
40
. This intracellular calcium level is important for activity of mitochondrial citric acid 
cycle enzyme.  
In the light of these results, the mechanism through which neurons favor lactate 
production rather than oxidative phosphorylation  is at least partly due to a more favorable 
gradient for lactate excretion by the plasma membrane monocarboxylate transporters in the 
current in vitro studies. Lactate transport is readily reversible depending on the pH and lactate 
concentrations across the plasma membrane..For the current experiments, neurons were 
incubated in lactate-free buffer, and without glial cells as a major lactate producer, whereas in 
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vivo the concentration of extracellular lactate can reach low millimolar levels. Accordingly, 
lactate efflux is much more thermodynamically favorable in these cultured neurons. In fact, one 
of the modulations used in the present experiments was supplementation of the media with 2mM 
lactate, which substantially reduced the rate of lactate extrusion by the CGNs (see Table 5).  
The cytoplasmic reducing equivalent, NADPH, in our system was predominately 
produced by the PPP (93.4 ± 0.2 %) rather than by ME (6.6 ± 0.2%). This finding confirmed the 
leading role of the PPP in maintaining the neuronal redox status through NADPH supply. The 
produced NADPH is critical for the reduction of glutathione disulfide by glutathione reductase 
27
. The neuronal redox status in turn, is controlling the activity of pro-apoptotic proteins (i.e. 
cytochrome c, and caspase) suggesting a crucial role of PPP in mediating the neuronal survival
41
. 
In agreement with this idea, cells with high PPP activity (i.e. tumor cells) were resistant to death 
by apoptosis
27
. 
The net rate of ATP production in our cell model was 2043.4 ± 59.0 pmol ATP/min. Of 
this, 65.8 ± 0.5% was derived from mitochondria (the PHO block), 23% was from glycolysis (the 
GLY block), and 5.9% was from the NonPPP. It should be emphasized that the NonPPP is not 
typically an ATP producer, but in this study the ATP producing reactions of glycolysis were 
grouped within the NonPPP; thus, in total 28.9% of cellular ATP was derived from the glycolytic 
reactions. This percentage of mitochondria-derived ATP is very close to that reported for 
activated neurons
42
. 
Metabolites were measured in healthy neurons with or without modulation (Table 6). 
First column includes absolute concentrations whereas the other columns contain measured 
metabolites in modulation-treated neurons normalized to control (healthy neurons). 
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E.3. Modulation-treated neurons 
Tables 5, and 6 summarize the fluxes and metabolite concentrations for each modulation. 
All modulations caused measurable perturbation in their direct target reactions (see Chapter 2, 
Section E.1.). Interestingly, changes occurred not only in the direct targets but also in other 
fluxes and metabolites in the system. For example, in β-hydroxybutyrate(BHB)-treated neurons, 
the expected change in the rate of NADH and pyruvate oxidation relative to control was 
extensive (<0.01±0.02% and 0.61±0.06%, respectively). However, and due to the connected 
nature of fluxes by common metabolites, many fluxes and  metabolites were notably changed. As 
discussed in Chapter 2, Section E.1.7., BHB can be oxidized by mitochondrial -
hydroxybutyrate dehydrogenase into acetoacetate to generate NADH; the acetoacetate can be 
excreted or further oxidized in the TCA cycle, which was taken into account in our model. 
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The measured rate of BHB consumed was 84.5±7.1 pmol/min. Of this, 58.57.1 
pmol/min was oxidized to acetoacetate, while 31.0±3.91 pmol/min  was completely oxidized 
within the TCA cycle. Since BHB provided a third source of mitochondrial substrate, the 
mathematical model was modified to take into account the additional source. Accordingly, the 
mitochondrial contribution to total cellular ATP production increased to 76.3±1.2% whereas 
glycolytic ATP (from both GLY and NonPPP) was reduced to 20.6±1.3%. The additional 
mitochondrial substrate directly affected the rate of consumption of pyruvate and glycolytic 
NADH. Our results indicated a notable decrease in the rate of pyruvate oxidation relative to 
control (0.62±0.06) causing accumulation of pyruvate as measured 1.46±0.34 fold. Glycolytic 
rate decreased (0.77±0.02) while its substrate G6P increased 1.52±0.22 fold. Apparently, 
accumulated G6P was not only due to low glycolysis, but also because 30% less G6P was used 
by the pentose cycle. This reduction of PPP may be caused by increased ME (1.42±0.09 fold 
)which provide another source to the cytosolic NADPH pool that was increased in BHB-treated 
neurons (16.3±1.6% of total NADPH instead of 6.62 ± 0.22% in control).The expected change in 
NADH and pyruvate oxidation due to BHB modulation was propagated throughout the system 
by the virtue of connectedness.  
Likewise, the addition of cyanide (100µM), inhibitor of the respiratory chain complex IV, 
caused a remarkable decrease in the kinetics of PYR and NAO (0.54±0.52 and 0.51±0.45, 
respectively) that propagated throughout the system by the virtue of connectedness. The 
inhibition of complex IV of respiratory chain prevents electron transfer for the reduction of 
oxygen molecules to water causing low mitochondrial ATP yield (22.1±2.0% Vs 65.8±0.5% for 
control). Consequently, glycolytic ATP was increased (57.9±2.3% Vs 26.9±2.5% for control) to 
meet cellular demand and to compensate the decrease in mitochondrial ATP. This was noted by 
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reduced PYR flux (0.52±0.06 fold) and NAO (0.45±0.13) as well as activated LAC (1.61±0.08 
fold). Accordingly, the percent of pyruvate converted to lactate increased to 91.7±0.9% whereas 
pyruvate oxidation contribution was reduced to 8.3±0.9%. Also, the cellular level of 
NADH/NAD increased 1.58±0.24 fold in response to inhibited PYR and NAO.  
Pyruvate dehydrogenase (PDH) was expected to be activated in dichloroacetate (DCA)-
treated neurons due to the inhibitory effect of DCA on pyruvate dehydrogenase kinase enzyme 
(see Chapter 2, Section E.1.6.). Accordingly, blocks that including PDH, PYR and NAO, were 
expected to directly activated. Surprisingly, PYR showed minimal response (1.06±0.06 fold) 
despite a remarkable decrease in pyruvate (0.29±0.38 of controls). Interestingly and 
unexpectedly, the activity of malic enzyme decreased (0.52±0.03) which may partly explain the 
decrease in pyruvate level. The shortage in pyruvate supply (i.e. reduced pyruvate recycling) 
may influenced the rate of its oxidation regardless of the enzyme activity. In agreement with this, 
maintained supply of NADH (GLY= 0.97±0.03) was coupled with activated NAO (1.69±0.48) in 
DCA-treated neurons.  Despite only a modest increase in PYR flux, this was sufficient to 
significantly increase the percentage of ATP generated by the mitochondria(69.3±2.2% Vs 
64.1±0.5% in control) and decreased the ATP derived from glycolysis (25.5±2.3% Vs 
30.8±0.6% in control) to cellular ATP pool. Despite the measured inhibition in ME and marginal 
change in PYR, the fraction of pyruvate oxidized by mitochondria increased to 31.1±3.1% from 
25.8±0.7% in the controls. 
The addition of 0.5 µM FCCP, the proton ionophore uncoupler, to healthy neurons 
caused, as expected, extensive increase in the proton leak rate (9.71±1.13 fold). This perturbation 
caused further changes in fluxes through changes in common metabolites. For example, the 
decrease in m (0.93±0.01 fold) due to increased proton leak caused activation of GTP 
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(1.64±0.26) and hence GLY (1.77±0.07) to compensate for the loss in proton motive force. Low 
substrate (H
+
) due to perturbed proton motive force may reduce the activity of ATP-synthase and 
hence PHO block. Our results, however, showed slightly greater PHO flux (1.17±0.14 fold) 
which is likely an artifact of errors in measurement of the leak rate with FCCP. The fact that 
ATP/ADP ratio declined (0.85±0.09) suggests that PHO activity was compromised despite the 
inability to detect it in these experiments.  Despite this, the contribution of PHO to ATP 
synthesis decreased to 52.53.4% and the contribution by glycolysis increased to 41.7±3.8%) 
because GLY and NonPPP fluxes were more strongly increased. Stimulation of mitochondrial 
substrate oxidation indirectly by FCCP was also reflected in more pyruvate being oxidized rather 
than reduced to lactate (compare 56.5% of pyruvate to lactate with FCCP vs. 75% for controls). 
Addition of lactate (2mM) to CGNs, as expected (see Chapter 2, Section E.1.4.), caused 
lactate production and transportation to be less favorable (0.42±0.08) which directly caused the 
observed accumulation of pyruvate (1.37±0.34). As a result, the percent of pyruvate oxidized by 
mitochondria increased (39.7±5.1% Vs 25.8±0.7% for control) while that reduced to lactate 
decreased (60.3±5.1% Vs 74.2±0.7% for control). Glycolysis substantially declined (0.50±0.06) 
while activating PYR (1.370.06 fold).  As a result, the contribution of mitochondria to total 
cellular ATP synthesis increased (75.3±3.2% Vs 64.1±0.5% for control). Likewise, inhibition of 
glycolysis reduced its contribution to cellular ATP (18.3±3.4% Vs 30.8±0.6% for control). 
Low glucose-treated neurons showed an expected reduction in GTP and GLY fluxes 
(0.60±0.05 and 0.53±0.06, respectively). This initial perturbation was propagated throughout the 
cell by the effect of common metabolites such as G6P (0.57±0.13 fold) and pyruvate (0.36±0.10 
fold). However, PYR block was minimally affected by the low pyruvate content as 
mitochondrial respiration rate was not affected. As a result, the fraction of pyruvate reduced to 
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lactate decreased significantly (54.2±6.7% Vs 74.2±0.7% for control) while the fraction oxidized 
by mitochondria increased (45.8±5.16% Vs 25.8±0.7% for control). Since glycolysis was 
substantially reduced but mitochondrial substrate oxidation was not, there was a significant shift 
to a greater proportion of ATP generated by the mitochondria (76.51.7% vs. 65.80.5% for 
controls). 
Addition of 10ng/L oligomycin to healthy neurons caused kinetic inhibition of F1F0-
ATPase and hence inactivation of PHO block (0.15±0.00). This kinetic change resulted in further 
change in other fluxes through changes in common metabolites that established new steady state. 
Reduced H
+
 influx into mitochondrial matrix through ATPase increased m, thus increasing 
PRL flux (2.20±0.00 fold). Also, the fraction of pyruvate oxidized by the mitochondria was 
remarkably decreased (2.6±0.4% Vs 25.8±0.7 for control) while that reduced into pyruvate was 
increased (97.4±0.4% Vs 74.2±0.7% for control). Consequently, the glycolytic ATP contribution 
to total ATP produced by the cell was substantially increased (88.9±1.8% Vs 30.8±0.6% for 
control). In contrast, the mitochondrial ATP yield was notably reduced in oligo-treated cells 
(9.6±1.5% Vs 64.1±0.5). 
Addition of (25μM) tert-butyl hydroperoxide (tBHP) to neurons was expected to directly 
activate NADPH consumers (i.e. glutathione reductase), however, this effect was not pronounced 
(1.09±0.12 fold). Consequently, the cellular level of NADPH decreased as observed (0.76±0.17 
fold) which should contribute to stimulation of the NADPH producers. Of these producers, is 
ME block which was activated 1.11±0.13 fold while the main producer, OxPPP, was slightly 
increased (1.09±0.12 fold) . The net glucose metabolized through glycolysis was similar 
(59.5±2.9% Vs 57.6±2.5% for control) while that used by the pentose cycle was also unchanged 
(22.5±1.0% Vs 22.1±0.9%). Despite a slight increase in NADPH consumption, this modulation 
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did not significantly impact the proportion of glucose used for glycolysis or the OxPPP, so the 
concentration of oxidant was insufficient to perturb the fluxes as intended.  
E.4. Elasticity coefficients of the reaction blocks to the metabolites in healthy 
neurons 
Table 8 below summarizes the responsiveness of each block to each explicit metabolite. 
This study is the first to determine elasticity coefficients in primary neurons. The coefficients 
were calculated from the measured fractional flux (𝑑𝐽 𝐽 ) and metabolite (𝑑𝑥 𝑥 ) changes 
induced by the modulations which do not directly affect a block‟s kinetics. For each modulation 
that satisfies this criterion, the fractional flux change is a function of the fractional metabolite 
changes and the elasticity of the block to each metabolite (Eq. 12). For calculation of the 
elasticities to be valid, the number of modulations applied must equal or exceed the  
number of explicit metabolites (xm).   
𝑑𝐽 𝑖
𝐽 𝑖
 ≈  𝜀𝑥1
𝑖  ∙  
𝑑𝑥1
𝑥1
+  𝜀𝑥2
𝑖  ∙  
𝑑𝑥2
𝑥2
+  𝜀𝑥3
𝑖  ∙  
𝑑𝑥3
𝑥3
+∙∙∙∙∙∙∙∙∙∙∙∙∙+𝜀𝑥𝑚
𝑖  ∙  
𝑑𝑥𝑚
𝑥𝑚
                                         (12) 
In theory, a set of m equations can be solved for the m elasticities, but in practice the presence of 
experimental error precluded unique solutions to each set of equations. The elasticities were 
estimated using the Microsoft Excel solver function which minimized the error between the 
measured and calculated fractional fluxes for all valid modulations (i.e., those not directly 
affecting a block)(Eq. 6). Thus, the solver function was used to iteratively adjust the elasticities 
to minimize the least squares error. 
  
𝑑𝐽𝑖
𝑚𝑜𝑑
𝐽 𝑖
−  𝜀𝑥
𝑖
𝑎𝑙𝑙  𝑥 ∙
𝑑𝑥
𝑥
 𝑎𝑙𝑙  𝑚𝑜𝑑
2
 𝑚𝑜𝑑 ≥ m 
 
(13) 
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Where “mod” is a specific modulation, and “all mod” is all valid modulations used. For 
calculating the elasticities some of the valid modulations were not used, and some constraints 
were placed on the solver so that the solutions were compatible with established biochemical and 
MCA concepts, provided that the least squares error did not exceed 5% of the fractional flux sum 
of squares. Essentially, the constraints placed on the solver and the valid modulations excluded 
were chosen so that (a) 𝜀𝑠𝑢𝑏𝑠𝑡𝑟𝑎𝑡𝑒
𝑏𝑙𝑜𝑐𝑘 > 0, (b) 𝜀𝑝𝑟𝑜𝑑𝑢𝑐𝑡
𝑏𝑙𝑜𝑐𝑘 < 0, and (c) 𝜀∆𝜑
𝑏𝑙𝑜𝑐𝑘  was minimized for those 
blocks not directly producing or consuming m (Table 7). The first two constraints are based 
on principles of enzymology, while the latter constraint was included because m is spatially 
restricted to the mitochondrial compartment while many of the blocks are exclusively 
cytoplasmic. For GLY, LAC, OxPPP, and NonPPP blocks, their respective elasticities to m 
were minimized by assuming that the sum of the absolute values of the elasticities to their 
respective substrates and products was greater than to m (for LAC and OxPPP, where each of 
these has one substrate and one product) or to the sum of the absolute value to m and 
NADPH/NADP (for GLY and NonPPP, where each of these produces/consumes four 
metabolites). For GTP, ATC, and NPO blocks, their respective elasticities to m were 
minimized by excluding FCCP (for GTP and ATC) or HB (for NPO) from the analysis. 
Importantly, after systematic removal of each modulation, exclusion of BHB was the only 
condition under which𝜀𝑁𝐴𝐷𝑃𝐻
𝑁𝐴𝐷𝑃
𝑁𝑃𝑂 > 0, so it appeared that this modulation was directly affecting 
NPO kinetics. 
There were only five modulations available for calculating the six elasticities to each of 
the m producers (i.e., PYR and NAO), as one of the intended modulations to inhibit the 
OxPPP (androsterone) appeared to directly affect PYR and NAO by virtue of the measured flux 
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and metabolite changes (decreased respiration rate, decreased m, and increased lactate 
production- data not shown) and thus was excluded. To run the analysis with five equations and 
five unknowns, it was assumed that 𝜀𝑃𝑦𝑟
𝑃𝑌𝑅 = 0.17, as determined by Ainscow and Brand43in 
hepatocytes. This assumption was reasonable given that the analysis resulted in𝜀∆𝜑
𝑃𝑌𝑅 = −11.7, 
which is similar to that determined by Ainscow and Brand (-16.5) despite differences in 
organization of the reaction blocks
43
.Similarly, for the NAO block it was assumed that 𝜀∆𝜑
𝑁𝐴𝑂 =
−23.2, as determined by Ainscow and Brand43. This assumption also seemed reasonable given 
that the analysis resulted in 𝜀𝑁𝐴𝐷𝐻
𝑁𝐴𝐷
𝑁𝐴𝑂 = 0.41, similar to that determined in hepatocytes (0.74). 
For the PHO block, two valid modulations (FCCP, Lactate) were excluded because of 
substantial errors between measured and calculated fluxes with the constraint imposed on the 
solver (Table 7). For FCCP, the increase in respiration rate (1.74-fold) stimulated respiratory 
chain H
+
 pumping by 3402 H
+
 per min., but the measured FCCP leak kinetics and m indicated 
an increase of only 2906 H
+
 used per min. This meant that the calculated PHO block flux 
increased 1.17-fold, contrary to the expected decrease due to reduction in m. This unexpected 
result likely was from measurement error in the FCCP-induced H
+
 leak kinetics. With FCCP 
excluded, the residual least square error was an unacceptably high 31% of the fractional flux sum 
of squares, and this error was largely due to discrepancy between the calculated and measured 
PHO flux in the presence of lactate. Most of this error could be attributed to the very small 
increase in m with lactate (compared to HB). Exclusion of FCCP and Lactate left only five 
modulations for the analysis, so it was assumed that 𝜀𝑁𝐴𝐷𝐻
𝑁𝐴𝐷
𝑃𝐻𝑂 = 0 as this was the result obtained 
when FCCP was the only modulation excluded. 
 
158 
 
Table 7-C. Solver constraints and excluded valid modulations used in calculating elasticity values. Blocks GTP, 
glucose uptake and transportation; GLY, glycolysis; PYR, pyruvate oxidation; LAC, lactate production and 
transportation; NAO, NADH oxidation; PHO, oxidative phosphorylation block; PRL, proton leak block; ATC, ATP 
consumers; OxPPP, oxidative phase of pentose phosphate pathway (PPP); NPO, NADPH oxidation block; NonPPP, 
non-oxidative phase of PPP; ME, malic enzyme block. Solver constraints were set for all blocks except GTP, ATC, 
NPO, and ME. Constant values of elasticity (ε) were set for PYR (Pyr = 0.17), NAO (Pyr = -23.2) and PRL (G6P, 
NADPH, Pyr, NADH, ATP = 0). Solver constraint for GLY, LAC, OxPPP, and NonPPP, were set to minimize their 
respective elasticities to m. Excludes modulations are FCCP, in GTP; DCA, in GLY; oligo, in LAC; FCCP, in 
PHO; BHB, foe NPO; and DCA, for NonPPP. 
Block Solver constraint Valid modulations excluded 
GTP None FCCP: Excluded to minimize  
GLY  𝜀𝐺6𝑃,𝑃𝑦𝑟 ,𝐴𝑇𝑃 ,𝑁𝐴𝐷𝐻  ≥ 𝜀∆𝜑 ,𝑁𝐴𝐷𝑃𝐻  DCA: Excluded so that Pyr< 0 
PYR Pyr = 0.17 None 
LAC  𝜀𝑃𝑦𝑟 ,𝑁𝐴𝐷𝐻  ≥ 𝜀∆𝜑  
Oligo: Excluded to minimize  and to 
reduce the least squares error. 
NAO  = -23.2 None 
PHO NADH = 0; ATP< 0; ATP 𝜀𝐺6𝑃,𝑃𝑦𝑟 ,𝑁𝐴𝐷𝑃𝐻  
FCCP: Excluded due to dJ/J > 0 contrary to 
the expected.  
Lac: Excluded to reduce the least squares 
error. 
PRL G6P, NADPH, Pyr, NADH, ATP = 0 Not Applicable 
ATC None 
FCCP: Excluded to minimize  and 
because it may directly affect the ATC. 
OxPPP  𝜀𝐺6𝑃,𝑁𝐴𝐷𝑃𝐻  ≥  𝜀∆𝜑  None 
NPO None 
BHB: Excluded to minimize  and so 
NADPH>0. 
NonPPP  𝜀𝐺6𝑃,𝑃𝑦𝑟 ,𝐴𝑇𝑃 ,𝑁𝐴𝐷𝐻  ≥ 𝜀∆𝜑 ,𝑁𝐴𝐷𝑃𝐻  DCA: Excluded so that Pyr< 0 
ME None 
BHB and Lac: Excluded as they most likely 
substantially change [malate], which could 
affect the elasticities, and so NADPH< 0. 
 
The least-squares elasticity solutions are shown in Table 8. While some of the elasticities 
can be explained by simple enzymology, there were a number of seemingly unexpected results, 
some of which are a consequence of how the blocks were organized, and others of which are 
more difficult to reconcile within the context of conventional biochemistry. Of the three products 
generated by the GLY block, ATP/ADP exerts the strongest feedback inhibition (𝜀𝐴𝑇𝑃/𝐴𝐷𝑃
𝐺𝐿𝑌 =-
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3.09), similar to ATP in hepatocytes (𝜀𝐴𝑇𝑃/𝐴𝐷𝑃
𝐺𝐿𝑌  = -2.7)
43
. The inhibition of GLY is notably 
stronger than for PHO (𝜀𝐴𝑇𝑃/𝐴𝐷𝑃
𝑃𝐻𝑂  = -0.61), the latter of which is considered quite sensitive to 
ATP/ADP. This is similar to the findings reported for hepatocytes (𝜀𝐴𝑇𝑃/𝐴𝐷𝑃
𝑃𝐻𝑂 = −1.24)43. Thus, 
changes in ATP/ADP have a much greater impact on glycolytic flux than on oxidative 
phosphorylation. Unexpectedly, the elasticity of GLY to one of its products – NADH/NAD- was 
significantly positive (𝜀𝑁𝐴𝐷𝐻/𝑁𝐴𝐷
𝐺𝐿𝑌  = 1.1), suggesting that unknown sites of allosteric activation 
supersedes any possible feedback inhibition. This was not the case in hepatocytes, where 
NADH/NAD exerted modest feedback inhibition (𝜀𝑁𝐴𝐷𝐻/𝑁𝐴𝐷
𝐺𝐿𝑌  = -0.23)
43
. 
In addition to GLY, ATP/ADP exerted inhibitory effects on a number of blocks not 
traditionally considered to respond to adenine nucleotides, including GTP, LAC, NAO, OxPPP, 
and NPO. This pleiotropic effect is consistent with a recent study indicating that ATP, ADP, and 
AMP may exert allosteric effects on a number of glycolytic enzymes in situ that have not 
traditionally been considered to respond to these nucleotides in vitro
44
. While ATP/ADP is a 
substrate for the GTP block, G6P has long been considered the main regulator of hexokinase 
(and thus GTP flux), but the current result indicates that ATP/ADP is the more important 
negative regulator for the combined activities of GLUT transporters and hexokinase. According 
to our system arrangement and grouping, a change in G6P was expected to strongly affect the 
activity of both GLY and OxPPP blocks. Interestingly, neither block is particularly responsive to 
G6P (𝜺𝑮𝟔𝑷
𝑮𝑳𝒀= 0.28 vs. 𝜺𝑮𝟔𝑷
𝑶𝒙𝑷𝑷𝑷 =0.07), but GLY is more strongly affected than the OxPPP. 
Furthermore, PYR and LAC compete for the substrate pyruvate, but the LAC flux is more 
strongly affected by this metabolite (𝜺𝑷𝒚𝒓𝒖𝒗𝒂𝒕𝒆
𝑳𝑨𝑪  = 0.50 vs 𝜺𝑷𝒚𝒓𝒖𝒗𝒂𝒕𝒆
𝑷𝒀𝑹 =0.17). This is consistent with 
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the findings in hepatocytes
43
 and indicates that increased glycolytic supply of pyruvate will 
disproportionally increase lactate production over mitochondrial pyruvate oxidation. acetate. 
Although m is a common metabolite between PRL and PHO blocks, PHO is about 2.5 
times more sensitive to small changes in this substrate than PRL (𝜀m
𝑃𝐻𝑂 = 16.9 vs 𝜀m
𝑃𝑅𝐿 =6.7). 
Thus, in neurons, stimulation of mitochondrial substrate oxidation will have a more profound 
effect on activating oxidative phosphorylation than proton leak. This differs from hepatocytes, 
where PRL and PHO had identical elasticities (6.9)
43
. It is worth noting that the kinetics of H
+
 
leak to m in neurons was virtually the same as that in hepatocytes
43
. Here it should be noted 
that mitochondrial membrane potential exerted surprisingly strong pleiotropic effects on many of 
the blocks not directly producing or consuming it (i.e. GLY, LAC, and NonPPP). Furthermore, 
GLY was strongly stimulated bym (𝜀m
𝐺𝐿𝑌  = 4.0), as were the ME (𝜀m
𝑀𝐸  = 4.9), NonPPP 
(𝜀𝑚
𝑁𝑜𝑛𝑃𝑃𝑃  = 4.8), and LAC (𝜀m
𝐿𝐴𝐶  = 1.6) blocks. These positive elasticities, coupled with 
feedback inhibition of m on PYR and NAO, promote anaerobic glycolysis and lactate 
production. Because m is spatially distinct from most of these blocks (the exception being 
ME), the allosteric activator is likely to be a factor which varies with m (e.g., superoxide or 
another ROS). Mitochondrial membrane potential exerted inhibitory allosteric effects on the 
ATC (𝜀m
𝐴𝑇𝐶  = -3.1), OxPPP (𝜀m
𝑂𝑥𝑃𝑃𝑃  = -0.94) and NPO (𝜀m
𝑁𝑃𝑂  = -0.73). Notably, in hepatocytes 
m exerted stimulatory rather than inhibitory effects on the ATP consumers (𝜀m
𝐴𝑇𝐶  = 0.90)
43
. 
Strikingly, ATC had week responsiveness to its direct substrate ATP/ADP (𝜀𝐴𝑇𝑃
𝐴𝐷𝑃
𝐴𝑇𝐶 =
0.11), this in contrast to the much greater responsiveness of the ATP consumers to ATP in 
hepatocytes (𝜀𝐴𝑇𝑃
𝐴𝐷𝑃
𝐴𝑇𝐶= 2.68)43. This can partly explained by the differences in the explicit 
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metabolite (ATP/ADP neurons vs ATP hepatocytes). This observation, however, indicates that 
neuronal ATP consumption rate is relatively insensitive to small changes in ATP/ADP ratio. 
Both NADPH consumers were subject to feedback inhibition by NADPH/NADP, 
although the OxPPP was more sensitive to this than ME (𝜀NADPH /NADP
𝑂𝑥𝑃𝑃𝑃  = -0.87 vs. 𝜀NADPH /NADP
𝑀𝐸  
= -0.56), which is not surprising given that the OxPPP accounted for 91% of NADPH 
production. Interestingly, the elasticities of GLY, LAC, NonPPP, PYR, NAO, ME, and ATC to 
NADPH/NADP were opposite in sign to their elasticities to m. Thus, increased 
NADPH/NADP promotes mitochondrial substrate oxidation and ATP consumption while 
reducing glycolysis and lactate production. The antagonistic effects of NADPH/NADP and m 
on these blocks are intriguing given that high NADPH/NADP promotes NADPH consumption 
(𝜀NADPH /NADP
𝑁𝑃𝑂 = 0.39). High NADPH consumption in turn promote protection of protein thiols 
from ROS and increased ROS scavenging, while increased m has been linked to greater ROS 
production (at least in isolated mitochondria). Hence it is possible that these effects are mediated 
through ROS.  
It should be noted that the elasticities of the NonPPP generally parallel those for GLY. 
This is a consequence of the lower portion of glycolysis (all reactions converting the triose 
phosphates to pyruvate) being grouped within the NonPPP. It is likely that there is some error in 
the NonPPP elasticities since the effect of the substrate (ribulose-5-phosphate, ribose-5-
phosphate, and xyulose-5-phosphate)on the flux was not quantified. Nonetheless, because of the 
way the block was organized, the strongest metabolite effects on the NonPPP are most likely the 
glycolytic products, which would most likely minimize the error associated with not determining 
the substrate elasticity. 
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E.5. Concentration control coefficients for healthy neurons 
The concentration control coefficients quantify the extent to which each reaction controls 
the concentration of a specific metabolite (x) within the system boundaries (𝐶𝐸1
𝑥 ). Here it should 
be noted that the metabolite controlled by a block is not necessarily limited to the block‟s 
substrate or product, as it can be controlled by virtue of the influence the block exerts on one or 
more of the producers or consumers of the metabolite. Mathematically, a concentration control 
coefficient is the fractional change in metabolite x (dx/x) due to a fractional change in flux (dJ/J) 
through a block 
𝐶𝐸1
𝑥 =
𝑑𝑥 𝑥 
𝑑𝐽 𝑏𝑙𝑜𝑐𝑘 𝐽𝑏𝑙𝑜𝑐𝑘 
                                                                                                        (14) 
A reaction block is expected to exert the most control over a metabolite that is either a substrate 
or a product. Reactions typically exert positive control over their products so that a more active 
flux increases the metabolite. Similarly, reactions typically exert negative control over their 
substrates so that a more active flux decreases the metabolite. Table 9 summarizes the control 
that each block exerts over the metabolites. The results indicate that the explicit metabolites were 
not only controlled by the blocks that produce and consume the metabolites, but also by more 
distant blocks through their effects on other metabolites that affect the producers/consumers. 
Glucose-6-phosphate is produced by GTP and the NonPPP, and consumed by GLY and 
OxPPP, so most of the control of this metabolite was expected to reside with these blocks. Both 
G6P consumers exerted similarly large, negative control over G6P (𝐶𝐺𝐿𝑌
𝐺6𝑃 = −1.61, 𝐶𝑂𝑥𝑃𝑃𝑃
𝐺6𝑃 =
−1.68), but the ATC also contributed (𝐶𝐴𝑇𝐶
𝐺6𝑃 = −0.54) because of the large negative elasticities 
of GLY and OxPPP to ATP/ADP (i.e., the ATC negatively affected ATP/ADP, which in turn 
stimulated both of the G6P consumers). Positive control by the two G6P producers balanced only 
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half of the negative control by the two consumers (𝐶𝐺𝑇𝑃
𝐺6𝑃 = 1.26,𝐶𝑁𝑜𝑛𝑃𝑃𝑃
𝐺6𝑃 = 0.39). The 
remaining positive control was due to LAC (𝐶𝐿𝐴𝐶
𝐺6𝑃 = 1.05), NPO (𝐶𝑁𝑃𝑂
𝐺6𝑃 = 0.55), and NAO 
(𝐶𝑁𝐴𝑂
𝐺6𝑃 = 0.44). The LAC block positively affected G6P production by both the GTP and 
NonPPP primarily through its control over pyruvate (which was most important in affecting the 
NonPPP given the negative elasticity of this block to pyruvate), NADH/NAD, and 
NADPH/NADP (the latter two were most important in affecting GTP given the positive 
elasticity of this block to NADH/NAD and negative elasticity to NADPH/NADP). Positive 
control by NAO was primarily mediated through its negative effects on G6P consumption by 
both GLY and the OxPPP; the NAO negatively affected G6P consumption primarily by its 
positive control over ATP/ADP coupled with the strong negative elasticities of the G6P 
consumers to this metabolite. Positive control by NPO was primarily mediated by its negative 
effect on the NADPH/NADP ratio, coupled with the relatively large negative elasticities of both 
G6P producers (GTP and NonPPP) to NADPH/NADP (i.e., the NPO relieved inhibition by 
NADPH/NADP over GTP and NonPPP). 
The control pattern over pyruvate was expected to primarily reside within the pyruvate 
producers (GLY, NonPPP, and ME) and consumers (LAC and PYR). The positive control of the 
producers (𝐶𝐺𝐿𝑌
𝑝𝑦𝑟𝑢𝑣𝑎𝑡𝑒
= 0.52,𝐶𝑁𝑜𝑛𝑂𝑥𝑃𝑃𝑃
𝑝𝑦𝑟𝑢𝑣𝑎𝑡𝑒
=0.93𝐶𝑀𝐸
𝑝𝑦𝑟𝑢𝑣𝑎𝑡𝑒
= 0.62) almost balanced the negative 
control of the consumers (𝐶𝐿𝐴𝐶
𝑝𝑦𝑟𝑢𝑣𝑎𝑡𝑒
= −1.33, 𝐶𝑃𝑌𝑅
𝑝𝑦𝑟𝑢𝑣𝑎𝑡𝑒
= −0.58). Glycolysis was the primary 
source of pyruvate (accounting for 74% of pyruvate production), so it was surprising that the 
NonPPP exerted more control over pyruvate than GLY; this was primarily a consequence of the 
NonPPP having negative control over ATP/ADP, which promoted pyruvate production by 
glycolysis because of the strong negative elasticity of GLY to ATP/ADP. Surprisingly, the GTP 
block exerted strongest positive control over pyruvate (𝐶𝐺𝑇𝑃
𝑝𝑦𝑟𝑢𝑣𝑎𝑡𝑒
= 1.56) which was primarily 
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due to its negative effect on ATP/ADP (𝐶𝐺𝑇𝑃
𝐴𝑇𝑃/𝐴𝐷𝑃
= −0.42) and its strong positive effect on 
G6P (𝐶𝐺𝑇𝑃
𝐺6𝑃 = 1.26) coupled with the elasticities of GLY to both metabolites. Negative control 
by NPO (𝐶𝑁𝑃𝑂
𝐺6𝑃 = −1.12) exceeded that for PYR primarily because of the large negative 
elasticity of LAC to NADPH/NADP and the strong negative control the NPO exerted over 
NADPH/NADP (i.e., consumption of NADPH by NPO relieves inhibition on LAC to stimulate 
pyruvate consumption).  
Control over NADH/NAD by both the NADH producers (GLY and NonPPP) and 
consumers (LAC, NAO) were opposite to that expected. Both producers had negative control 
(𝐶𝐺𝐿𝑌
𝑁𝐴𝐷𝐻/𝑁𝐴𝐷
=  −0.34; 𝐶𝑁𝑜𝑛𝑃𝑃𝑃
𝑁𝐴𝐷𝐻
𝑁𝐴𝐷 = −0.05) while both consumer share positive control 
(𝐶𝑁𝐴𝑂
𝑁𝐴𝐷𝐻/𝑁𝐴𝐷
= 0.12; 𝐶𝐿𝐴𝐶
𝑁𝐴𝐷𝐻/𝑁𝐴𝐷
= 0.10). Negative control by glycolysis was attributed to 
strong inhibition of NADH production by the NonPPP and GLY mediated by the control GLY 
exerted over G6P and ATP/ADP and the corresponding effects these metabolites had on GLY 
and the NonPPP to decrease NADH production. Negative control by the NonPPP was attributed 
primarily to stimulation of consumption by LAC because of the control the NonPPP exerted over 
pyruvate and ATP/ADP and the corresponding effects these metabolites had on increasing 
NADH consumption by the LAC block. Negative control was strongest by PYR  (𝐶𝑃𝑌𝑅
𝑁𝐴𝐷𝐻/𝑁𝐴𝐷
=
−0.74) because it stimulated NADH consumption by LAC through effects on NADPH/NADP 
and ATP/ADP. NADH consumption was dominated by LAC, but control over NADH/NAD was 
positive because of the strong effect this block exerted on increasing NADH production by GLY 
and NonPPP because of the strong control LAC exerted over G6P and pyruvate, and the 
elasticities of GLY and the NonPPP to these metabolites. Most of the positive control over 
NADH/NAD was by the ATC (𝐶𝐴𝑇𝐶
𝑁𝐴𝐷𝐻/𝑁𝐴𝐷
= 0.77), NPO (𝐶𝑁𝑃𝑂
𝑁𝐴𝐷𝐻/𝑁𝐴𝐷
= 0.22) and GTP 
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(𝐶𝐺𝑇𝑃
𝑁𝐴𝐷𝐻/𝑁𝐴𝐷
= 0.18). The latter two blocks exerted their effects by stimulating NADH 
production by both GLY and NonPPP: NPO stimulated both GLY and NonPPP (which have 
negative elasticities to NADPH/NADP) by negatively affecting NADPH/NADP, while GTP 
stimulated the NADH producers primarily through both positive control over G6P and negative 
control over ATP. The ATC similarly stimulated NADH production by negatively affecting both 
ATP/ADP and NADPH/NADP.  
Control of the ATP/ADP ratio was expected to primarily reside within the ATP producers 
(GLY, NonPPP, PHO, and PYR) and consumers (ATC and GTP). The GTP block exerted more 
negative control over ATP/ADP than did the ATC(𝐶𝐺𝑇𝑃
𝐴𝑇𝑃
𝐴𝐷𝑃 = −0.42, 𝐶𝐴𝑇𝐶
𝐴𝑇𝑃
𝐴𝐷𝑃 = −0.06)which was 
unexpected given that the ATC accounted for 86% of the ATP consumed. The stronger control 
by GTP was primarily due to the positive elasticity of the ATC to G6P (𝜀𝐺6𝑃
𝐴𝑇𝐶 = 0.38) coupled 
with the strong positive control GTP exerted over G6P.The elasticity of the ATC to G6P in this 
study was essentially identical to that found in hepatocytes
42
, and indicates that the concentration 
of G6P may be an important effector of cellular ATP consumption. Surprisingly, GLY was the 
only ATP producer exerting positive control over ATP/ADP (𝐶𝐺𝐿𝑌
𝐴𝑇𝑃/𝐴𝐷𝑃
= 0.27).The PHO block 
synthesized 66% of ATP, but exerted essentially no control over ATP/ADP (𝐶𝑃𝐻𝑂
𝐴𝑇𝑃/𝐴𝐷𝑃
=
−0.001). There were two effects underlying this lack of control. First, a fractional increase in 
PHO activity to increase ATP production is strongly opposed by m  consumption because of 
the large positive elasticity of the PHO to this metabolite. Second, an increase in PHO activity 
stimulates ATP consumption by the ATC through control over G6P and m, and the elasticities 
of the ATC to these metabolites (PHO activity tended to increase G6P and decreasem both of 
which will stimulate the ATC).The PYR block exerted negative control (𝐶𝑃𝑌𝑅
𝐴𝑇𝑃/𝐴𝐷𝑃
= −0.20) 
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primarily because of the strong negative control it had over NADH/NAD, which stimulated ATP 
consumption by reducing inhibition on the ATC (𝜀𝑁𝐴𝐷𝐻
𝑁𝐴𝐷
𝐴𝑇𝐶 = −0.51). The NonPPP exerted negative 
control (𝐶𝑁𝑜𝑛𝑃𝑃𝑃
𝐴𝑇𝑃/𝐴𝐷𝑃
= −0.16) despite producing ATP primarily because of the positive control it 
had over G6P coupled with the positive elasticity of the ATP consumers to G6P.The OxPPP was 
the most notable block not directly producing ATP that positively controlled ATP/ADP 
(𝐶𝑂𝑥𝑃𝑃𝑃
𝐴𝑇𝑃/𝐴𝐷𝑃
= 0.34). This occurred because of control exerted by the OxPPP on G6P and m, 
which reduced ATP consumption and increased its production by the respective elasticities of the 
ATC and PHO to these metabolites .Most of the effect was through strong negative control over 
G6P, which substantially impacted ATP consumption by the ATC.  
The NADPH/NADP ratio was evenly controlled by the NADPH producers 
( 𝐶𝑂𝑥𝑃𝑃𝑃
𝑁𝐴𝐷𝑃𝐻 /𝑁𝐴𝐷𝑃
= 0.43 𝐶𝑀𝐸
𝑁𝐴𝐷𝑃𝐻 /𝑁𝐴𝐷𝑃
= 0.33), despite the OxPPP accounted for 91% of 
NADPH synthesis. This balanced control appeared to result (a) partly from the antagonistic 
effect that ME had on the OxPPP because of its control over ATP/ADP and the strong negative 
elasticity of the OxPPP to this metabolite, and (b) partly from the stimulatory effect that the 
OxPPP had on ME because of the control the OxPPP had on G6P and ATP/ADP and the 
elasticity of ME to these metabolites. The GTP block exerted as much positive control as the 
OxPPP (𝐶𝐺𝑇𝑃
𝑁𝐴𝐷𝑃𝐻/𝑁𝐴𝐷𝑃
= 0.46) despite not producing NADPH primarily because of its control 
over ATP/ADP and pyruvate to which OxPPP is highly responsive. The NAO block also exerted 
notable positive control (𝐶𝑁𝐴𝑂
𝑁𝐴𝐷𝑃𝐻/𝑁𝐴𝐷𝑃
= 0.28), which was due primarily to its positive effect on 
ATP/ADP coupled with the strong negative elasticity of the NADPH consumers to ATP/ADP.As 
predicted, the NADPH consumers exerted the most substantial negative control over 
NADPH/NADP (𝐶𝑁𝑃𝑂
𝑁𝐴𝐷𝑃𝐻/𝑁𝐴𝐷𝑃
= −0.94), with some negative control also by the ATC primarily 
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because of the strong effect increased ATP consumption had on stimulating the NADPH 
consumers. 
E.6. Flux control coefficients for healthy neurons 
Table10 below represents the control that each block within the system exerts over one 
another a term known as flux control coefficient. Mathematically, flux control coefficient is the 
differential change in E1 block flux due to infinitesimal change in another block 
𝐶𝐸2
𝐸1 =
𝑑𝐽𝐸1
𝐽𝐸1
 
𝑑𝑉𝐸2
𝑉𝐸2
 
                                                                                                        (15) 
Some of these coefficients can be rendered to the direct/indirect connection between blocks 
through common intermediates whereas others cannot. 
E.6.1. Control of Glycolysis and Lactate Excretion 
The control over GLY was primarily distributed among OxPPP, GTP, ATC, NPO, GLY, LAC, 
and ME (with OxPPP, ATC, and GTP exerted most of control (𝐶𝑂𝑥𝑃𝑃𝑃
𝐺𝐿𝑌 =  −1.9,𝐶𝐴𝑇𝐶
𝐺𝐿𝑌 =
1.07 𝑎𝑛𝑑 𝐶𝐺𝑇𝑃
𝐺𝐿𝑌 = 1.3)). Most of the negative control by the OxPPP was through its positive 
control on ATP/ADP rather than its negative control over G6P as might be expected. This was 
because of the much stronger elasticity of GLY to ATP/ADP than to G6P.Glycolysis was one of 
only two blocks that exerted negative control over its own flux (𝐶𝐺𝐿𝑌
𝐺𝐿𝑌 = −0.61).This was due to 
the concerted effects that consumption of G6P and production of ATP, NADH, and pyruvate had 
on restraining its activity (i.e., the changes in these metabolites together overcame the intrinsic 
positive control a block has over its own flux). 
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Interestingly, the negative control by ME (𝐶𝑀𝐸
𝐺𝐿𝑌 = −0.42) was mainly due to the positive 
control it had on ATP rather than pyruvate. It is notable that PHO ranked as the weakest negative 
controller, but this was not by positive control over ATP (since it had none), but by negative 
control over NADH/NAD and m. The positive control by the ATC was primarily mediated 
through NADH/NAD rather than through ATP/ADP, as the ATC had much stronger control over 
the former than the latter metabolite. The positive control by GTP was about 96% mediated by 
through effects on ATP/ADP level coupled with the strong negative elasticity of GLY to 
ATP/ADP. The NADPH consumers also exerted significant positive control (𝐶𝑁𝑃𝑂
𝐺𝐿𝑌 = 0.93) 
primarily by consuming NADPH to relieve inhibition this metabolite had on GLY. Strikingly, 
the pyruvate consumer, LAC, exerted strong positive control over GLY (𝐶𝐿𝐴𝐶
𝐺𝐿𝑌 = 0.7) rather than 
the other pyruvate consumer, PYR, (𝐶𝑃𝑌𝑅
𝐺𝐿𝑌 = 0.02). The control by LAC was mediated by the 
strong positive control over G6P as well as the strong negative control over pyruvate coupled 
with the elasticity of GLY to these metabolites. These results indicate that small changes in LAC 
have much stronger effects on activation of GLY than do changes in PYR. Similar to 
hepatocytes
42
, the Pasteur Effect (negative control of glycolysis by increased mitochondrial 
activity), was observed in neurons, as the net control of the mitochondrial processes (PHO, 
NAO, PRL, PYR,) over GLY was substantial (-0.57; compare to -0.26 for hepatocytes
42
). 
Lactate production and export was controlled primarily by OxPPP, GTP, ATC, NPO, and 
GLY. Negative control was dominated by the OxPPP (𝐶𝑂𝑥𝑃𝑃𝑃
𝐿𝐴𝐶 =  −2.2) mainly due to the 
positive control over ATP/ADP and NADPH/NADP, to which LAC has high negative 
elasticities. Surprisingly, GLY was the second strongest negative controller despite being the 
primary supplier of substrates to LAC. The negative control was mediated through ATP/ADP, as 
LAC had a considerable negative elasticity to this metabolite. Positive control largely resided in 
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GTP (𝐶𝐺𝑇𝑃
𝐿𝐴𝐶 =  1.49), ATC (𝐶𝐴𝑇𝐶
𝐿𝐴𝐶 = 1.2), NPO (𝐶𝑁𝑃𝑂
𝐿𝐴𝐶 = 1.2), and LAC (𝐶𝐿𝐴𝐶
𝐿𝐴𝐶 = 0.74). Control 
by GTP was mediated through negative control over ATP/ADP and positive control over 
pyruvate, coupled with the high elasticity of LAC to these metabolites. The ATC and NPO 
exerted positive control primarily through effecting NADH/NAD and NADPH/NADP, 
respectively. Notably, the control of PYR over LAC was minimal because the negative effects 
mediated through pyruvate and NADH/NAD were largely offset by the positive effects mediated 
through NADPH/NADP and ATP/ADP. It is noteworthy that the control over LAC is most 
dependent on the reactions that control the levels of ATP and NADPH since LAC is most 
responsive to these metabolites. Thus, lactate production is not simply a consequence of greater 
glycolytic production of pyruvate and NADH.  
E.6.2. Control of Mitochondrial Substrate Oxidation 
According to our developed model, pyruvate and cytosolic NADH are transported and 
oxidized in mitochondria by citric acid cycle (for pyruvate) and respiratory chain reactions (for 
pyruvate and cytosolic NADH). Accordingly, the control over both fluxes is critical for 
mitochondrial respiration. 
Positive control over PYR was  distributed among many of the blocks (PHO, ME, PYR, 
OxPPP, NAO, and ATC), while negative control was principally restricted to NPO and LAC. 
The most prominent control was exerted by PHO (𝐶𝑃𝐻𝑂
𝑃𝑌𝑅 =  0.3) which was caused by negative 
control overm coupled with the high negative elasticity of PYR to m. Proton leak, the other 
m consumer, had far less positive control (𝐶𝑃𝑅𝐿
𝑃𝑌𝑅 = 0.03) because its rate of consumption was 
only 7% of that of PHO. Positive control by the NADPH producers (𝐶𝑂𝑥𝑃𝑃𝑃
𝑃𝑌𝑅 = 0.18,𝐶𝑀𝐸
𝑃𝑌𝑅 =
0.21) was primarily the result of the relative strong positive elasticity of PYR to 
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NADPH/NADP; similarly, negative control by the NADPH consumers (𝐶𝑁𝑃𝑂
𝑃𝑌𝑅 = −0.24) was 
also primarily mediated through NADPH/NADP. The NAO shares many of the same reactions 
with the PYR, so it was not surprising that the NAO positively controlled PYR. The ATP 
consumers had lesser control (𝐶𝐴𝑇𝐶
𝑃𝑌𝑅 = 0.13), and this occurred almost exclusively through 
positive control of the ATC over NADH/NAD.The LAC blocks was the second strongest (yet 
relatively weak) negative controller of PYR (𝐶𝐿𝐴𝐶
𝑃𝑌𝑅 = −0.05), and this occurred primarily 
through negatively controlling the concentration of pyruvate. 
Positive control over NAO was largely distributed among LAC, PHO, and GTP, while 
negative control was primarily through GLY, ME, and OxPPP. The control by GLY was greatest 
(𝐶𝐺𝐿𝑌
𝑁𝐴𝑂 = −1.63)because of its control over ATP/ADP coupled with the strong negative 
elasticity of NAO to ATP/ADP. Interestingly, the negative control exerted by OxPPP and ME 
was identical (𝐶𝑂𝑥𝑃𝑃𝑃
𝑁𝐴𝑂 = −0.76,𝑎𝑛𝑑 𝐶𝑀𝐸
𝑁𝐴𝑂 =  −0.77) and resulted primarily from the control of 
both fluxes over ATP/ADP, and m coupled with the elasticity of NAO to these metabolites. 
Despite the fact that LAC was the primary NADH consumer, it had strongest positive control 
over NAO (𝐶𝐿𝐴𝐶
𝑁𝐴𝑂 = 1.14),which was mediated mainly by the negative control over m and 
pyruvate coupled with the strong negative elasticity of NAO to these metabolites. The strong 
control by PHO (𝐶𝑃𝐻𝑂
𝑁𝐴𝑂 = 1.02) was expected because of its consumption of m and the high 
negative elasticity of NAO to m(which was assumed as -23.2 from hepatocytes
42
).  
E.6.3. Control of Mitochondrial ATP Synthesis 
Mitochondrial ATP production and export (PHO) was controlled mainly by its own 
kinetics (𝐶𝑃𝐻𝑂
𝑃𝐻𝑂 = 0.43). The m producers were the next most important positive 
controllers(𝐶𝑃𝑌𝑅
𝑃𝐻𝑂 = 0.22,𝐶𝑁𝐴𝑂
𝑃𝐻𝑂 = 0.17) primarily because of their effects on m and pyruvate. 
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ATP consumption is generally assumed as the primary controller of mitochondrial 
phosphorylation, but ranked as slightly less important (𝐶𝐴𝑇𝐶
𝑃𝐻𝑂 = 0.16) than the m producers. 
Notably, the ATC had much stronger control over GLY, and so from these control coefficients it 
can be calculated that glycolytic ATP synthesis would provide 60% of the additional ATP 
required upon an increase in neuronal ATP consumption, while mitochondrial phosphorylation 
would provide 24% of it. Because the NonPPP also produces ATP through the same reactions as 
glycolysis, total glycolytic provision of the additional ATP consumed would thus be 75%.A 
similar result was found for hepatocytes, except that the contribution was more evenly split (55% 
from ATP and 45% from mitochondrial phosphorylation)
42
.The NPO and GLY blocks exerted 
strongest negative control over PHO (𝐶𝑁𝑃𝑂
𝑃𝐻𝑂 = −0.20,𝐶𝐺𝐿𝑌
𝑃𝐻𝑂 = −0.19)through effects on m 
(for NPO),and ATP/ADP and pyruvate (for GLY). 
The proton leak flux (PRL) exerted a strong control over itself (𝐶𝑃𝑅𝐿
𝑃𝑅𝐿 = 0.98) due to its 
inherent kinetics. Similarly, the negative control by NPO and PHO (𝐶𝑁𝑃𝑂
𝑃𝑅𝐿 = −0.30and 𝐶𝑃𝐻𝑂
𝑃𝑅𝐿 =
−0.28), were mediated by control that each block had on m. Importantly this uncoupling 
pathway had only small negative control(𝐶𝑃𝑅𝐿
𝑃𝐻𝑂 = −0.03) over mitochondrial phosphorylation, 
raising the possibility that additional mild uncoupling to potentially reduce ROS production 
might not be as detrimental as has been suggested by a previous
44
. 
E.6.4. Control of ATP Consumption 
Positive control over ATC was primarily evenly distributed among GTP, ATC, LAC, and 
PHO, while negative control was primarily through OxPPP and GLY. The negative control by 
OxPPP(𝐶𝑂𝑥𝑃𝑃𝑃
𝐴𝑇𝐶 = −0.64) was mediated by the strong negative control over G6P. Negative 
control by GLY (𝐶𝐺𝐿𝑌
𝐴𝑇𝐶 = −0.45)occurred by the same means as the OxPPP. Similarly, positive 
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control by GTP (𝐶𝐺𝑇𝑃
𝐴𝑇𝐶 = 0.40, ) was mainly mediated by the strong positive control over G6P. 
Thus, the relative rates of G6P production and consumption together represent a primary 
controller of ATP turnover. The kinetics of the ATC exerted as much control over their own 
consumption as did LAC and PHO (𝐶𝐴𝑇𝐶
𝐴𝑇𝐶 = 0.35,𝐶𝐿𝐴𝐶
𝐴𝑇𝐶 = 0.35,𝐶𝑃𝐻𝑂
𝐴𝑇𝐶 = 0.32). The latter two 
blocks exerted positive control through controlling G6P (LAC, PHO) and m (PHO). Here it is 
noteworthy that, in neurons, the consumption of ATP was controlled by reactions that controlled 
G6P production and consumption rather than ATP/ADP. Accordingly, a fractional change in 
cytoplasmic glucose metabolism appears to affect the rate of ATP consumption in parallel by the 
virtue of changes in G6P. This pattern of shared control among ATP producer on ATC was 
reported in hepatocytes, however, the control of OxPPP was not considered
42
.    
E.6.5. Control of NADPH Production 
Positive control of the OxPPP was primarily by GTP (𝐶𝐺𝑇𝑃
𝑂𝑥𝑃𝑃𝑃 = 1.21), NPO (𝐶𝑁𝑃𝑂
𝑂𝑥𝑃𝑃𝑃 =
0.80), ATC (𝐶𝐴𝑇𝐶
𝑂𝑥𝑃𝑃𝑃 = 0.76), and the NonPPP (𝐶𝑁𝑜𝑛𝑃𝑃𝑃
𝑂𝑥𝑃𝑃𝑃 = 0.38).The NonPPP and GTP 
primarily mediated their effects by negative control over ATP/ADP (coupled with the negative 
elasticity of OxPPP to it).As expected, positive control by NPO was almost exclusively through 
negatively affecting NADPH/NADP, while the ATC acted through both NADH/NAD and 
NADPH/NADP. It was anticipated that the OxPPP would have strong positive control over its 
own flux, but, it was the only other block besides GLY to exert negative control over itself. 
However, the Monte Carlo simulation indicated that there was considerable uncertainty with this 
coefficient, as 76% of the simulations yielded positive control. From this perspective, it is likely 
that this coefficient is an artifact. With that in mind, negative control was exerted primarily by 
GLY (𝐶𝐺𝐿𝑌
𝑂𝑥𝑃𝑃𝑃 = −0.89), NAO (𝐶𝑁𝐴𝑂
𝑂𝑥𝑃𝑃𝑃 = −0.49), and ME (𝐶𝑀𝐸
𝑂𝑥𝑃𝑃𝑃 = −0.47). The negative 
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control by GLY was mediated by positive control over ATP/ADP and negative control over 
G6P, although the former effect dominated because of the strong negative elasticity of OxPPP to 
ATP/ADP. It is worth noting that, since they compete for the same substrate, the OxPPP was 
about twice as strong in negatively controlling GLY compared to negative control of the OxPPP 
by GLY. The negative control of NAO (𝐶𝑁𝐴𝑂
𝑂𝑥𝑃𝑃𝑃 =  −0.47) was mainly through positive control 
over NADPH/NADP and ATP/ADP coupled with the negative elasticity of OxPPP to these 
metabolites. Malic enzyme negatively controlled OxPPP through positively affecting 
NADPH/NADP.  
Positive control of ME was dominated by GLY (𝐶𝐺𝐿𝑌
𝑀𝐸 = 1.84), ME (𝐶𝑀𝐸
𝑀𝐸 = 1.34), and 
OxPPP (𝐶𝑂𝑥𝑃𝑃𝑃
𝑀𝐸 = 1.25).Control by GLY and OxPPP occurred by strong negative control over 
G6P and positive control over ATP/ADP ratio each of which is coupled with the strong elasticity 
of ME to these metabolites. The OxPPP was expected to exert negative control through NADPH, 
but this effect was much smaller than the stimulatory influence G6P and ATP/ADP had. This 
positive control suggests that a change in OxPPP due to high NADPH demand (i.e. high ROS) 
will stimulate ME to also produce NADPH despite the low contribution of ME to the NADPH 
pool. The reactions within ME, which includes the dicarboxylate transporter and cytoplasmic 
malic enzyme, intrinsically had strong control over its own flux. Negative control by LAC 
(𝐶𝐿𝐴𝐶
𝑀𝐸 = −1.4) dominated and was mediated by the negative control over pyruvate (coupled with 
the positive elasticity of ME to it), and the positive control over G6P (coupled with the negative 
elasticity of ME to it). The negative control of GTP over ME (𝐶𝐺𝑇𝑃
𝑀𝐸 = −0.82)was because of the 
positive control over G6P, and the negative control over ATP. Both NPO and PHO exerted 
negative control over ME (𝐶𝑁𝑃𝑂
𝑀𝐸 = −0.6,𝑎𝑛𝑑 𝐶𝑃𝐻𝑂
𝑀𝐸 = −0.5). The negative control by NPO was 
mediated through effects on pyruvate primarily, but also through G6P and m. Note that 
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positive control by the OxPPP dominates over negative control by NPO, and NPO exerts 
sufficiently large control over the OxPPP such that stimulation of the OxPPP through the NPO 
due to higher ROS levels will stimulate ME via increased OxPPP flux. 
E.6.6. Control of NADPH Oxidation 
Positive control over NPO was primarily through GTP (𝐶𝐺𝑇𝑃
𝑁𝑃𝑂 = 1.02), ATC (𝐶𝐴𝑇𝐶
𝑁𝑃𝑂 =
0.69), and NPO (𝐶𝑁𝑃𝑂
𝑁𝑃𝑂 = 0.67). The positive control by GTP was primarily mediated by the 
negative control over ATP coupled with the strong negative elasticity of NPO to ATP. Also, The 
control exerted by ATP consumers was mediated through positive control of the NADH/NAD 
ratio and negative control of the ATP/ADP ratio and G6P. Both GLY and OxPPP, substrate 
producers, were negatively controlling NPO to the same extent (𝐶𝐺𝐿𝑌
𝑁𝑃𝑂 = −0.65,𝑎𝑛𝑑 𝐶𝑂𝑥𝑃𝑃𝑃
𝑁𝑃𝑂 =
−0.50, respectively). Interestingly, this control pattern for both blocks was mediated by the same 
mechanism including the positive effect both blocks had over ATP/ADP and their negative 
effects over NADH/NAD coupled with the strong elasticity of NPO to these metabolites. Since 
the OxPPP produces the substrate for NPO, it was expected to exert positive control over the 
NPO, but the positive effect of providing substrate was far outweighed by the negative effects of 
ATP and NADH. However, Monte Carlo analysis indicated that there was a 77% probability that 
the control coefficient was positive, so as with OxPPP control over itself, there was considerable 
uncertainty in the control exerted by the OxPPP over NPO. Control by ME over NPO was also 
negative, again because of the positive effect it had on ATP/ADP. Thus, high cellular energy 
charge appears to be the most important negative effector of NADPH consumption in healthy 
neurons. 
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E.6.7. Control of Non-Oxidative PPP 
Since the NonPPP shares many of the same reactions with GLY, the control pattern of the 
two blocks was expected to be similar, and generally this was the case, with the exception of the 
positive control the NonPPP exerted over itself. Excluding the inherent control, the top four 
positive controllers of the NonPPP were the same as for GLY (𝐶𝐺𝑇𝑃
𝑁𝑜𝑛𝑃𝑃𝑃 = 1.60,𝐶𝑁𝑃𝑂
𝑁𝑜𝑛𝑃𝑃𝑃 =
1.55,𝐶𝐿𝐴𝐶
𝑁𝑜𝑛𝑃𝑃𝑃 = 1.32,𝐶𝐴𝑇𝐶
𝑁𝑜𝑛𝑃𝑃𝑃 = 1.04). The underlying metabolites through which these blocks 
affected the NonPPP was essentially the same (see Section E.6.1). Negative control over 
NonPPP was dominated by OxPPP(𝐶𝑂𝑥𝑃𝑃𝑃
𝑁𝑜𝑛𝑃𝑃𝑃 = −2.7) and GLY (𝐶𝐺𝐿𝑌
𝑁𝑜𝑛𝑃𝑃𝑃 = −2.35). 
Interestingly, this control pattern was mediated largely by the control over, ATP/ADP and G6P. 
The strong negative control by OxPPP may be surprising since the return of carbons from the 
OxPPP to glycolysis has been shown to increase upon exposure of cells to an oxidant (i.e., the 
pentose cycle increases). The grouping of the NonPPP to include some of the glycolytic 
reactions clearly influenced the control pattern to be more similar to that of GLY, including 
strong positive control by the GTP, LAC, and ATC.  
E.6.8. Control of Glucose Transport and Phosphorylation 
The kinetics of the reactions within GTP (GLUT transporters and hexokinase) were most 
important in positively controlling its own flux (𝐶𝐺𝑇𝑃
𝐺𝑇𝑃 = 1.12). Another important positive 
controller was the ATC (𝐶𝐴𝑇𝐶
𝐺𝑇𝑃 = 0.82) which occurred through influencing NADH/NAD, 
G6P,NADPH/NADP, and ATP/ADP. This indicates that the rate of ATP consumption is an 
important controller of glucose uptake, consistent with the use of labeled glucose analogues to 
assess regional brain metabolism. NADPH consumption by the NPO also exerted notable 
positive control (𝐶𝑁𝑃𝑂
𝐺𝑇𝑃 = 0.55) through negatively affecting the NADPH/NADP ratio coupled 
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with the negative elasticity of the GTP to this metabolite. Thus, oxidative stress can also 
contribute significantly to regional changes in glucose uptake.Interestingly, the control of the 
G6P consumer, GLY, was (𝐶𝐺𝐿𝑌
𝐺𝑇𝑃 = -0.13) was less than that of the other G6P consumer, OxPPP, 
(𝐶𝑂𝑥𝑃𝑃𝑃
𝐺𝑇𝑃 = −0.50) because the negative effects of ATP and NADH production were largely 
balanced by the positive effect of G6P consumption, whereas for the OxPPP the negative effect 
through NADPH consumption and ATP dominated over the positive effect through G6P. This 
indicates that the process of glucose phosphorylation and transportation is more sensitive to 
changes in OxPPP rather than changes in GLY. Similar to the OxPPP, ME exerted negative 
control (𝐶𝑀𝐸
𝐺𝑇𝑃 = −0.37) through both positively affecting NADPH/NADP and ATP/ADP. The 
PHO also exerted some negative control (𝐶𝑃𝐻𝑂
𝐺𝑇𝑃 = −0.15) through effecting G6P positively and 
NADH negatively. 
These data provide a quantitative description of the control pattern establishing the 
steady-state rate of glucose and mitochondrial metabolism in healthy neurons, and can be used as 
a reference to determine the change in neuronal metabolic behavior under any condition (i.e. 
stress, hormone, and apoptosis).  
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F. Metabolic targets of apoptotic signaling 
Trophic factor deprivation (i.e., low K) has previously been shown to acutely decrease 
mitochondrial respiration rate
8
, indicating that one or more reactions within the energy 
metabolism model shown in Fig. 1 are targeted by low K. However, the extent to which the 
reaction blocks are perturbed has yet to be determined. Thus, the first goal was to re-measure all 
reaction fluxes for CGNs in low K. A second, and more informative goal was to use metabolic 
control analysis to partition each measured change in flux into that caused by altered reaction 
kinetics (e.g. a change in kcator Km) and that caused by perturbation of the metabolites. The latter, 
metabolite-mediated effects are unimportant for understanding how apoptosis targets 
metabolism, but are nonetheless essential for quantifying the direct effects on the blocks so that 
the most important targets can be identified. This approach allowed testing of the hypothesis that 
direct kinetic inhibition of the ATP consumer block is the most important change perturbing the 
steady-state catabolism of glucose, with the remaining blocks changing primarily as a result of 
changes in the explicit metabolites. This hypothesis is based on the observation that low K 
decreases plasma membrane Ca
2+
 cycling via closure of Ca
2+
 channels, and so should decrease 
overall cellular ATP consumption. This analysis additionally serves as a starting point for future 
investigations into the molecular mechanisms underlying the kinetic changes. 
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F.1. Reaction block fluxes and metabolite levels in apoptotic neurons 
The steady-state variables (fluxes and metabolite levels) were measured in apoptotic 
neurons (Tables 11&12). Although OxPPP flux decreased (IR = -0.20), there was a small but 
significant increase influx relative to the rate of glucose uptake (i.e., OxPPP/GTP; 89.40.7% in 
low K vs 87.30.3% in high K), indicating a greater proportion of glucose consumed was used 
for NADPH synthesis. While there was a slight decrease in NonPPP flux (IR = -0.06), there was 
a significant increase in the fraction of pentose phosphates produced by the OxPPP that was 
returned to glycolysis (i.e., [2/3*NonPPP]/OxPPP; 51.42.9% in low K vs 47.21.3% in high 
K). The fraction of glucose consumed by the pentose cycle relative to the rate of glucose uptake 
also increased (22.91.1% in low K vs 20.60.5% in high K). Relatively less glucose was used 
for nucleotide biosynthesis (16.04.1% in low Kvs 17.71.8% in high K).The reported higher 
ROS during early apoptotic stages may explain the relative activation of the PPP reactions which 
act to maintain cellular redox status
26,45,46
 but clearly other factors must be superimposed with 
this to cause a decrease in the absolute flux.  
While GLY flux modestly decreased in low K (IR = -0.10), the fraction of glucose 
consumed that was catabolized through GLY increased slightly (56.62.9% in low K vs. 
53.51.3% in high K). Since lactate excretion was essentially unchanged in low K (IR = 0.04) 
while mitochondrial pyruvate oxidation decreased significantly (IR = -0.37), there was a 
significant increase in the proportion of pyruvate reduced to lactate (81.91.1% in low K vs 
74.90.7% in high K) indicating that apoptotic neurons became more glycolytic than healthy 
neurons. Consequently, a greater percentage of ATP used by neurons in low K was derived from 
glycolysis (35.01.3% in low K vs 22.80.5% in high K); this increase was slightly greater when 
182 
 
the ATP derived from the NonPPP was also included (44.01.7% in low K vs. 28.70.6% in 
high K). 
 
 
 
 
 
 
 
 
 
 
 
 
Table11-C. Measured and calculated fluxes in apoptotic neurons (low K). Blocks are; glucose uptake 
and phosphorylation (GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation 
(NAO), mitochondrial phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-
phase of pentose phosphate pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP 
(NonPPP), and malic enzyme (ME).  Data of high K CGNs are mean in plom/min *10
6
 ± SEM 
(n=23). Data of low K CGNs are mean of normalized values to control ± SEM (n=7) 
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This also meant that the contribution of mitochondria to ATP production decreased (49.91.6% 
in low Kvs 65.80.5% in high K). It is also important to point out that ATP consumer activity 
decreased to 54.54.9% of the high K rate, as predicted from the decrease [Ca2+]c in low K. The 
decrease in cellular ATP consumption in low K is predicted to have a substantial impact on 
decreasing overall glucose catabolism, and this may partly explain the decrease in GLY, OxPPP, 
NonPPP, PHO, PYR, and NAO fluxes. Metabolic control analysis was used to determine the 
importance of the decreased ATP consumption to the overall measured flux changes. 
 
 
 
 
 
 
 
 
 
Table 12-C. Measured concentrations of metabolites in apoptotic neurons (low K).  Metabolites are; 
glucose-6-phophate (G6P), pyruvate (Pyr), NADH/NAD, mitochondrial membrane potential (∆Ѱm), 
ATP/ADP, and NADPH/NADP.  Data of high K CGNs are mean ± SEM (19≤n≤23). Data of low K CGNs 
are mean of normalized values to control ± SEM (6≤n≤11) 
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F.2. Direct targets of apoptotic signaling: Integrated elasticity analysis 
The equation below was used to quantitate the extent to which low K caused direct 
kinetic changes to each of the blocks. Such changes are referred to as „integrated elasticities‟ 
because they reflect the change in activity of a reaction (i.e., this is an enzymatic property, not a 
system property) caused by a step change in a parameter
19
 (in this case the step change from high 
to low K) rather than an infinitesimally small change (see Chapter 2, Section F.2.).  
𝐼𝐸𝑙𝑜𝑤  𝐾
𝑏𝑙𝑜𝑐𝑘 =
∆𝐽𝑏𝑙𝑜𝑐𝑘
𝐽𝑏𝑙𝑜𝑐𝑘
−  𝜀𝑥𝑖
𝑏𝑙𝑜𝑐𝑘𝑛
𝑖=1 ∙
∆𝑥𝑖
𝑥𝑖
 
The summation term is the expected change in activity due to metabolite (xi) changes, where n= 
the number of explicit metabolites and 𝜀𝑥𝑖
𝑏𝑙𝑜𝑐𝑘 are elasticities determined in healthy CGNs. The 
measured fractional flux change of any block  
∆𝐽𝑏𝑙𝑜𝑐𝑘  
𝐽𝑏𝑙𝑜𝑐𝑘
  induced by trophic factor deprivation (low 
K) is referred to as the integrated response of the block to low K (𝐼𝑅𝑙𝑜𝑤  𝐾
𝐽
). The change in block 
activity due to each of the metabolites is referred to as the partial integrated responses mediated 
by each of the fractional changes in the metabolites (these are the individual terms of the 
summation portion of Eq. 11, and each is denoted as 𝐼𝑥 𝑅𝑙𝑜𝑤  𝐾
𝐽
; see Table 13).Thus, when viewed 
in isolation, a step change in trophic factor support perturbs the activity of a block by directly 
affecting its kinetics and/or the levels of the explicit metabolites to which the block responds; 
quantification of both effects provides an understanding of the importance of each effect for any 
block in the system and also highlights which blocks are most strongly targeted by the loss of 
trophic factor support. One of the main observations from this analysis was that the ATP 
consumer block was directly inhibited, as expected, but cannot account for all of the remaining 
flux changes because many blocks exhibited direct kinetic changes. A second main observation 
(16) 
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was that low K targeted kinetic activation of glycolytic ATP synthesis and inhibition of 
mitochondrial ATP synthesis. 
F.2.1.Kinetic effect on the ATP consumers 
The integrated elasticity (IE) of the ATC to low K (𝐼𝐸𝑙𝑜𝑤  𝐾
𝐴𝑇𝐶 =-0.47) was sufficiently large 
to fully account for the measured response (𝐼𝑅𝑙𝑜𝑤  𝐾
𝐴𝑇𝐶  = -0.47). However, without taking into 
account the control the ATC has over its own flux, it is premature to conclude that the direct 
kinetic change by low K entirely explained the decrease in ATP consumption. On the other hand, 
and according to our initial hypothesis, this significant direct inhibition was expected, at least in 
part, because of the effect low K has on [Ca
2+
]c
8,47
.The high K media that promotes CGN 
survival maintains the plasma membrane potential (p) in a relatively depolarized state (≈ -35 
mV) which promotes opening of voltage-gated L-type Ca
2+
 channels and Ca
2+
influx
47
. As a 
consequence, plasma membrane Ca
2+
-ATPase activity, and thus ATP consumer activity, is 
relatively high. Conversely, neurons in low K media are hyperpolarized (p  -75 mV), a 
condition that results in closure of voltage-gated L-type Ca
2+
 channels (Fig. 6). Low [Ca
2+
]c 
reduces Ca
2+
-ATPase activity and so lowers overall ATC activity. Since [Ca
2+
]c was not included 
as an explicitly metabolite, the decrease in [Ca
2+
]c from high to low K would manifest as a direct 
kinetic change to the ATC.  
F.2.2. Kinetic effect on the NADPH consumers 
Low K resulted in decreased NADPH consumption (𝐼𝑅𝑙𝑜𝑤𝐾
𝑁𝑃𝑂  = -0.17) despite direct 
kinetic activation by low K (𝐼𝐸𝑙𝑜𝑤𝐾
𝑁𝑃𝑂  = 0.31), indicating that the changes in the metabolites 
(primarily 𝐼
ATP /ADP
𝑅𝑙𝑜𝑤𝐾
𝑁𝑃𝑂 =  −0.38,𝑎𝑛𝑑 𝐼
NADH /NAD
𝑅𝑙𝑜𝑤𝐾
𝑁𝑃𝑂 =  −0.17) which tend to decrease 
activity were stronger than the direct stimulation of NPO activity. Despite the decrease in flux, 
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CGNs in low K consumed more NADPH relative to the rate of glucose consumed (NPO/GTP = 
2.000.00 in low K vs 1.920.00 in high K) or mitochondrial oxygen (NPO/Mito RR = 
1.3570.135 vs. 0.9680.087 low vs. high K) used. The kinetic stimulation is consistent with 
increased ROS levels tending to increase NADPH consumption via glutathione reductase and 
thioredoxin reductase, but is counteracted by the negative effects of the metabolite changes on 
these (and perhaps other) NADPH consumers. Thus, despite the established higher ROS in early 
stage apoptotic neurons, the lower NADPH consumption indicates that the NADPH-dependent 
antioxidant defenses were relatively restrained by the changes to the explicit metabolites. 
Here it should be noted that the measurement of flux in high and low K would lead to the 
conclusion that this block was not activated, but the MCA allowed the overall response to be 
partitioned, which showed kinetic activation despite overall decrease in flux. 
F.2.3.Kinetic effects on the pentose cycle and malic enzyme  
Despite the lower measured fluxes for OxPPP and NonPPP (𝐼𝑅𝑙𝑜𝑤  𝐾
𝑂𝑥𝑃𝑃𝑃 = −0.20, and 
𝐼𝑅𝑙𝑜𝑤  𝐾
𝑁𝑜𝑛𝑂𝑥𝑃𝑃𝑃 = −0.06), the ratio of OxPPP to glucose uptake only marginally increased in low K 
(OxPPP/GTP= 0.894 vs 0.873in low vs high K). Also, the rate of pentose phosphate returned to 
GLY by NonPPP is higher (NonPPP/GTP = 0.679 vs. 0.582 low vs high K), so the relative rate 
of G6P use by the pentose cycle is greater (PC/GTP = 0.226 vs. 0.206low vs high K). 
Furthermore, both PPP blocks (OxPPP and NonPPP) were kinetically stimulated in response to 
the apoptotic stimulus (𝐼𝐸𝑙𝑜𝑤  𝐾
𝑂𝑥𝑃𝑃𝑃 = 0.56,𝑎𝑛𝑑 𝐼𝐸𝑙𝑜𝑤  𝐾
𝑁𝑜𝑛𝑂𝑥𝑃𝑃𝑃 = 0.89) . Such kinetic activation 
suggests stimulation of one or more enzymes within these blocks (i.e. G6P dehydrogenase, and 
NonPPP transaldolase/transketolase) by apoptotic stimulus. This kinetic stimulation is 
superimposed by inhibition mediated by the indirect effects of changed metabolites including 
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ATP/ADP, NADH/NAD, and NADPH/NADP (
ATP/ADP𝐼𝑅𝑙𝑜𝑤  𝐾
𝑂𝑥𝑃𝑃𝑃=-0.35, 
NADPH/NADP𝐼𝑅𝑙𝑜𝑤  𝐾
𝑂𝑥𝑃𝑃𝑃=-
0.21, and 
NADH/NAD𝐼𝑅𝑙𝑜𝑤  𝐾
𝑂𝑥𝑃𝑃𝑃=-0.19). The kinetic stimulation of NonPPP by low K was closely 
balanced by inhibition due to the changed metabolites including ATP/ADP and NADH/NAD 
(
ATP/ADP𝐼𝑅𝑙𝑜𝑤  𝐾
𝑁𝑜𝑛𝑂𝑥𝑃𝑃𝑃 =-0.46, and 
NADH/NAD𝐼𝑅𝑙𝑜𝑤  𝐾
𝑁𝑜𝑛𝑂𝑥𝑃𝑃𝑃 = −0.33) such that there was little change 
in the measured NonPPP flux (𝐼𝑅𝑙𝑜𝑤  𝐾
𝑁𝑜𝑛𝑂𝑥𝑃𝑃𝑃 = −0.06). This result is consistent with the reported 
over expression of transaldolase enzymes in response to HIV induced oxidative stress and cell 
death in two human CD4b and T cell lines
48
, although the time course of the current experiments 
likely preclude changes in gene expression as a major underlying cause of the kinetic changes. 
The kinetic stimulation of OxPPP and NonPPP blocks is a strategy by stressed cells to protect 
against ROS and oxidative damage, which may be critical to prevent mitochondrial outer 
membrane permeabilization (MOMP), cytochrome c release, and caspase activation 
26
. This 
suggests that the kinetic stimulation of OxPPP and NonPPP blocks is an upstream event to 
MOMP, cytochrome c release, and caspase activation.  In neurons, NO, a highly active ROS, 
activates glucose-6-phosphate dehydrogenase (G6PDH) which is a primary controller of G6P 
oxidation through the OxPPP
49
.Apoptotic CGNs are characterized by high ROS
45,46
 that is 
required for induction of oxidative stress-mediated cell death. This ROS level may be the 
threshold level that can be reached by neurons whose PPP cannot activated to the level necessary 
for redox-status maintenance.  
The measured flux of ME was increased (𝐼𝑅𝑙𝑜𝑤  𝐾
𝑀𝐸 = 0.12) and exceeded the total kinetic 
inhibition due to low K  (𝐼𝐸𝑙𝑜𝑤  𝐾
𝑀𝐸 = −0.54). The measured increased activity is a consequence of 
the changes in metabolites including ATP/ADP, ∆Ѱm , and pyruvate (
∆Ѱm𝐼𝑅𝑙𝑜𝑤  𝐾
𝑀𝐸  = 0.25, 
ATP/ADP𝐼𝑅𝑙𝑜𝑤  𝐾
𝑀𝐸  =0.22, and 
pyruvate𝐼𝑅𝑙𝑜𝑤  𝐾
𝑀𝐸 = 0.16). 
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F.2.4. Kinetic effects on glucose uptake, glycolysis, and lactate production 
Glucose uptake/phosphorylation and glycolytic fluxes were modestly reduced in low K 
(𝐼𝑅𝑙𝑜𝑤  𝐾
𝐺𝑇𝑃 = −0.20, 𝐼𝑅𝑙𝑜𝑤  𝐾
𝐺𝐿𝑌 = −0.10) while lactate production was essentially unchanged. Low K 
kinetically stimulated all three blocks (𝐼𝐸𝑙𝑜𝑤  𝐾
𝐺𝑇𝑃 = 0.30, 𝐼𝐸𝑙𝑜𝑤  𝐾
𝐺𝐿𝑌 = 0.65, 𝐼𝐸𝑙𝑜𝑤  𝐾
𝐿𝐴𝐶 = 0.90) but the 
effects on glycolysis and lactate production were most significant. The metabolite changes 
(primarily ATP/ADP, NADPH/NADP, and NADH/NAD) either exactly opposed (for LAC; 
ATP/ADP𝐼𝑅𝑙𝑜𝑤  𝐾
𝐿𝐴𝐶 = −0.33,NADPH/NADP 𝐼𝑅𝑙𝑜𝑤  𝐾
𝐿𝐴𝐶 = −0.42NADH/NAD𝐼𝑅𝑙𝑜𝑤  𝐾
𝐿𝐴𝐶 = −0.33) or exceeded (for 
GTP 
ATP/ADP𝐼𝑅𝑙𝑜𝑤  𝐾
𝐺𝑇𝑃 = −0.19,NADPH/NADP 𝐼𝑅𝑙𝑜𝑤  𝐾
𝐺𝑇𝑃 = −0.15NADH/NAD𝐼𝑅𝑙𝑜𝑤  𝐾
𝐺𝑇𝑃 = −0.18 and GLY 
ATP/ADP𝐼𝑅𝑙𝑜𝑤  𝐾
𝐺𝐿𝑌 = −0.38,NADPH/NADP 𝐼𝑅𝑙𝑜𝑤  𝐾
𝐺𝐿𝑌 = −0.16NADH/NAD𝐼𝑅𝑙𝑜𝑤  𝐾
𝐺𝐿𝑌 = −0.33) the kinetic 
effects. This direct kinetic activation by low K, however, cannot explain the observed high 
ATP/ADP level especially in case of limited ATP supply due to early mitochondrial 
dysfunction
50,51
.  The high cellular ATP/ADP is at least partly a consequence of the decrease in 
ATC flux, but may also be an attempt by apoptotic cell to maintain ATP which is important for 
apoptosis to proceed
50,52
. These findings are consistent with the idea that a threshold level of 
ATP is essential for cells to die through apoptosis not necrosis
51,52
. This threshold level of ATP 
is essential for the activity of the pro-apoptotic proteins. One of the most ATP-dependent 
enzymes in apoptotic neurons are the proteolytic caspase enzymes that are recruited in the final 
executioner phase of apoptosis. In trophic factor-deprived cerebellar granule neurons, caspases 
are activated in a time frame between 2-4 hrs without substantial loss of cells
53,54
. This means 
that the glycolytic ATP switch (initiated after 2hr of apoptotic stimuli) either coincides or 
precedes caspases activation
52
. These data indicate that early-stage apoptotic neurons become 
increasingly dependent on glycolytic-derived ATP to execute apoptosis as less ATP is 
synthesized by mitochondria
52
.  
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Kinetic activation of glycolytic enzymes (e.g. phosphofructokinase-1) in low K is 
intriguing, as this pathway is typically thought to be inhibited by trophic factor deprivation. A 
possible mechanism for this kinetic effect could involve the p53-induced glycolysis and 
apoptosis regulator  (TIGAR) 
55
. Activation of TIGAR promotes resistance to apoptosis and 
inhibition of glycolysis (the latter effect via decreasing F-2,6-bisphosphate, a potent activator of 
PFK-1). Accordingly, the inhibition of TIGAR is expected to promote activation of glycolysis 
through increasing F-2,6-P2, which, in neurons exposed to low K, is opposed by the changed 
metabolites. But this would not explain the IE to LAC block.The findings that apoptosis can be 
triggered in different cell lines lacking functional mitochondria was somewhat paradoxical given 
the ATP requirement for apoptosis 
56,57
. On the other hand, anaerobic glycolysis with lactate 
production was found to promote survival of striated muscles under condition of suppressed 
mitochondrial ATP synthesis
58
. Such a puzzle cannot be solved without understanding the 
metabolic behavior in healthy cells and to what extent mitochondrial phosphorylation and 
glycolysis are coordinately affected during apoptosis. 
F.2.5. Kinetic effects on m producers (PYR and NAO) 
There was little kinetic effect of low K on PYR (𝐼𝐸𝑙𝑜𝑤  𝐾
𝑃𝑌𝑅 = 0.05) whereas NAO was 
kinetically stimulated (𝐼𝐸𝑙𝑜𝑤  𝐾
𝑁𝐴𝑂 = 0.74). Despite the activation, the measured flux was 
significantly reduced (𝐼𝑅𝑙𝑜𝑤  𝐾
𝑁𝐴𝑂 = −0.78) due to changes in metabolites including ATP/ADP, 
m, and pyruvate (ATP/ADP𝐼𝑅𝑙𝑜𝑤  𝐾
𝑁𝐴𝑂 = −0.44, m𝐼𝑅𝑙𝑜𝑤  𝐾
𝑁𝐴𝑂 = −1.2, pyruvate𝐼𝑅𝑙𝑜𝑤  𝐾
𝑁𝐴𝑂 = −0.17). The 
lack of effect on PYR suggests that the respiratory chain (commonly shared by NAO and PYR) 
is not included in the kinetic changes due to low K. Kinetic stimulation of NAO may therefore be 
through the shuttle reactions (e.g., malate-aspartate shuttle) transferring NADH into the matrix. 
Alternatively, a possible kinetic activation in respiratory chain that could activate NADH 
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oxidation may not activate PYR because the activation is counteracted by kinetic inhibition in 
the citric acid cycle. This conclusion is supported by the finding that pyruvate dehydrogenase is a 
specific phosphorylation target for JNK that caused a decline in its activity in primary cortical 
neurons 
59
. This decline was suggested to cause a shift to anaerobic pyruvate metabolism that 
involves lactate accumulation and decreased ATP production. Also, it supports the finding that 
mitochondrial pyruvate carrier can repress the Warburg effect and colon cancer cell growth
60
. 
Irrespective of the mechanism, kinetic inhibition of NAO only accounted for 18% of the 
decrease in respiration rate, as pyruvate oxidation was responsible for 95% of the oxygen 
consumed by mitochondria. In this respect, the lack of low K targeting of PYR indicates that 
most of the 42% decrease in mitochondrial respiration occurred indirectly through the metabolite 
changes. 
F.2.6. Kinetic effects on the m consumers (PHO and PRL) 
The low K kinetic inhibition in PHO was remarkably high (𝐼𝐸𝑙𝑜𝑤  𝐾
𝑃𝐻𝑂 = −1.22), however, 
the measured flux inhibition was notably lower (𝐼𝑅𝑙𝑜𝑤  𝐾
𝑃𝐻𝑂 = −0.57) indicating indirect 
stimulation by the changed metabolites. Notably, 100% of this stimulation was by changes in 
m (
m𝐼𝑅𝑙𝑜𝑤  𝐾
𝑃𝐻𝑂 = 0.87). The kinetics of proton leak to m in low K were shifted up and 
more „ohmic‟ relative to that in high K (compare Fig. 4 with Fig. 3), indicating a substantial 
increase in mitochondrial inner membrane proton permeability. Consequently, the proton leak 
block (PRL) was directly activated and ranked as the most affected block (𝐼𝐸𝑙𝑜𝑤  𝐾
𝑃𝑅𝐿 = 1.52). 
Inhibition of PHO (𝐼𝐸𝑙𝑜𝑤  𝐾
𝑃𝐻𝑂 = −1.22) and stimulation of NAO and OxPPP kinetics accounted for 
about 18% of the measured increase in PRL flux because of their control over m, but the 
remaining 82% was due to inherent changes in the leak through unknown mechanisms. This 
analysis is based on the assumption that the leak is only affected by m and not the other 
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explicit metabolites. The mechanism underlying the kinetic change may partly be explained by 
the recruitment of apoptotic proteins to the mitochondria and/or to increased oxidative stress. In 
trophic factor-deprived neurons, apoptosis is triggered through an intrinsic mechanism which is 
characterized by the recruitment of BcL-2 family proteins to mitochondria 
61,62
. Although the 
mechanism through which the BcL-2 family proteins are regulated during apoptosis remains 
controversial
63–66
, it is known that the activation of Bax and Bak leads to insertion and 
oligomerization of these proteins in the mitochondrial outer membrane (MOM)
66
. It is unclear 
how Bax/Bak insertion into the MOM might increase mitochondrial inner membrane (MIM) 
proton permeability. One possibility is based on the recent finding that Bax interacts with the 
MOM protein VDAC
12
, while VDAC interacts with the MIM adenine nucleotide translocase 
(ANT) at mitochondrial contact sites. Conformational changes to the ANT have been proposed 
to convert the ANT into a proton permeable pore
9,10,67
. Alternatively, increased leak could be 
associated with oxidative stress, as different ROS have been shown to increase proton leak 
through activation of one or more uncoupling proteins (e.g., UCP2, UCP3) and/or through 
conformational changes to ANT
9
. Reactive oxygen species-mediated proton leak has been 
proposed as a negative feedback mechanism to decrease mitochondrial ROS production, and thus 
could indicate that the uncoupling is an antioxidant mechanism involved to protect the neuron 
from oxidative stress. Note that, if the ANT is affected to function as a H
+
 carrier rather than 
adenine nucleotide carrier, this could also partly explain the large kinetic inhibition of PHO, as 
impaired ATP/ADP transport across the MIM would be a substantial impediment to ATP 
synthesis. One consequence of the increased leak is reduced efficiency of mitochondrial ATP 
synthesis (i.e., lower ATP/O ratio).It can be calculated that, given the rate of respiration in low 
K,the observed kinetic stimulation of the leak resulted in a 20% decrease in ATP synthesis by  
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PHO. If uncoupling functions to reduce ROS, activation of the leak can be viewed as 
anti-apoptotic since relatively high ROS are known to induce apoptosis. On the other hand, if 
uncoupling is related to Bax activation/insertion into the MOM, it could have a role in 
facilitating apoptosis. 
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G. System interactions underlying the flux changes triggered by low K: the 
partial integrated responses mediated by each of the blocks 
When the kinetics of a block (block 1) have been directly affected by low K, this will 
perturb flux through another block (block 2) by virtue of the control that block 1 exerts on block 
2 (through effects on the metabolite levels). This is known as the partial integrated response of 
block 2 to trophic factor deprivation (low K) mediated by kinetic changes in block1 
21 block
q
block IR  
𝐼𝑅𝑙𝑜𝑤  𝐾
𝑏𝑙𝑜𝑐𝑘  2𝑏𝑙𝑜𝑐𝑘 1 = 𝐶𝑏𝑙𝑜𝑐𝑘 1
𝑏𝑙𝑜𝑐𝑘  2 ∙ 𝐼𝐸𝑙𝑜𝑤  𝐾
𝑏𝑙𝑜𝑐𝑘  1
 
The partial integrated response (Table 14) is a system measure of the extent to which 
block 2 flux is changed due to the direct kinetic changes in activity ofblock1 by low K because 
the strength of the effect depends on the control pattern of the system(i.e., 𝐶𝑏𝑙𝑜𝑐𝑘 1
𝑏𝑙𝑜𝑐𝑘 2,the control 
that block1 exerts on block 2;see Table 10). These partial integrated responses indicate how 
important kinetic changes to each block in the system are to changing flux through a block of 
interest. 
G.1.System effect on the ATP consumers 
Direct kinetic inhibition of the ATC only accounted for 36% of the decrease in flux 
because of the relatively low control the ATC exerted over its own flux ( 𝐼𝐴𝑇𝐶 𝑅𝑙𝑜𝑤  𝐾
𝐴𝑇𝐶 = −0.17). 
Thus, intrinsic changes to the kinetics of the reactions within the ATC (e.g., reduced ATP 
consumption as a result of lower Ca
2+
 cycling) cannot fully explain the reduced ATP 
consumption. The effect of other blocks on ATC (Figure 7-C) due to kinetic changes in response 
to low K coupled with their control over ATC accounted for the remaining 64% of the flux 
(12) 
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decrease (Table 14-C). One of the major targets of low K that affected the ATC was PHO 
( 𝐼𝑃𝐻𝑂 𝑅𝑙𝑜𝑤  𝐾
𝐴𝑇𝐶 = −0.39) which exerted 81% of the net change in flux. This high negative response 
of ATC to PHO was due to its strong kinetic inhibition(𝐼𝐸𝑙𝑜𝑤  𝐾
𝑃𝐻𝑂 = −1.2) in response to trophic 
factor deprivation. The inhibition of ATC by OxPPP ( 𝐼𝑂𝑥𝑃𝑃𝑃 𝑅𝑙𝑜𝑤  𝐾
𝐴𝑇𝐶 = −0.30) and GLY 
( 𝐼𝐺𝐿𝑌 𝑅𝑙𝑜𝑤  𝐾
𝐴𝑇𝐶 = −0.29)was mediated by the relatively high kinetic activation by low K (𝐼𝐸𝑙𝑜𝑤  𝐾
𝑂𝑥𝑃𝑃𝑃 =
 0.56,𝑎𝑛𝑑 𝐼𝐸𝑙𝑜𝑤  𝐾
𝐺𝐿𝑌 =  0.65) coupled with the relatively high control of both blocks over ATC. 
Note that most of these effects were mediated through G6P, one of the main stimulators of ATC. 
Unexpectedly, and despite the high kinetic change in PRL and ME 
(𝐼𝐸𝑙𝑜𝑤  𝐾
𝑃𝑅𝐿 =  1.52,𝑎𝑛𝑑 𝐼𝐸𝑙𝑜𝑤  𝐾
𝑀𝐸 =  −0.54), PRL and ME effect on ATC was minimal due to the 
very low control of each block over ATC. 
G.2. System effect on the NADPH consumers 
The inhibition of NPO flux (𝐼𝑅𝑙𝑜𝑤  𝐾
𝑁𝑃𝑂 = −0.17) was most strongly influenced by low K 
targeting of GLY ( 𝐼GLY 𝑅𝑙𝑜𝑤𝐾
𝑁𝑃𝑂 =  −0.42), ATC ( 𝐼ATC 𝑅𝑙𝑜𝑤𝐾
𝑁𝑃𝑂 =  −0.33), NAO ( 𝐼NAO 𝑅𝑙𝑜𝑤𝐾
𝑁𝑃𝑂 =
 −0.31), and OxPPP ( 𝐼OxPPP 𝑅𝑙𝑜𝑤𝐾
𝑁𝑃𝑂 =  −0.28) mediated primarily through ATP (for GLY, NAO, 
and OxPPP) and NADH (for ATC).These inhibitory effects were offset by the stimulation by 
other low K targeted blocks (Figure 8-C) including GTP ( 𝐼GTP 𝑅𝑙𝑜𝑤𝐾
𝑁𝑃𝑂 =  0.31), 
NonPPP( 𝐼NonPPP 𝑅𝑙𝑜𝑤𝐾
𝑁𝑃𝑂 =  0.30), NPO (over its own flux, 𝐼NPO 𝑅𝑙𝑜𝑤𝐾
𝑁𝑃𝑂 =  0.21) coupled with the 
control each block exerted over NPO. Most of these stimulatory effects were mediated by effects 
on ATP/ADP level. Note thatdirect kinetic activation of the NPO (possibly because of higher 
ROS) only accounted for 18%of the combined stimulatory effects of those blocks which 
stimulated NPO, indicating the system effects through other blocks were more important. 
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G3. System effects on the pentose cycle and malic enzyme  
The decrease in OxPPP (Figure 9-C) and NonPPP(Figure 10-C) (𝐼𝑅𝑙𝑜𝑤  𝐾
𝑂𝑥𝑃𝑃𝑃 = −0.20, and 
𝐼𝑅𝑙𝑜𝑤  𝐾
𝑁𝑜𝑛𝑂𝑥𝑃𝑃𝑃 = −0.06) were largely exerted by the inhibitory effect of GLY (GLY𝐼𝑅𝑙𝑜𝑤𝐾
𝑂𝑥𝑃𝑃𝑃 =
−0.58) because of glycolytic stimulation (𝐼𝐸𝑙𝑜𝑤𝐾
𝐺𝐿𝑌 = 0.65) coupled with its strong negative 
control over OxPPP. Other inhibitory effects resulted from the control exerted by OxPPP 
(
OxPPP𝐼𝑅𝑙𝑜𝑤𝐾
𝑂𝑥𝑃𝑃𝑃 = −0.37), NAO (NAO𝐼𝑅𝑙𝑜𝑤𝐾
𝑂𝑥𝑃𝑃𝑃 = −0.36), and ATC (ATC𝐼𝑅𝑙𝑜𝑤𝐾
𝑂𝑥𝑃𝑃𝑃 = −0.35) over 
OxPPP coupled with the low K kinetic change. The inhibitory effect due to kinetic stimulation of 
the OxPPP is suspect because of the large uncertainty associated with the negative control this 
block had over its own flux. Although the measured decrease in NonPPP was relatively low 
(𝐼𝑅𝑙𝑜𝑤  𝐾
𝑁𝑜𝑛𝑃𝑃𝑃 = −0.06), the inhibitory effect through GLY (GLY𝐼𝑅𝑙𝑜𝑤𝐾
𝑁𝑜𝑛𝑃𝑃𝑃 = −1.52) and OxPPP 
(
OxPPP𝐼𝑅𝑙𝑜𝑤𝐾
𝑁𝑜𝑛𝑂𝑥𝑃𝑃𝑃 = −1.50) dominated. This is because of the very high control these blocks had 
over NonPPP flux. However, the large negative effect exerted by the OxPPP is suspect, as Monte 
Carlo analysis indicated that 77% of the simulated partial integrated responses through the 
OxPPP were positive, which makes more sense in light of a number of studies showing that the 
pentose cycle increases with increasing oxidative stress (i.e., stimulation of the OxPPP by 
increased NADPH consumption increases flux through the NonPPP). 
The other NADPH producer, ME, was activated (𝐼𝑅𝑙𝑜𝑤𝐾
𝑀𝐸 = 0.12) by low K and the major 
targets contributing to this stimulation were OxPPP, GLY, and PHO (
OxPPP𝐼𝑅𝑙𝑜𝑤  𝐾
𝑀𝐸  = 0.71, 
GLY𝐼𝑅𝑙𝑜𝑤  𝐾
𝑀𝐸 =1.19, and 
PHO𝐼𝑅𝑙𝑜𝑤  𝐾
𝑀𝐸 0.61) (Figure 11-C). Much of the stimulatory effect was offset 
by inhibition through targeting LAC, ME, and GTP (
LAC𝐼𝑅𝑙𝑜𝑤  𝐾
𝑀𝐸  = -1.26, 
ME𝐼𝑅𝑙𝑜𝑤  𝐾
𝑀𝐸  =-0.72, and 
GTP𝐼𝑅𝑙𝑜𝑤  𝐾
𝑀𝐸 = −0.24).  Thus, despite substantial direct kinetic inhibition of ME, kinetic effects 
on GLY and OxPPP mediated primarily through G6P were major factors increasing ME flux. 
197 
 
G.4. System effects on glucose uptake, glycolysis, and lactate production 
The decrease in GTP flux (IR = -0.20) largely resulted from low K targeting of ATC 
( 𝐼𝐴𝑇𝐶 𝑅𝑙𝑜𝑤𝐾
𝐺𝑇𝑃 = −0.39), NAO ( 𝐼𝑁𝐴𝑂 𝑅𝑙𝑜𝑤𝐾
𝐺𝑇𝑃 = −0.32), and OxPPP ( 𝐼𝑂𝑥𝑃𝑃𝑃 𝑅𝑙𝑜𝑤𝐾
𝐺𝑇𝑃 = −0.27). These 
effects (Figure 12-C) were primarily mediated through effects on ATP/ADP and NADH/NAD. 
About 75% of these inhibitory effects were offset by stimulatory effects from low K targeting 
GTP ( 𝐼𝐺𝑇𝑃 𝑅𝑙𝑜𝑤𝐾
𝐺𝑇𝑃 = 0.33), ME ( 𝐼𝑀𝐸 𝑅𝑙𝑜𝑤𝐾
𝐺𝑇𝑃 = 0.20) and PHO ( 𝐼𝑃𝐻𝑂 𝑅𝑙𝑜𝑤𝐾
𝐺𝑇𝑃 = 0.19), leaving a 
modest, but significant, overall decrease in glucose uptake/phosphorylation. 
Glycolytic flux was mildly reduced in low K (𝐼𝑅𝑙𝑜𝑤  𝐾
𝐺𝐿𝑌 =-0.10) primarily because of direct 
kinetic stimulation of OxPPP(
OxPPP𝐼𝑅𝑙𝑜𝑤  𝐾
𝐺𝐿𝑌 = -1.06) and NAO (
NAO𝐼𝑅𝑙𝑜𝑤  𝐾
𝐺𝐿𝑌 = -0.24) and inhibition 
of ATC (
ATC𝐼𝑅𝑙𝑜𝑤  𝐾
𝐺𝐿𝑌 = -0.50) (Figure 13-C). Kinetic stimulation of the OxPPP (𝐼𝐸𝑙𝑜𝑤  𝐾
𝑂𝑥𝑃𝑃𝑃 =
0.56)dominated because of its substantial negative control over glycolysis, which was a function 
of its negative control over G6P and positive control over ATP. Kinetic stimulation of glycolysis 
also contributed (
GLY𝐼𝑅𝑙𝑜𝑤  𝐾
𝐺𝐿𝑌 = -0.39) because of the negative control it had over its own flux 
(which was a function of the control over G6P and ATP/ADP, coupled with the elasticities to 
these metabolites). Given its central position in the system, it is not surprising that a number of 
blocks targeted by low K (LAC, GTP, NPO, NonPPP, ME, and PHO) contributed to 
counteracting much of this inhibition, mostly through effects on ATP, G6P, and pyruvate. The 
NADPH consumer block was a notable exception, as its positive influence on glycolysis (partial 
IR = 0.29) was mediated through negatively affecting NADPH/NADP. 
The rate of lactate production and transportation was essentially unchanged 
(𝐼𝑅𝑙𝑜𝑤  𝐾
𝐿𝐴𝐶 =0.04) (Figure 14-C). This is due to the strong control that many blocks within the 
system had on LAC (OxPPP, ATC, LAC, GTP, GLY, PHO, NPO, NAO). The kinetic 
stimulation of OxPPP, GLY, and NAO in response to low K contribute largely to inhibitory 
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effects on LAC (
OxPPP𝐼𝑅𝑙𝑜𝑤  𝐾
𝐿𝐴𝐶 = −1.25, GLY𝐼𝑅𝑙𝑜𝑤  𝐾
𝐿𝐴𝐶 = −0.49, NAO𝐼𝑅𝑙𝑜𝑤  𝐾
𝐿𝐴𝐶 = −0.57). This 
inhibition was offset by the stimulatory effect of GTP
(GTP𝐼𝑅𝑙𝑜𝑤  𝐾
𝐿𝐴𝐶 = 0.44), LAC (LAC𝐼𝑅𝑙𝑜𝑤  𝐾
𝐿𝐴𝐶 =
0.66) , PHO (PHO𝐼𝑅𝑙𝑜𝑤  𝐾
𝐿𝐴𝐶 = 0.44), NonPPP (NonPPP𝐼𝑅𝑙𝑜𝑤  𝐾
𝐿𝐴𝐶 = 0.44), and NPO (NPO𝐼𝑅𝑙𝑜𝑤  𝐾
𝐿𝐴𝐶 =
0.37) being kinetically changed due to low K coupled with their significant control over LAC.  
These effects of the kinetically changed fluxes were mediated by the strong control each flux had 
on LAC coupled with the elasticity of LAC to NADH/NAD, NADPH/NADP, ATP/ADP. 
G.5. System effects on m producers (PYR and NAO) 
The flux of PYR decreased (𝐼𝑅𝑙𝑜𝑤  𝐾
𝑃𝑌𝑅 = −0.37) despite no direct effects of low K on 
PYR(𝐼𝐸𝑙𝑜𝑤  𝐾
𝑃𝑌𝑅 = 0.05). On the other hand, low K caused kinetic stimulation to NAO (𝐼𝐸𝑙𝑜𝑤  𝐾
𝑁𝐴𝑂 =
0.74) despite the significant reduction in flux (𝐼𝑅𝑙𝑜𝑤  𝐾
𝑁𝐴𝑂 = −0.78) (Figures 15-C and 16-C). The 
flux inhibition of NAO and PYR was largely affected by the low K kinetic changes of PHO 
(
PHO𝐼𝑅𝑙𝑜𝑤  𝐾
𝑁𝐴𝑂 = −1.25, PHO𝐼𝑅𝑙𝑜𝑤  𝐾
𝑃𝑌𝑅 = −0.38). This influence of PHO on PYR and NAO fluxes 
was mainly due to the high control that PHO has on PYR coupled with their strong negative 
elasticity to ∆Ѱm.   Interestingly, the contribution of other blocks to PYR inhibition was minimal 
due to low control each block exerted over PYR. An important finding was that GLY had 
essentially no control over pyruvate oxidation by PYR despite the fact that GLY supplied 74% of 
the pyruvate for use by mitochondria; this implies that pyruvate supply to mitochondria was not 
important to affecting mitochondrial function. The low K stimulation of GLY (
GLY𝐼𝑅𝑙𝑜𝑤  𝐾
𝑁𝐴𝑂 =
−1.06) and OxPPP (OxPPP𝐼𝑅𝑙𝑜𝑤  𝐾
𝑁𝐴𝑂 = −0.43) also contributes to the flux inhibition of NAO due to 
the control each flux had on NAO coupled with the strong elasticity to ATP/ADP. 
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G.6. System effects on the m consumers (PHO and PRL) 
According to the assumption that the leak is not affected by any explicit metabolite 
except m, the system effects(discussed in Section F.2.6.) to m were the only indirect 
changes in PRL (Figure 17-C).Due to the relatively high control of PHO on its own flux, the low 
K kinetic inhibition in PHO (𝐼𝐸𝑙𝑜𝑤  𝐾
𝑃𝐻𝑂 = −1.22)accounted for about 90% (PHO𝐼𝑅𝑙𝑜𝑤  𝐾
𝑃𝐻𝑂 = −0.52)of 
the measured flux inhibition (𝐼𝑅𝑙𝑜𝑤  𝐾
𝑃𝐻𝑂 = −0.57) (Figure18-C). The remainder was due to the low 
kinetic stimulation of GLY (
GLY𝐼𝑅𝑙𝑜𝑤  𝐾
𝑃𝐻𝑂 = −0.12), 
PRL(
PRL𝐼𝑅𝑙𝑜𝑤  𝐾
𝑃𝐻𝑂 = −0.05),NPO(NPO𝐼𝑅𝑙𝑜𝑤  𝐾
𝑃𝐻𝑂 = −0.06),  and the kinetic inhibition of ME 
(
ME𝐼𝑅𝑙𝑜𝑤  𝐾
𝑃𝐻𝑂 = −0.06),  and ATC(ATC𝐼𝑅𝑙𝑜𝑤  𝐾
𝑃𝐻𝑂 = −0.07). 
From our findings, we can propose a mechanism (Figure 19-C) of apoptotic stimuli that 
drive the observed changes in glucose metabolism. Our initial hypothesis was that decreased 
ATP turnover may bring about all other metabolic changes in apoptotic neurons. However, this 
change in ATC cannot account for the entire flux change in PHO, PYR, NAO, GLY blocks. 
Clearly, application of MCA made it easy to quantify the effect of ATC kinetic changes on each 
flux (by the virtue of control of ATC over each block) and to differentiate this from the kinetic 
changes due to low K stimulation. Our results confirmed kinetic changes in most of the system 
blocks including PRL, GLY PHO, OxPPP. These changes cannot rendered to the initial change 
in ATC but rather to kinetic change in enzymes of each block in response to low K stimulus. 
These findings didn't prove our initial hypotheses, but implying a directly targeted metabolic 
reactions by apoptotic stimulus. 
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H. Proposed apoptotic pathway including metabolic direct targets 
From our findings, we can propose a mechanism  (Figure 19-C) of apoptotic stimuli that 
drive the observed changes in glucose metabolism. Our initial hypothesis was that decreased 
ATP turnover may bring about all other metabolic changes in apoptotic neurons. However, and 
despite the observed kinetic inhibition in ATC, this kinetic change cannot explain the other 
kinetic changes in GLY,  GTP, PHO, OxPPP, and PRL blocks.  
Interestingly, the inhibitory effect that this kinetic change in ATC had on the modest 
strong stimulation in PRL was minimal. These findings didn't prove our initial hypotheses, but 
implying a directly targeted metabolic reactions by apoptotic stimulus. 
Trophic factor deprivation-mediated apoptosis in CGNs is suggested to recruit different 
signaling pathways. One of these pathways is Akt/PI3K which is inactivated in response to 
trophic factor deprivation leading to activation of pro-apoptotic BcL-2 family proteins specially 
Bax and Bak and insertion of these proteins in the MOM
68,69
. Activation of Bax and Bak and a 
consequent insertion into MOM may increase MIM proton permeability, however, the 
underlying  mechanism remains unclear. Nevertheless, the finding that Bax interacts with VDAC 
which is in turn interacts with ANT of MIM
12
 as well as the proposed conformational changes of 
ANT to a proton permeable pore may explain the mechanism of induced proton 
permeability
9,10,67
. 
Elevated ROS provide another way for apoptotic signal to proceed. This pathway 
involves activation of pentose phosphate pathway (PPP) in neurons as they normally tend to 
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maintain their intracellular redox status
26
. Activated PPP especially OxPPP increases ATP/ADP 
production and thus reduces glycolysis activity by the virtue of high negative elasticity of GLY 
to ATP/ADP (
OxPPP𝐼𝑅𝑙𝑜𝑤  𝐾
𝐺𝐿𝑌 =  −1.06).This indirect effect was high to overlap the kinetic 
activation in GLY due to apoptotic stimuli leading to the measured net decrease in glycolysis. 
Although small, the kinetic activation of GLY is suggested to maintain the threshold level of 
ATP that is required for impaired mitochondria neurons to avoid death through the ATP-
independent necrotic route. The way through which glycolytic ATP produced and preferred 
during apoptosis may help to understand the complementary glycolytic activation in tumor cells. 
A possible mechanism is by the inhibition of TIGAR causing increased fructose-2,6-
bisphosphate that is a potent activator of PFK-1
55
. The reduced GTP and GLY fluxes was one of 
the unexpected observations because of the low K kinetic activation. However, the strong 
inhibition due to the low K kinetic inhibition of ATC mediated by high control on GLY and GTP 
coupled with high elasticity to ATP (for GLY) and to NADH (for GTP). 
The low K kinetic changes were expected to be relatively close in both NAO and PYR 
since both blocks are sharing many reactions except citric acid cycle and pyruvate/NADH 
transportation into mitochondrial matrix. The finding that NAO is kinetically activated despite 
no kinetic change in PYR is suggesting a possible activation in the respiratory chain during early 
apoptosis which results in stimulated NAO. Such activation in the respiratory chain may be 
restrained by a possible suppression in citric acid cycle enzymes.   
Applying MCA in this study was of great importance to understand the control 
distribution in glucose metabolism in healthy neurons. Importantly, it allows for the first time to 
identify and rank the direct kinetic changes in glucose metabolism of apoptotic neurons. 
Furthermore, these direct changes were not detectable by simply measuring the flux changes 
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during apoptosis because of the local enzymatic features of the system represented in the 
elasticity of enzymes "blocks"  to each explicit metabolite in the system. This effect of 
metabolites  was at some extent maximal in case of PRL block and ∆Ѱ m. Interestingly, the 
system effect (global effect) represented by the control each reaction "block" exerted over the 
flux of one another was contributed to the measured fluxes. This global effect was remarkably 
high in ATC. In this study, the direct kinetic changes were successfully distinguished from the 
indirect changes (caused by enzymatic and system effects) in the proposed model of glucose 
metabolism in neurons  
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Figure 7-C. Partial integrated response (IR) of ATP consumer (ATC) block tokinetic changes (IE) in each 
block of the system due to trophic factor deprivation (low K) . Blocks are; glucose uptake and phosphorylation 
(GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), mitochondrial 
phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose phosphate 
pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic enzyme (ME). 
On the blue arrows, the control that each block exerts over ATC, 𝐶𝑥
𝐴𝑇𝐶 , where x is each block of the system. 
Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect of a block on ATC 
flux. Green arrows are the positive effect on ATC flux. Both green and red arrows thickness reflecting the 
strength of the response acting through each block 
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Figure 8-C. Partial integrated response (IR) of NADPH consumer (NPO) block tokinetic changes (IE) in each 
block of the system due to trophic factor deprivation (low K). Blocks are; glucose uptake and phosphorylation 
(GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), mitochondrial 
phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose phosphate 
pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic enzyme (ME). 
On the blue arrows, the control that each block exerts over NPO, 𝐶𝑥
𝑁𝑃𝑂 , where x is each block of the system. 
Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect of a block on NPO 
flux. Green arrows are the positive effect on NPO flux. Both green and red arrows thickness reflecting the 
strength of the response acting through each block 
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Figure 9-C. Partial integrated response (IR) of oxidative phase of PPP (OxPPP) block tokinetic changes (IE) in 
each block of the system due to trophic factor deprivation (low K) . Blocks are; glucose uptake and 
phosphorylation (GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), 
mitochondrial phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose 
phosphate pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic 
enzyme (ME). On the blue arrows, the control that each block exerts over OxPPP, 𝐶𝑥
𝑜𝑥𝑃𝑃𝑃 , where x is each 
block of the system. Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect 
of a block on OxPPP flux. Green arrows are the positive effect on OxPPP flux. Both green and red arrows 
thickness reflecting the strength of the response acting through each block 
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Figure 10-C. Partial integrated response (IR) of non-oxidative phase of PPP (NonPPP) block tokinetic changes 
(IE) in each block of the system due to trophic factor deprivation (low K) . Blocks are; glucose uptake and 
phosphorylation (GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), 
mitochondrial phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose 
phosphate pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic 
enzyme (ME). On the blue arrows, the control that each block exerts over NonPPP, 𝐶𝑥
𝑁𝑜𝑛𝑃𝑃𝑃 , where x is each 
block of the system. Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect 
of a block on NonPPP flux. Green arrows are the positive effect on NonPPP flux. Both green and red arrows 
thickness reflecting the strength of the response acting through each block 
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Figure 11-C. Partial integrated response (IR) of malic enyzme (ME) block tokinetic changes (IE) in each block 
of the system due to trophic factor deprivation (low K) . Blocks are; glucose uptake and phosphorylation 
(GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), mitochondrial 
phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose phosphate 
pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic enzyme (ME). 
On the blue arrows, the control that each block exerts over ME, 𝐶𝑥
𝑀𝐸 , where x is each block of the system. 
Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect of a block on ME 
flux. Green arrows are the positive effect on ME flux. Both green and red arrows thickness reflecting the 
strength of the response acting through each block 
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Figure 12-C. Partial integrated response (IR) of glucose uptake and transportation (GTP) block tokinetic 
changes (IE) in each block of the system due to trophic factor deprivation (low K). Blocks are; glucose uptake 
and phosphorylation (GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), 
mitochondrial phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose 
phosphate pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic 
enzyme (ME). On the blue arrows, the control that each block exerts over GTP, 𝐶𝑥
𝐺𝑇𝑃 , where x is each block of 
the system. Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect of a 
block on GTP flux. Green arrows are the positive effect on GTP flux. Both green and red arrows thickness 
reflecting the strength of the response acting through each block 
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Figure 13-C.Partial integrated response (IR) of glycolysis (GLY) block to kinetic changes (IE) in each block of 
the system due to trophic factor deprivation (low K). Blocks are; glucose uptake and phosphorylation (GTP), 
pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), mitochondrial phosphorylation 
(PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose phosphate pathway (PPP) 
(OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic enzyme (ME). On the blue 
arrows, the control that each block exerts over GLY, 𝐶𝑥
𝐺𝐿𝑌 , where x is each block of the system. Under the blue 
arrow, the metabolites that mediate IR. Red arrows are the negative effect of a block on GLY flux. Green 
arrows are the positive effect on GLY flux. Both green and red arrows thickness reflecting the strength of the 
response acting through each block 
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Figure 14-C. Partial integrated response (IR) of lactate production and transportation (LAC) block to kinetic 
changes (IE) in each block of the system due to trophic factor deprivation (low K). Blocks are; glucose uptake 
and phosphorylation (GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), 
mitochondrial phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose 
phosphate pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic 
enzyme (ME). On the blue arrows, the control that each block exerts over LAC, 𝐶𝑥
𝐿𝐴𝐶 , where x is each block of 
the system. Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect of a 
block on LAC flux. Green arrows are the positive effect on LAC flux. Both green and red arrows thickness 
reflecting the strength of the response acting through each block 
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Figure 15-C. Partial integrated response (IR) of pyruvate oxidation (PYR) block to kinetic changes (IE) in each 
block of the system due to trophic factor deprivation (low K). Blocks are; glucose uptake and phosphorylation 
(GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), mitochondrial 
phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose phosphate 
pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic enzyme (ME). 
On the blue arrows, the control that each block exerts over PYR, 𝐶𝑥
𝑃𝑌𝑅 , where x is each block of the system. 
Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect of a block on PYR 
flux. Green arrows are the positive effect on PYR flux. Both green and red arrows thickness reflecting the 
strength of the response acting through each block 
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Figure 16-C. Partial integrated response (IR) of NADH oxidation (NAO) block t okinetic changes (IE) in each 
block of the system due to trophic factor deprivation (low K). Blocks are; glucose uptake and phosphorylation 
(GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), mitochondrial 
phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose phosphate 
pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic enzyme (ME). 
On the blue arrows, the control that each block exerts over NAO, 𝐶𝑥
𝑁𝐴𝑂 , where x is each block of the system. 
Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect of a block on NAO 
flux. Green arrows are the positive effect on NAO flux. Both green and red arrows thickness reflecting the 
strength of the response acting through each block 
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Figure 17-C. Partial integrated response (IR) of proton leak (PRL) block to kinetic changes (IE) in each block 
of the system due to trophic factor deprivation (low K). Blocks are; glucose uptake and phosphorylation 
(GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), mitochondrial 
phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose phosphate 
pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic enzyme (ME). 
On the blue arrows, the control that each block exerts over PRL, 𝐶𝑥
𝑃𝑅𝐿 , where x is each block of the system. 
Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect of a block on PRL 
flux. Green arrows are the positive effect on PRL flux. Both green and red arrows thickness reflecting the 
strength of the response acting through each block 
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Figure 18-C. Partial integrated response (IR) of phosphorylation (PHO) block to kinetic changes (IE) in each 
block of the system due to trophic factor deprivation (low K). Blocks are; glucose uptake and phosphorylation 
(GTP), pyruvate oxidation (PYR), lactate production (LAC), NADH oxidation (NAO), mitochondrial 
phosphorylation (PHO), proton leak (PRL), ATP consumers (ATC), oxidative-phase of pentose phosphate 
pathway (PPP) (OxPPP), NADPH oxidation (NPO), non-oxidative PPP (NonPPP), and malic enzyme (ME). 
On the blue arrows, the control that each block exerts over PHO, 𝐶𝑥
𝑃𝐻𝑂 , where x is each block of the system. 
Under the blue arrow, the metabolites that mediate IR. Red arrows are the negative effect of a block on PHO 
flux. Green arrows are the positive effect on PHO flux. Both green and red arrows thickness reflecting the 
strength of the response acting through each block 
 
216 
 
 
 
 
 
 
 
 
 
 
 
Activated PPP
?
High ROS/BcL-2 family proteins
Mitochondrial dysfunction
•MMP
•MOMP
Mito (VDAC + ANT)
Akt
Activated glycolysis
Increased ATP
Caspases activation
Apoptosis hallmarks
•DNA laddering
•Chromosome condensation
(-)
Apoptotic 
signal
High ROS
Mito (proton pores)
Activated PRL
Inactive TIGAR
Inhibited ATC
Low Ca 2+ cycling
(-)
?
Inhibited  PHO
(-)
(-)
Inhibited ATC
(-)
Activated GTP
Activated OxPPP
Figure 19-C. A proposed mechanism of the apoptotic pathway that triggers direct metabolic changes in apoptotic 
CGNs. Apoptotic signaling recruits pro-apoptotic proteins (i.e. BcL-2 family protein) through Akt-mediated 
signaling pathway. Activated BcL-2 family proteins induce mitochondrial dysfunction by promoting formation of 
proton pores from adenine nucleotide translocase (ANT) leading to increased proton leak rate (PRL) and 
dissipated mitochondrial membrane potential (MMP). Dysfunctional mitochondria triggers activation of 
glycolysis to achieve a threshold ATP level. One of ATP-dependent pro-apoptotic proteins is caspase enzymes 
that trigger proteolysis of cellular contents. Apoptosis can proceed through ROS-mediated signaling pathway. 
Activated pentose phosphate pathway may be one of its direct targets which indirectly inactivates glycolysis 
through controlling ATP level. A mechanism that may explain the reduced total response of glycolysis to 
apoptosis. On the other hand the mechanism through which glucose uptake and phosphorylation block was 
activated is poorly understood, however, activated PPP may cause indirect activation of glucose (GTP).Blocks in 
green are the metabolic direct targets of apoptosis. Dashed arrows representing the indirect effects of low K 
kinetic changes of the system blocks . Green blocks are the major apoptotic targets in glucose metabolic pathway. 
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